<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
- ----- EXCHANGE ACT OF 1934.
For the quarterly period ended June 30, 1998.
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
- ----- EXCHANGE ACT OF 1934.
For the transition period from to .
------------- --------------
Commission file number 000-27056
Medirisk, Inc.
(Exact name of registrant as specified in its charter)
Delaware 58-2256400
- --------------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
Two Piedmont Center, Suite 400, 3565 Piedmont Rd., Atlanta, Georgia 30305
- --------------------------------------------------------------------------------
(Address of principal executive office) (Zip code)
Registrant's Telephone Number Including Area Code: (404) 364-6700
--------------------------
Indicate by check mark whether the registrant: (1) has filed all
reports required to be filed by Section 13 or 15 (d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports); and (2) has been subject to such
filing requirements for the past 90 days. Yes x No
--- ---
The number of shares outstanding of the issuer's only class of Common
Stock, $0.001 par value as of August 12, 1998 was 7,230,370.
-1-
<PAGE> 2
PART I - FINANCIAL INFORMATION
ITEM 1 - FINANCIAL STATEMENTS
MEDIRISK, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
(Amounts in thousands)
<TABLE>
<CAPTION>
(UNAUDITED)
6/30/98 12/31/97
----------- ---------
<S> <C> <C>
CURRENT ASSETS
Cash and cash equivalents $23,460 $ 3,516
Accounts receivable, less allowance for
doubtful accounts of $386 and $148 at June 30, 1998
and December 31, 1997, respectively 6,103 3,802
Prepaid expenses 1,230 697
Other current assets 654 475
------- -------
Total current assets 31,447 8,490
------- -------
Property and equipment 4,942 3,083
Less accumulated depreciation and amortization 1,878 1,444
------- -------
Property and equipment, net 3,064 1,639
------- -------
Excess of cost over net assets of businesses acquired, less accumulated
amortization of $899 and $537 at June 30, 1998 and
December 31, 1997, respectively 17,102 7,556
Intangible assets, less accumulated amortization of $629 and $409 at
June 30, 1998 and December 31, 1997, respectively 2,757 1,794
Software development costs, less accumulated amortization of $157
and $97 at June 30, 1998 and December 31, 1997, respectively 2,011 1,008
Other assets 646 171
------- -------
Total other assets 22,516 10,529
------- -------
Total assets $57,027 $20,658
======= =======
</TABLE>
-2-
<PAGE> 3
MEDIRISK, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
(Amounts in thousands, except per share data)
<TABLE>
<CAPTION>
(UNAUDITED)
6/30/98 12/31/97
----------- ---------
<S> <C> <C>
CURRENT LIABILITIES
Accounts payable $ 352 $ 258
Accrued expenses 1,798 758
Income taxes payable 771 816
Current installments of long-term debt and obligations
under capital leases 161 168
Deferred revenue 3,157 2,309
-------- --------
Total current liabilities 6,239 4,309
Long-term debt and obligations under capital leases,
excluding current installments 34 165
-------- --------
Total liabilities 6,273 4,474
STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value; 1,000 shares authorized;
none outstanding -- --
Common stock - $0.001 par value; 20,000 shares authorized;
7,201 and 4,193 shares issued and outstanding at
June 30, 1998 and December 31, 1997, respectively 7 4
Additional paid in capital 76,157 28,559
Accumulated deficit (25,410) (12,379)
-------- --------
Total stockholders' equity 50,754 16,184
-------- --------
Total liabilities and stockholders' equity $ 57,027 $ 20,658
======== ========
</TABLE>
See accompanying notes to consolidated condensed financial statements.
-3-
<PAGE> 4
MEDIRISK, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
(Amounts in thousands, except per share data)
<TABLE>
<CAPTION>
THREE MONTHS SIX MONTHS
ENDED JUNE 30, ENDED JUNE 30,
----------------------- -----------------------
1998 1997 1998 1997
-------- -------- -------- --------
<S> <C> <C> <C> <C>
Revenue $ 5,415 $ 3,243 $ 10,592 $ 5,893
Salaries, wages and benefits 2,964 1,718 5,539 3,480
Other operating expenses 1,572 894 3,094 1,539
Depreciation and amortization 651 249 1,079 450
Acquired in-process research and development costs
and integration costs 8,599 3,100 13,914 3,100
-------- -------- -------- --------
Operating loss (8,371) (2,718) (13,034) (2,676)
Interest income (expense), net (34) 157 3 197
-------- -------- -------- --------
Loss before extraordinary item (8,405) (2,561) (13,031) (2,479)
Extraordinary item - loss on early extinguishment of debt -- -- -- (806)
-------- -------- -------- --------
Net loss (8,405) (2,561) (13,031) (3,285)
Convertible preferred stock dividend requirement -- -- -- (25)
-------- -------- -------- --------
Net loss attributable to common stock $ (8,405) $ (2,561) $(13,031) $ (3,310)
======== ======== ======== ========
Net loss per share of common stock - basic and diluted:
Loss per share before extraordinary item $ (1.59) $ (0.63) $ (2.67) $ (0.68)
Loss per share - extraordinary item -- -- -- (0.22)
-------- -------- -------- --------
Net loss per share of common stock $ (1.59) $ (0.63) $ (2.67) $ (0.90)
======== ======== ======== ========
Weighted average number of common shares outstanding -
basic and diluted 5,275 4,051 4,885 3,658
======== ======== ======== ========
</TABLE>
See accompanying notes to consolidated condensed financial statements.
-4-
<PAGE> 5
MEDIRISK, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(Amounts in thousands)
<TABLE>
<CAPTION>
SIX MONTHS
ENDED JUNE 30,
-----------------------
1998 1997
-------- --------
<S> <C> <C>
Cash flows from operating activities:
Net loss $(13,031) $ (3,285)
Adjustments to reconcile net loss to net cash used in
operating activities:
Acquired in-process research and development costs 13,500 3,100
Depreciation and amortization 1,079 450
Loss due to early extinguishment of debt -- 806
Decrease (increase) in:
Accounts receivable (1,939) 257
Other assets (976) 80
Increase (decrease) in:
Accounts payable (577) (504)
Accrued expenses and other liabilities (1,322) (458)
Deferred revenue 157 (938)
-------- --------
Net cash used in operating activities (3,109) (492)
-------- --------
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired (14,309) (3,533)
Purchases of property and equipment (1,001) (253)
Additions to software development costs (811) (242)
Loan to officer 23 23
-------- --------
Net cash used in investing activities (16,098) (4,005)
-------- --------
Cash flows from financing activities:
Proceeds from issuance of common stock 40,998 22,614
Payments of dividends -- (643)
Payments on long-term debt and obligations under capital leases (1,847) (8,726)
-------- --------
Net cash provided by financing activities 39,151 13,245
-------- --------
Net increase in cash and cash equivalents 19,944 8,748
Cash and cash equivalents at beginning of period 3,516 447
-------- --------
Cash and cash equivalents at end of period $ 23,460 $ 9,195
======== ========
Acquisitions of businesses:
Fair value of assets acquired $ 10,419 $ 2,896
Acquired in-process research and development costs 13,500 3,100
Fair value of liabilities assumed (5,492) (1,578)
Common stock issued (6,603) (792)
Contingent consideration paid 3,000 --
-------- --------
Total cash paid for acquisitions 14,824 3,626
Cash acquired (515) (93)
-------- --------
Net cash paid for acquisitions $ 14,309 $ 3,533
======== ========
</TABLE>
See accompanying notes to consolidated condensed financial statements.
-5-
<PAGE> 6
MEDIRISK, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(UNAUDITED)
1. GENERAL:
The consolidated condensed financial statements as of June 30, 1998 and
for the six month and three month periods ended June 30, 1998 and 1997 are
unaudited. In the opinion of management, all adjustments, consisting of normal
recurring accruals, necessary for the fair presentation of the consolidated
financial position and results of operations and cash flows for the periods
presented have been included. Results for the interim period are not necessarily
indicative of results that may be expected for the full year.
These consolidated condensed financial statements should be read in
conjunction with the consolidated financial statements and notes included in the
Annual Report on Form 10-K of Medirisk, Inc. ("Medirisk" or the "Company") for
the year ended December 31, 1997.
2. MAJOR CUSTOMERS:
One customer accounted for 9% and 15% of the Company's revenue for the
six months ended June 30, 1998 and 1997, respectively.
3. LOSS PER SHARE OF COMMON STOCK:
Loss per share of Common Stock for all periods presented are based on
the weighted average shares of Common Stock outstanding. Loss per share does not
include the effect of outstanding Common Stock equivalents because the effect is
antidilutive.
4. LINE OF CREDIT:
In June 1998 the Company entered into an Amended and Restated Credit
Agreement with NationsBank under which a $25 million revolving credit facility
(the "NationsBank Revolver") was made available to the Company. The NationsBank
Revolver is available to fund working capital needs as well as new product
development and acquisitions.
5. FOLLOW-ON OFFERING:
In June 1998 the Company completed a follow-on offering of 2,250,000
shares of Common Stock. As a result of the offering, the Company received
approximately $40.5 million, net of offering costs of approximately $600,000.
6. ACQUISITIONS:
Effective March 23, 1998, the Company acquired all of the outstanding
shares of Healthdemographics of San Diego, California, which provides databases
and decision-support applications to forecast the supply of and demand for
health care services, for $2.7 million in cash, 171,315 shares of the Company's
common stock. The acquisition was accounted for using the purchase method of
accounting with the results of operations of the business acquired included in
the Company's results of operations from the effective date of the acquisition.
The acquisition resulted in purchased in-process research and development costs
of $5.3 million, acquired products of $500,000, and excess of cost over net
assets acquired of $1.1 million. Potential contingent consideration will be paid
by the Company based upon a multiple of
-6-
<PAGE> 7
Healthdemographics' operating income over a predetermined amount through the
year 2000. These potential payments could be significant. Contingent
consideration ultimately paid will be added to excess of cost over net assets
acquired and amortized prospectively. The contingent consideration will be paid
by the Company in cash and common stock or a newly designated Series 1998 - A
Redeemable Preferred Stock.
Effective May 28, 1998, the Company acquired all of the outstanding
shares of Successful Solutions, Inc. of Vidalia, Georgia, which provides
decision-support tools, consulting services and training materials to hospitals
and physician group practices to assist them in improving patient outcomes,
achieving the efficient delivery of care and establishing billing and coding
practices that comply with industry requirements. Medirisk purchased Successful
Solutions for $2.9 million in cash, and 189,811 shares of the Company's common
stock. The acquisition was accounted for using the purchase method of accounting
with the results of operations of the business acquired included in the
Company's results of operations from the effective date of the acquisition. The
acquisition resulted in estimated purchased in-process research and development
costs of $4.0 million, estimated acquired products of $250,000 and estimated
excess of cost over net assets acquired of $1.6 million. Potential contingent
consideration will be paid by the Company based upon a multiple of Successful
Solutions' operating income over a predetermined amount through the year 1999.
These payments could be significant. Contingent consideration ultimately paid
will be added to excess of cost over net assets acquired and amortized
prospectively. The contingent consideration will be paid by the Company in cash
and common stock.
Effective June 25, 1998, the Company acquired all of the outstanding
shares of Sweetwater Health Enterprises, Inc. of Dallas, Texas, which provides a
comprehensive selection of physician credentialing services to hospitals and
managed care organizations to evaluate professional relationships with
physicians and secure accreditation by industry associations. In addition,
Sweetwater provides a suite of quality management software used by healthcare
organizations to facilitate in-house credentialing and network management, as
well as track perceptions of care and individual physician performance.
Sweetwater also provides managed care and interim management services for
health care organizations throughout the country. Medirisk purchased Sweetwater
for $6.2 million in cash. The acquisition was accounted for using the purchase
method of accounting with the results of operations of the business acquired
included in the Company's results of operations from the effective date of the
acquisition. The acquisition resulted in estimated purchased in-process research
and development costs of $4.3 million, estimated acquired products of $250,000
and estimated excess of cost over net assets acquired of $4.2 million.
The unaudited pro forma results of operations of the Company for the
six months ended June 30, 1998 and the year ended December 31, 1997 as if the
acquisitions described above and the Company's acquisitions in 1997 of CIVS,
Inc. and CareData Reports, Inc. had been effective January 1, 1997 is summarized
as follows:
<TABLE>
<CAPTION>
SIX MONTHS YEAR ENDED
ENDED JUNE 30, DECEMBER 31,
1998 1997
-------------- ------------
(in thousands)
<S> <C> <C>
Revenue $ 14,772 $ 33,542
======== ========
Loss before extraordinary item $ (4,517) $ (573)
Extraordinary item - Loss on early extinguishment of debt -- (806)
-------- --------
Net loss (4,517) (1,379)
Convertible preferred stock dividend requirement -- (25)
-------- --------
Net loss attributable to common stock $ (4,517) $ (1,404)
======== ========
Net loss per share of common stock - basic and diluted:
Loss per share before extraordinary item $ (0.88) $ (0.13)
Loss per share - extraordinary item -- (0.18)
-------- --------
Net loss per share of common stock $ (0.88) $ (0.31)
======== ========
Weighted average number of common shares outstanding 5,124 4,404
======== ========
</TABLE>
-7-
<PAGE> 8
The unaudited pro forma results do not reflect the charges for acquired
in-process research and development costs discussed above. The unaudited pro
forma results do not necessarily represent results which would have occurred if
the acquisitions had taken place on the dates indicated nor are they necessarily
indicative of the results of future operations.
Many of the Company's acquisition agreements provide for the payment of
contingent consideration based upon the performance of the acquired businesses
over a prescribed period of time. If such acquired businesses exceed the
relevant performance goals, the Company will be required to make additional
payments, which could be material. In connection with the CareData acquisition,
additional consideration of $3.0 million was paid in April 1998, was added to
excess of cost over assets acquired, and is being amortized on a prospective
basis.
7. Subsequent Events:
The Company and certain of its officers and directors are named as
defendants in three purported securities class action lawsuits entitled Richard
Sturm v. Medirisk, Inc., et al. (Civil Action No. 1-98-CV-1922), John T.
Gallagher v. Medirisk, Inc., et al. (Civil Action No. 1-98-CV-2099), and
Frederick T. Casiello v. Medirisk, Inc., et al. (Civil Action No. 1-98-CV-2100).
The Sturm action was filed on July 9, 1998. The Gallagher and Casiello actions
were each filed on July 24, 1998. Each of these lawsuits is pending in the
United States District Court for the Northern District of Georgia. The
complaints in these lawsuits allege that the Company violated federal securities
laws by failing to disclose in its public statements and/or the Registration
Statement/Prospectus for its June 11, 1998, follow-on offering: (i) that the
Company's operating results for the second quarter of 1998 would be below
analysts' expectations and a departure from prior historical financial results;
(ii) that demand for its Market Performance and Physician Credentialing Products
was weakening such that sales would continue to slow for the remainder of the
fiscal year; and (iii) that the Company was preparing to change sales
management, implement new product distribution channels and introduce new
product enhancements as a result of weakening demand for its products. The Sturm
complaint asserts claims based on Sections 10(b) and 20(a) of the Securities
Exchange Act of 1934 and Rule 10b-5, the Casiello complaint alleges claims under
Sections 11 and 15 of the Securities Act of 1933, and the Gallagher complaint
asserts claims based on Sections 11, 12(a)(2) and 15 of the 1993 Act. All of the
plaintiffs seek compensatory damages and reimbursement of their attorney's fees
and costs. Because of the uncertainty of the litigation process, the Company
cannot predict the outcome of these cases and, therefore, it is possible that
their outcome could have a material adverse effect on the Company. The Company
believes that plaintiffs' claims have no merit and intends to defend these cases
vigorously.
On July 29, 1998 the Company adopted a Shareholder Protection Rights
Agreement. The Rights under this agreement will cause substantial dilution to a
person or group that attempts to acquire the Company on terms not approved by
the Board of Directors of the Company.
ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
OVERVIEW
Medirisk is a provider of proprietary database products,
decision-support software and analytical services to the healthcare industry.
The Company's products and services enable its customers to make objective
comparisons of the financial costs and clinical outcomes of physician services
to customer-specific and industry benchmarks, assess member satisfaction with
specific managed care plans, and obtain information concerning the background
and credentials of physicians. These capabilities assist health care industry
participants in measuring the performance of health care payers and providers
and forecasting the supply of and demand for health care services.
8
<PAGE> 9
Applications of Medirisk's products include pricing managed care
contracts, evaluating physician fee schedules and utilization of physician
services, comparing provider outcomes and health plan performance, credentialing
and recruiting physicians, developing health care delivery networks, and
marketing health care services. The Company actively sells its products to over
1,000 major customers, including leading health plans, insurers, hospitals,
large multi-specialty physician groups, physician practice management companies,
employers, equipment suppliers and pharmaceutical companies, as well as several
hundred smaller customers, including single-specialty physician groups. Medirisk
believes that it is the leading provider of clinical and financial database
products comprised of physician-oriented content and managed care member
satisfaction information in the United States.
ACQUISITIONS
Following the completion of its initial public offering in January
1997, Medirisk significantly expanded its operations by acquiring four companies
in 1997 (the "1997 Acquisitions") and three companies in 1998 (the "1998
Acquisitions"). The acquisition of businesses with complementary products and
services has broadened the Company's customer base, created additional
cross-selling opportunities, increased market share within existing products and
resulted in new product extensions and enhancements. The following summarizes
these recent transactions.
- In May 1997, Medirisk acquired substantially all of the assets of
Staff-Link, Inc. ("Staff-Link") of St. Louis, Missouri, a provider of a
physician database and related software utilities designed to assist
healthcare organizations with their in-house recruiting efforts.
Staff-Link's customer base increased the market share of the Company's
physician credentials products.
- In June 1997, Medirisk acquired CIVS, Inc. ("CIVS") of Rockville,
Maryland, a leading national provider of physician credentialing
services and information products to health care organizations. The
acquisition of CIVS added new customers to the Company's physician
credentials product line and broadened the range of products and
outsourced services offered by the Company.
- In August 1997, Medirisk acquired CareData Reports, Inc. ("CareData")
of New York, New York, which creates reports analyzing consumer
satisfaction with more than 150 aspects of managed health care plans
and ranks specific health plans accordingly. CareData's products are
used by managed care plans to assess their competitive position and
quality of care, by employers to evaluate health plans and by
pharmaceutical companies to target potential markets for their
products.
-9-
<PAGE> 10
- In November 1997, Medirisk acquired Medsource, Inc. ("Medsource") of
St. Paul, Minnesota, which licenses databases of physician information
for use in recruiting physicians and developing health care networks.
The acquisition strengthened the Company's physician credentials
product line and extended the application of these products to the
administrative and the marketing functions of health care
organizations.
- In March 1998, Medirisk acquired Healthdemographics of San Diego,
California, which provides databases and decision-support applications
to forecast the supply of and demand for health care services.
Health care delivery organizations, insurers, equipment suppliers,
consultants and other health care industry participants use the
proprietary demographic and market segmentation information and
software provided by Healthdemographics to make more informed business
decisions regarding strategic planning and market planning and
analysis. The acquisition of Healthdemographics resulted in an
expansion of the Company's market performance products and customer
base.
- In May 1998, Medirisk acquired Successful Solutions, Inc. ("Successful
Solutions") of Vidalia, Georgia, which provides decision-support tools,
consulting services, and training materials to hospitals and physician
group practices to assist them in improving patient outcomes, achieving
the efficient delivery of care and establishing billing and coding
practices that comply with industry requirements. Successful Solutions
collects clinical and billing record data from its customers and
profiles the relative performance of individual physicians using its
analytical tools and statistical algorithms. Successful Solutions
implements on-site education through physician consultants and medical
record specialists to influence physician behavior and promote the
effective and efficient delivery of health care. Successful Solutions'
tools and services for bill coding and medical record documentation
help its customers achieve optimal and appropriate reimbursement for
services delivered, while improving the quality of data for future
comparative analysis.
- In June 1998, Medirisk acquired Sweetwater Health Enterprises, Inc.
("Sweetwater") of Dallas, Texas, which offers a comprehensive selection
of physician credentialing services to hospitals and managed care
organizations to evaluate professional relationships with physicians
and secure accreditation by industry associations. In addition,
Sweetwater provides a suite of quality management software used by
health care organizations to facilitate in-house credentialing and
network management, as well as to track perceptions of care and
individual physician performance. Sweetwater also provides managed
care consulting and interim management services for health care
organizations throughout the country.
In connection with these acquisitions, the Company acquired intangible
assets which are being amortized over various useful lives. The amortization
periods are based on, among other things, the nature of the products and
markets, the competitive position of the acquired companies and the adaptability
to changing market conditions of the acquired companies.
Also in connection with the recent acquisitions, the Company recorded
non-recurring charges related to acquired in-process research and development
costs of $3.1 million for CIVS, $975,000 for CareData, $300,000 for Medsource,
$5.3 million for Healthdemographics, $4.0 million for Successful Solutions and
$4.3 million for Sweetwater. The amount of each of these non-recurring charges
was equal to the estimated current fair value, based on the adjusted cash flows
(discounted by a risk-adjusted weighted average cost of capital of 24% for CIVS
and CareData, 25% for Successful Solutions and Sweetwater, and 29% for Medsource
and Healthdemographics) of specifically identified technologies for which
technological feasibility had not yet been established pursuant to Statement of
Financial Accounting Standards No. 86, "Accounting for the Costs of Computer
Software to be Sold, Leased or Otherwise Marketed" and for which future
alternative uses did not exist. Similar charges could result in the future as a
result of additional acquisitions accounted for as purchases. The Company also
incurred approximately $65,000 and $349,000 of integration costs during the
first and second quarters of 1998, respectively. The Company estimates that it
will incur additional integration costs of approximately $400,000 in connection
with the acquisitions of each of Healthdemographics and Successful Solutions and
$800,000 in connection with the acquisition of Sweetwater, all during the
remainder of 1998 and the first half of 1999.
As a result of the 1997 Acquisitions and 1998 Acquisitions, the
Company's historical financial statements are not representative of financial
results to be expected for future periods. See Note 2 of Notes to Consolidated
Financial Statements of the Company.
-10-
<PAGE> 11
SOURCES OF REVENUE
The Company provides services and licenses its products primarily
pursuant to single- and multi-year contracts that provide for the payment of
non-refundable annual fees or quarterly fees that are generally billed in
advance of service delivery. The products and services consist of market
performance, clinical performance and physician credentials products.
The market performance products provide customers with information from
the Company's market performance product databases. Revenue from these sales is
recognized upon the delivery of the data. The Company also licenses the
exclusive right to market the results of its managed care consumer satisfaction
surveys. Revenue from the licenses of disease-specific customized surveys to the
pharmaceutical industry is recognized as the related costs of producing the
survey are incurred, and revenue from non-customized data licensing is
recognized upon delivery. The clinical performance products revenues relate to
the delivery of services and are recognized over the contract terms as the
services are provided. The physician credentials products consist of (i) data
and services provided to customers over time, for which revenue is recognized
ratably over the life of the contract; (ii) credentials reports that validate
physicians' education, training and other matters, for which revenue is
recognized upon delivery of the completed reports; and (iii) physician
credentialing information products and software utility tools, for which revenue
is recognized upon the delivery of the data and software. Customer service
revenues are recognized ratably over the service contract period. All other
revenue, including fees for training, consulting fees and other miscellaneous
services, is recognized upon the completion of the applicable services.
The Company's three groups of products contribute varying percentages
of the Company's total revenue from quarter to quarter based on a variety of
factors, including, without limitation, the timing and size of acquisitions and
the differences in seasonality among the groups of products. Of its total
revenue for the year ended December 31, 1997, the Company derived approximately
37% from market performance products, approximately 20% from clinical
performance products and approximately 43% from physician credentials products.
Of its total revenue for the quarter ended June 30, 1998, the Company derived
approximately 38% from market performance products, approximately 23% from
clinical performance products and approximately 39% from physician credentials
products. Of its total revenue for the six months ended June 30, 1998, the
Company derived approximately 43% from Market performance products,
approximately 18% from clinical performance products and approximately 39% from
physician credentials products.
The Company's revenue is composed of both recurring revenue from the
Company's current customer base as well as revenue from new customers. The
Company defines its recurring revenue percentage with respect to any particular
period as the quotient, expressed as a percentage, of (i) revenue recognized
during such period from a sale of a product to a customer who purchased a
similar product in the prior period divided by (ii) the company's total revenue
in the prior period. In determining its recurring revenue percentage, the
Company includes in its revenue the revenue of entities acquired during the
period as if such acquisitions had occurred at the beginning of the prior
period. The Company does not include revenue in its recurring revenue percentage
to the extent that such revenue exceeds total revenue in the prior period. The
Company's recurring revenue percentage has been in excess of 70% for each of the
last four years.
-11-
<PAGE> 12
RESULTS OF OPERATIONS
The following table sets forth, for the fiscal periods indicated,
certain items from the statements of operations of the Company expressed as a
percentage of revenue:
<TABLE>
<CAPTION>
THREE MONTHS SIX MONTHS
STATEMENTS OF OPERATIONS: ENDED JUNE 30, ENDED JUNE 30,
-------------------- --------------------
1998 1997 1998 1997
-------- -------- -------- --------
<S> <C> <C> <C> <C>
Revenue 100% 100% 100% 100%
Salaries, wages and benefits 55 53 53 59
Other operating expenses 29 27 29 26
Depreciation and amortization 12 8 10 8
Acquired in-process research and
development costs and integration costs 159 96 131 52
---- ---- ---- ----
Operating loss (155) (84) (123) (45)
Interest income (expense), net -- 5 -- 3
---- ---- ---- ----
Loss before extraordinary item (155) (79) (123) (42)
Extraordinary item: loss on early extinguishment of debt -- -- -- (14)
---- ---- ---- ----
Net loss (155)% (79)% (123)% (56)%
==== ==== ==== ====
</TABLE>
QUARTER ENDED JUNE 30, 1998 COMPARED TO QUARTER ENDED JUNE 30, 1997
Revenue. Revenue for the three months ended June 30, 1998 was $5.4
million, an increase of $2.2 million or 67% over the same period in the prior
year. The increase was primarily attributable to the 1998 and 1997 acquisitions.
Revenue associated with the 1998 Acquisitions and 1997 Acquisitions represented
$2.2 million of the total increase. The Company's revenue excluding acquisitions
decreased 2% for the first quarter of 1998 over the first quarter of 1997 as a
result of low new business revenue for the Company's financial products product
set. The decrease in new business revenue resulted from the Company's failure to
close identified sales opportunities consistent with historical patterns and
expectations.
Salaries, wages and benefits. Salaries, wages and benefits for the
three months ended June 30, 1998 were $3.0 million, an increase of $1.2 million
or 73% over the same period in the prior year. The increase was primarily the
result of the 1998 Acquisitions and 1997 Acquisitions and incremental expenses
associated with internal growth. Salaries, wages and benefits as a percentage of
revenue increased to 55%, up from 53% in the same period in the prior year, as a
result of slower than expected revenue growth in the Company's financial
products and outsourced credentialing product sets.
Other operating expenses. Other operating expenses for the three months
ended June 30, 1998 were $1.6 million, an increase of $678,000 or 76% over the
same period in the prior year. This increase is primarily related to costs
associated with the 1998 Acquisitions and 1997 Acquisitions. Other operating
expenses as a percentage of revenue increased to 29%, up from 27% in the same
period in the prior year, primarily as a result of differences in expense
structures of the acquired companies.
Depreciation and amortization. Depreciation and amortization expenses
for the three months ended June 30, 1998 were $652,000, an increase of $402,000
or 161% over the same period in the prior year. The increase was primarily the
result of the amortization of intangible assets acquired in the 1998
Acquisitions and 1997 Acquisitions; consequently, depreciation and amortization
as a percentage of revenue increased to 12% compared to 8% in the same period in
the prior year.
Acquired in-process research and development costs and integration
costs. Acquired in-process research and development costs and integration costs
for the three months ended June 30, 1998 were $8.6 million as compared to $3.1
million in the same period in the prior year. In connection with the
acquisitions of Sweetwater and Successful Solutions in 1998, the Company
recorded non-recurring charges resulting from expensing the acquired in-process
research and development costs of $4.3 million and $4.0 million, respectively.
Integration costs for the three months ended June 30, 1998 were $349,000 as
compared to $0 in the same period in the prior year. These integration charges
were associated with the 1997 Acquisitions and the acquisition of
Healthdemographics in 1998.
Interest income (expense), net. Net interest expense for the three
months ended June 30, 1998 was $34,000, compared to net interest income of
$157,000 for the same period in the prior year. The net interest expense
resulted from borrowings in 1998 to fund the acquisitions of Healthdemographics
and Successful Solutions
-12-
<PAGE> 13
and the contingent consideration payment of $3.0 million made to CareData in
April 1998. In the same period in the prior year, the Company had no outstanding
borrowings under its credit line and generated interest income on the proceeds
remaining from its initial public offering.
SIX MONTHS ENDED JUNE 30, 1998 COMPARED TO SIX MONTHS ENDED JUNE 30, 1997
Revenue. Revenue for the six months ended June 30, 1998 was $10.6
million, an increase of $4.7 million or 80% over the same period in the prior
year. The increase was primarily attributable to the 1998 Acquisitions and
1997 Acquisitions. Revenue associated with the 1998 and 1997 acquisitions
represented $3.3 million or 71% of the total increase. The Company's revenue
excluding acquisitions represented $1.4 million or 29% of the total increase for
the first six months of 1998 over the first six months of 1997 due to internal
growth.
Salaries, wages and benefits. Salaries, wages and benefits for the six
months ended June 30, 1998 were $5.5 million, an increase of $2.1 million or 59%
over the same period in the prior year. The increase was primarily the result of
the 1998 Acquisitions and 1997 Acquisitions and incremental expenses associated
with internal growth. Salaries, wages and benefits as a percentage of revenue
decreased to 53% from 59% in the same period in the prior year. This decrease
resulted primarily from leveraging personnel investments made during 1997 as
revenue increased through acquisitions and internal growth.
Other operating expenses. Other operating expenses for the six months
ended June 30, 1998 were $3.1 million, an increase of $1.6 million or 101% over
the same period in the prior year. This increase is primarily related to costs
associated with the 1998 Acquisitions and 1997 Acquisitions. Other operating
expenses increased as a percentage of revenue to 29% as compared to 26% in
the same period in the prior year primarily as a result of differences in
expense structures of the acquired companies.
Depreciation and amortization. Depreciation and amortization expenses
for the six months ended June 30, 1998 were $1.1 million, an increase of
$629,000 or 140% over the same period in the prior year. The increase was
primarily the result of the amortization of intangible assets acquired in the
1998 Acquisitions and 1997 Acquisitions; consequently, depreciation and
amortization as a percentage of revenue increased to 10% compared to 8% in the
same period in the prior year.
Acquired in-process research and development costs and integration
costs. Acquired in-process research and development costs and integration costs
for the six months ended June 30, 1998 were $13.9 million, an increase of $10.8
million or 349% over the same period in the prior year. In connection with the
acquisitions of Sweetwater, Successful Solutions and Healthdemographics in 1998,
the Company recorded non-recurring charges resulting from expensing the acquired
in-process research and development costs of $4.3 million, $4.0 million and $5.3
million, respectively. Integration costs for the six months ended June 30, 1998
were $349,000 as compared to $0 in the same period in the prior year. These
integration charges were associated with the 1997 Acquisitions and the
acquisition of Healthdemographics.
Interest income, net. Net interest income for the six months ended June
30, 1998 was $3,000, compared to net interest income of $197,000 for the same
period in the prior year. The decrease in net interest income resulted from
borrowings in 1998 to fund the acquisitions of Healthdemographics and Successful
Solutions and a $3.0 million payment of the contingent consideration to the
former shareholders of CareData in April 1998. In the same period in the prior
year, the Company had no outstanding borrowings under its credit line and
generated interest income on the proceeds remaining from its initial public
offering.
Extraordinary items. The Company recorded an extraordinary loss for the
six months ended June 30, 1997 of $806,000 related to a one-time, non-recurring,
non-cash charge for bond discount and debt issue cost associated with the early
extinguishment of debt.
LIQUIDITY AND CAPITAL RESOURCES
The Company had working capital of $25.2 million as of June 30, 1998 as
compared to working capital of $4.2 million at December 31, 1997. The increase
was due primarily to the proceeds from the follow-on stock offering completed by
the Company in June 1998.
-13-
<PAGE> 14
Net cash used by operating activities totaled $3.1 million for the six
months ended June 30, 1998 as compared to cash used by operating activities of
$492,000 for the same period in the prior year. The increase in cash used of
$2.6 million was primarily due to an increase in accounts receivable and the
extinguishment of accrued liabilities assumed in the 1998 acquisitions, offset
by an increase in deferred revenue.
Net cash used in investing activities was approximately $16.1 million
for the six months ended June 30, 1998 as compared to $4.0 million in the same
period in the prior year. In the six months ended June 30, 1998, the Company
used $14.3 million to partially fund the acquisitions of Healthdemographics,
Successful Solutions and Sweetwater as well as the $3.0 million contingent
consideration paid to the former shareholders of CareData. The remaining $1.8
million of net cash used in investing activities for the six months ended June
30, 1998 was used to fund $1.0 million in fixed asset purchases and $800,000 of
software development.
Net cash provided by financing activities was $39.1 million for the six
months ended June 30, 1998 as compared to $13.2 million for the same period in
the prior year. In 1997 the Company received net proceeds of $22.6 million from
its initial public offering, and in 1998 the Company received net proceeds of
$40.5 million from its follow-on offering completed in June 1998. At June 30,
1998, the Company had $25 million in borrowing availability remaining on its
revolving line of credit.
Many of the Company's acquisition agreements provide for the payment of
contingent consideration based upon the performance of the acquired businesses
over a prescribed period of time. If such acquired businesses exceed the
relevant performance goals, the Company will be required to make additional
payments, which could be material. In connection with the CareData acquisition,
additional consideration of $3.0 million was paid in April 1998.
In June 1998 the Company entered into an Amended and Restated Credit
Agreement with NationsBank under which a $25 million revolving credit facility
(the "NationsBank Revolver") was made available to the Company. The NationsBank
Revolver is available to fund working capital needs as well as new product
development and acquisitions.
In June 1998 the Company completed a follow-on offering of 2,250,000
shares of Common Stock. As a result of the offering, the Company received
approximately $40.5 million, net of offering expenses of approximately $600,000.
The Company's future liquidity and cash requirements will depend on a
wide range of factors, including costs associated with development of new
products, enhancements of existing products and acquisitions. The Company
believes that the remaining proceeds of its follow-on offering, available
borrowings under the NationsBank Revolver and cash generated from operations
will be sufficient to meet the capital expenditure and working capital needs for
the Company's operations for the near term.
EFFECTS OF INFLATION
Management does not believe that inflation has had a material impact on
results of operations for the periods presented. Substantial increases in costs,
particularly the cost of labor for product development, marketing and sales,
could have an adverse impact on the Company and the healthcare information
industry.
YEAR 2000 COMPLIANCE
Both the Company's internal operations and products use a significant
number of computer software programs and operating systems. Given the
information known at this time about the Company's systems and products, coupled
with the Company's ongoing efforts to maintain systems and products as
necessary, the Company does not anticipate that the year 2000 issue or related
costs will have a material adverse effect on the Company's business, results of
operations or financial condition. The Company has conducted an analysis of the
databases and software applications it licenses to customers as well as those
used in its internal operations and believes that the costs related to
addressing the year 2000 issue will not be material. The Company continues to
analyze its databases and software applications and analyzes year 2000
compliance issues before acquiring companies.
The Company is analyzing year 2000 issues as they relate to its key
suppliers of data and customers. If a supplier of data encounters year 2000
issues that it is unable to address, such supplier's data could be unavailable
to the Company. If a customer encounters year 2000 issues that it is unable to
address, such customer may determine not to license the Company's databases or
software applications.
-14-
<PAGE> 15
The Company's analysis of year 2000 issues, particularly as they relate
to its key suppliers of data and key customers, is ongoing, and to the extent
the databases or systems of the Company, key suppliers of data or key customers
are not fully year 2000 compliant, there can be no assurance that the costs
necessary to update databases or software or potential systems interruptions,
interruptions in the supply of data or interruptions in demand for the Company's
products would not have a material adverse effect on the Company's business,
results of operations or financial condition.
RECENT ACCOUNTING PRONOUNCEMENTS
In June 1997, the Financial Accounting Standards Board issued Statement
of Financial Accounting Standards No. 130 ("SFAS 130"), "Reporting Comprehensive
Income" and Statement of Financial Accounting Standards No. 131 ("SFAS 131"),
"Disclosures About Segments of an Enterprise and Related Information." SFAS 130
established standards for reporting and display of comprehensive income and its
components. Comprehensive income generally includes all changes in equity during
a period except those resulting from investments by owners and distribution to
owners. There was no impact on the Company's consolidated financial statements
with the adoption of SFAS 130. SFAS 131 established standards for reporting
information about operating segments in annual financial statements and in
interim financial reports to shareholders. The Company adopted both statements
in the first quarter of 1998; however, the provisions of SFAS 131 need not be
applied to interim periods in the initial year of application.
FORWARD-LOOKING STATEMENTS
The Company may from time to time make written or oral forward-looking
statements contained in the Company's filings with the Securities and Exchange
Commission (the "Commission") and its reports to stockholders. Statements made
in this Quarterly Report on Form 10-Q, other than those concerning historical
information, should be considered forward-looking and subject to various risks
and uncertainties. Such forward-looking statements are made based on
management's belief, as well as on assumptions made by, and information
currently available to, management, and are made pursuant to, and in reliance
upon, the "safe harbor" provisions of the Private Securities Litigation Reform
Act of 1995. The Company's actual results may differ materially from the results
anticipated in these forward-looking statements due to numerous factors,
including the following: History of Operating Losses and Uncertain
Profitability; Risks Related to Growth; Risks of Integration of Acquired
Operations; Dependence on Data Sources and AMA Licenses; Dependence on
Intellectual Property Rights; Risks Related to Intangible Assets and Acquisition
of In-process Research and Development; Uncertainty and Consolidation in the
HealthCare Industry; Risks of Rapid Technological Change; Need for Additional
Financing; Competition; Risks of Customer Concentration; Potential for System
Defects; Dependence on Key Personnel; Variable Quarterly Operating Results and
Seasonality; Possible Volatility of Stock Price; Potential Adverse Effects of
Substantial Number of Shares Eligible for Future Sale; Year 2000 Compliance;
Adverse Impact of Anti-takeover Provisions; and Risks Associated with
Unspecified Use of Proceeds. For a more complete discussion of these factors,
please see the section entitled "Risk Factors" in the Company's Registration
Statement on Form S-3, as amended, as originally filed with the Commission on
April 13, 1998, Registration Number 333-50015.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
The Registrant currently maintains all cash in United States dollars in
highly liquid, interest-bearing, investment-grade instruments with maturities of
less than three months, which the Company considers cash equivalents; therefore,
the Registrant has no "market risk sensitive instruments," and no disclosure is
required under this Item.
-14-
<PAGE> 16
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
The Company and certain of its officers and directors are named as
defendants in three purported securities class action lawsuits entitled Richard
Sturm v. Medirisk, Inc., et al. (Civil Action No. 1-98-CV-1922), John T.
Gallagher v. Medirisk, Inc., et al. (Civil Action No. 1-98-CV-2099), and
Frederick T. Casiello v. Medirisk, Inc., et al. (Civil Action No. 1-98-CV-2100).
The Sturm action was filed on July 8, 1998. The Gallagher and Casiello actions
were each filed on July 24, 1998. Each of these lawsuits is pending in the
United States District Court for the Northern District of Georgia. The
complaints in these lawsuits allege that the Company violated federal securities
laws by failing to disclose in its public statements and/or the Registration
Statement/Prospectus for its June 11, 1998 follow-on offering: (i) that the
Company's operating results for the second quarter of 1998 would be below
analysts' expectations and a departure from prior historical financial results;
(ii) that demand for its Market Performance and Physician Credentialing Products
was weakening such that sales would continue to slow for the remainder of the
fiscal year; and (iii) that the Company was preparing to change sales
management, implement new product distribution channels and introduce new
product enhancements as a result of weakening demand for its products. The Sturm
complaint asserts claims based on Sections 10(b) and 20(a) of the Securities
Exchange Act of 1934 and Rule 10b-5, the Casiello complaint alleges claims under
Sections 11 and 15 of the Securities Act of 1933, and the Gallagher complaint
asserts claims based on Sections 11, 12(a)(2) and 15 of the 1933 Act. All of the
plaintiffs seek compensatory damages and reimbursement of their attorneys' fees
and costs. Because of the uncertainty of the litigation process, the Company
cannot predict the outcome of these cases and, therefore, it is possible that
their outcome could have a material adverse effect on the Company. The Company
believes that plaintiffs' claims have no merit and intends to defend these cases
vigorously.
ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS.
(a) On July 29, 1998, the Board of Directors of the Company declared a dividend
of one preferred stock purchase right (a "Right") for each outstanding share of
Common Stock of the Company (a "Common Share"). The dividend is payable on
August 14, 1998 (the "Record Date") to the stockholders of record on that date.
Each Right entitles the registered holder to purchase from the Company one
one-hundredth of a share of Series A Junior Participating Preferred Stock, par
value $0.001 per share (the "Preferred Shares"), of the Company, at a price of
$40.00 per one one-hundredth of a Preferred Share (the "Exercise Price"),
subject to adjustment. The description and terms of the Rights are set forth in
the Shareholder Protection Rights Agreement, as the same may be amended from
time to time (the "Rights Agreement"), dated as of July 29, 1998 between the
Company and SunTrust Bank, Atlanta, as Rights Agent (the "Rights Agent").
SEPARATION TIME
Until the date on which certain events take place (the "Separation
Time"), the Rights will be evidenced by, with respect to any Common Share
certificate outstanding on the Record Date, such Common Share and a Summary of
Rights mailed to each holder of record on or about August 20, 1998. The term
"Separation Time" means the close of business on the earlier of (a) the tenth
business day (or such earlier or later date as may be determined by the Board
of Directors of the Company) following a public announcement by the Company
that a person or group of affiliated or associated persons has acquired
beneficial ownership of 15% or more of the outstanding Common Shares
(collectively, an "Acquiring Person") (the "Flip-in Date") or (b) the tenth
business day (or such later date as may be determined by the Board of Directors
of the Company) after the date on which any person or group of affiliated or
associated persons commences a tender or exchange offer the consummation of
which would result in the beneficial ownership by such Person of 15% or more of
such outstanding Common Shares.
TRANSFER OF RIGHTS AND CERTIFICATES
The Rights Agreement provides that, until the Separation Time, the
Rights will be transferred with and only with the Common Shares. Until the
Separation Time (or the earlier termination or expiration of the Rights), new
Common Share certificates issued after the Record Date upon transfer or new
issuance of Common Shares will contain a notation incorporating the Rights
Agreement by reference. Until the Separation Time (or the earlier termination
or expiration of the Rights), the surrender for transfer of any certificates
for Common Shares outstanding as of the Record Date, even without such
notation, will also constitute the transfer of the Rights associated with the
Common Shares represented by such certificate. As soon as practicable following
the Separation Time, separate certificates evidencing the Rights (the "Right
Certificates") will be mailed to holders of record of the Common Shares as of
the close of business on the Separation Time, and such separate Right
Certificates alone will evidence the Rights.
EXERCISE PERIOD
The Rights are not exercisable until the Separation Time. After the
Separation Time and prior to the Expiration Time, each Right (unless previously
terminated) will entitle the holder to purchase, for the Exercise Price, one
one-hundredth of a Preferred Share having the rights described below. The
Rights will expire on the Expiration Time, unless the Expiration Time is
extended, or the Rights are earlier terminated by the Company. The term
"Expiration Time" is defined in the Rights Agreement and generally means July
29, 2008, unless the Rights are sooner exchanged or terminated.
ADJUSTMENTS
The Exercise Price payable, and the number of outstanding Rights and
the number of one one-hundredth interests in Preferred Shares issuable upon
exercise of each Right, are subject to adjustment in the event of a stock split
of the Common Shares or a stock dividend on the Common Shares payable in Common
Shares or subdivisions, consolidations or combinations of the Common Shares
occurring, in any such case, prior to the Separation Time.
If prior to the Separation Time, the Company distributes securities or
assets in exchange for Common Shares (other than regular cash dividends or a
dividend paid solely in Common Shares) whether by dividend, reclassification or
otherwise, the Company shall make such adjustments, if any, in the Exercise
Price, number of Rights and otherwise as the Board of Directors deems
appropriate.
EXERCISE OF RIGHTS FOR COMMON STOCK
At a Flip-in Date, Rights owned by the Acquiring Person or any
affiliate or associate thereof or any transferee thereof will automatically
become void and, subject to the Exchange Option summarized below, each other
Right will automatically become a right to buy, for the Exercise Price, that
number of Common Shares or, at the option of the Board of Directors, Preferred
Shares designed to have economic and voting terms similar to the Common Shares,
in either case, having a market value of twice the Exercise Price. If any
person or group acquires beneficial ownership of 15% or more of the outstanding
Common Shares without any intent to acquire or affect control of the Company,
that acquisition will not result in a Flip-in Date if such acquiror immediately
enters into an irrevocable commitment to promptly divest, and thereafter
promptly divests, sufficient Common Shares so that such 15% or greater
beneficial ownership ceases. After a Flip-in Date occurs, the Company may not
consolidate or merge with, or sell 50% or more of its assets or earning power
to, any person, if the Company's Board of Directors is controlled by the
Acquiring Person, unless proper provision is made so that each Right would
thereafter become a right to buy, for the Exercise Price, that number of
shares of common stock of such other person having a market value of twice the
Exercise Price.
OPTIONAL EXCHANGE OF RIGHTS
At any time after a Flip-in Date occurs and prior to the time a person
or group of persons become the beneficial owner of more than 50% of the
outstanding Common Shares, the Board of Directors of the Company may elect to
exchange all of the outstanding Rights (other than Rights owned by such person
or group which have become void), for Common Shares at an exchange ratio
(subject to adjustment) of one Common Share per Right (the "Exchange Option").
TERMINATION OF RIGHTS
At any time prior to a Flip-in Date, the Board of Directors of the
Company may terminate the Rights. Immediately upon any termination of the
Rights, the right to exercise the Rights will terminate.
AMENDMENTS
The Company and the Rights Agent may amend the Rights Agreement in any
respect prior to the occurrence of a Flip-in Date. Thereafter, the Company and
the Rights Agent may amend the Rights Agreement in any respect which shall not
materially adversely affect the interests of holders of Rights generally or to
cure an ambiguity or to correct or supplement any provision which may be
inconsistent with any other provision or otherwise defective.
RIGHTS PRIOR TO EXERCISE
Until a Right is exercised, the holder thereof, as such, will have no
rights as a stockholder of the Company, including, without limitation, the
right to vote or to receive dividends.
ANTI-TAKEOVER EFFECTS
The Rights may have certain anti-takeover effects. The Rights will
cause substantial dilution to a person or group that attempts to acquire the
Company on terms not approved by the Board of Directors of the Company (with,
where required by the Rights Agreement, the concurrence of a majority of the
continuing directors) unless the offer is conditioned on a substantial number
of Rights being acquired. However, the Rights should not interfere with any
merger, statutory share exchange or other business combination approved by a
majority of the directors since the Rights may be terminated by the Board of
Directors at any time on or prior to the close of business ten business days
after announcement by the Company that a person has become an Acquiring Person.
Thus, the Rights are intended to encourage persons who may seek to acquire
control of the Company to initiate such an acquisition through negotiations
with the Board of Directors. However, the effect of the Rights may be to
discourage a third party from making a partial tender offer or otherwise
attempting to obtain a substantial equity position in the equity securities of,
or seeking to obtain control of, the Company. To the extent any potential
acquirors are deterred by the Rights, the Rights may have the effect of
preserving incumbent management in office.
DOCUMENTS AND EFFECT OF THIS SUMMARY
A copy of the Rights Agreement is included as an Exhibit to the
Company's Current Report on Form 8-K filed with the Securities and Exchange
Commission on August 5, 1998. This summary description of the Rights does not
purport to be complete and is qualified in its entirety by reference to the
Rights Agreement, which is hereby incorporated herein by reference.
(b) See (a) above for a description of the Shareholder Protection Rights
Agreement and its effect on the Company's Common Stock.
(c) In May 1998, in connection with the acquisition of Successful Solutions, the
Company issued 190,000 shares of its Common Stock to shareholders of Successful
Solutions. Such transaction was conducted without any underwriter, and the
Company claims that such transaction was exempt from registration under the
Securities Act of 1933 (the "Securities Act") pursuant to Rule 505 of Regulation
D and Section 4(2) of the Securities Act.
(d) On January 28, 1997, the Company's Registration Statement on Form S-1,
Registration Number 333-12311, was declared effective. The offering of the
Company's Common Stock under such Registration Statement commenced on January
28, 1997 and was completed on January 31, 1997. The managing underwriters for
the offering were Equitable Securities Corporation and Jeffries & Company, Inc.
In such offering 2.3 million shares were registered and sold by the Company for
an aggregate offering price of $25.3 million.
In connection with such offering, (i) underwriting fees and discounts
of $1.8 million were incurred by the Company and (ii) other expenses of $903,000
were incurred by the Company resulting in (iii) total expenses of $2.7 million
and net offering proceeds of $22.6 million. Of such net proceeds, the following
payments were made to persons owning 10% or more of the Company's equity
securities: (i) $6.9 million in repayment of certain indebtedness; and (ii)
$643,000 in payment of accrued dividends. Of such net proceeds, the following
other uses have been made: (i) $2.3 million in repayment of certain
indebtedness; (ii) $8.7 million to acquire other businesses; (iii) $2.8 million
for fixed asset purchases and software development; and (iv) $1.3 million for
general working capital purposes. The above-described uses of proceeds do not
represent a material change in the uses of proceeds described in the prospectus.
ITEM 5. OTHER INFORMATION
SHAREHOLDER PROPOSALS
The proxy statement solicited by management of the Company with respect
to the 1999 Annual Meeting of Stockholders will confer discretionary authority
to vote on any proposals of stockholders of the Company intended to be presented
for consideration at such Annual Meeting that are submitted to the Company after
May 16, 1998.
-15-
<PAGE> 17
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
10.16 Amended and Restated Credit Agreement, dated as of
June 29, 1998, between the Company, as borrower, and
NationsBank, N.A., as lender.
11 Statements of Computation of Per Share Loss.
27 Financial Data Schedule (for SEC use only).
(b) Reports on Form 8-K
On April 13, 1998, the Company filed a Current Report on Form 8-K to
report the acquisition of all of the capital stock of Healthdemographics, which
acquisition was consummated March 31, 1998.
On May 29, 1998, the Company filed a Current Report on Form 8-K to
report the acquisition of all of the capital stock of Successful Solutions,
which acquisition was consummated May 28, 1998. On June 5, 1998, the Company
filed Form 8-K/A amending such Form 8-K to include required financial statements
and pro forma financial information.
On June 30, 1998, the Company filed a Current Report on Form 8-K to
report (i) the Company's expectations regarding financial results for the three
months ended June 30, 1998, (ii) the acquisition of all of the capital stock of
Sweetwater, which acquisition was consummated on June 25, 1998, and (iii) the
amendment and restatement of the Company's Credit Agreement with NationsBank.
-15-
<PAGE> 18
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Medirisk, Inc.
August 14, 1998 By: /s/ Kenneth M. Goins, Jr.
----------------------------------------
Kenneth M. Goins, Jr.
Executive Vice President
Chief Financial Officer
August 14, 1998 By: /s/ Thomas C. Kuhn III
----------------------------------------
Thomas C. Kuhn III
Vice President and Corporate Controller
Chief Accounting Officer
-17-
<PAGE> 19
EXHIBIT INDEX
Exhibit
Number Description
- ------- -----------
10.16 Amended and Restated Credit Agreement, dated as of
June 29, 1998, between the Company, as borrower, and
NationsBank, N.A., as lender
11 Statements of Computation of Per Share Loss
27 Financial Data Schedule (for SEC use only)
-18-
<PAGE> 1
EXHIBIT 10.16
AMENDED AND RESTATED CREDIT AGREEMENT
DATED AS OF
JUNE 29, 1998
BETWEEN
MEDIRISK, INC., AS BORROWER
AND
NATIONSBANK, N.A., AS LENDER
<PAGE> 2
MEDIRISK, INC.
AMENDED AND RESTATED CREDIT AGREEMENT
TABLE OF CONTENTS
<TABLE>
<CAPTION>
Page
-----
<S> <C> <C>
ARTICLE 1 THE LOANS......................................................................................2
Section 1.1 Extension of Credit..........................................................2
Section 1.2 Revolving Loan Borrowing Mechanics...........................................3
Section 1.3 Interest.....................................................................4
Section 1.4 Fees.........................................................................6
Section 1.5 Repayment and Prepayment.....................................................6
Section 1.6 Notes and Loan Account.......................................................6
Section 1.7 Manner of Payment............................................................7
Section 1.8 Reimbursement................................................................7
Section 1.9 Acquisition Advances.........................................................8
Section 1.10 Collateral...................................................................9
ARTICLE 2 CONDITIONS PRECEDENT...........................................................................9
Section 2.1 Conditions Precedent to Initial Advance.....................................10
Section 2.2 Conditions Precedent to Each Advance Subsequent to the
Agreement Date..............................................................12
ARTICLE 3 REPRESENTATIONS AND WARRANTIES................................................................13
Section 3.1 Representations and Warranties..............................................13
Section 3.2 Survival of Representations and Warranties..................................19
ARTICLE 4 GENERAL COVENANTS.............................................................................19
Section 4.1 Preservation of Existence and Similar Matters...............................19
Section 4.2 Compliance with Applicable Law..............................................19
Section 4.3 Maintenance of Properties...................................................19
Section 4.4 Insurance...................................................................19
Section 4.5 Payment of Taxes and Claims.................................................20
Section 4.6 Visits and Inspections......................................................20
Section 4.7 ERISA.......................................................................20
Section 4.8 Further Assurances..........................................................21
Section 4.9 Covenants Regarding Formation of New Subsidiaries and
Acquisitions................................................................21
Section 4.10 Indemnity...................................................................24
Section 4.11 Use of Proceeds.............................................................24
ARTICLE 5 INFORMATION COVENANTS.........................................................................24
Section 5.1 Quarterly Financial Statements and Information..............................24
Section 5.2 Audited Annual Financial Statements and Information: Certificate
of No Default...............................................................24
Section 5.3 Covenant Compliance Certificates............................................25
Section 5.4 Copies of Other Reports.....................................................25
Section 5.5 Notice of Litigation and Other Matters......................................26
</TABLE>
i
<PAGE> 3
<TABLE>
<S> <C> <C>
ARTICLE 6 NEGATIVE COVENANTS............................................................................27
Section 6.1 Indebtedness................................................................27
Section 6.2 Guaranties..................................................................27
Section 6.3 Liens.......................................................................28
Section 6.4 Restricted Payments and Purchases...........................................28
Section 6.5 Investments.................................................................28
Section 6.6 Liquidation; Disposition or Acquisition of Assets...........................28
Section 6.7 Change of Name or Year......................................................29
Section 6.8 Affiliate Transactions......................................................29
Section 6.9 Debt/Capitalization Ratio...................................................29
Section 6.10 Cash Flow Leverage Ratio....................................................29
Section 6.11 Debt Service Coverage Ratio.................................................29
Section 6.12 Restricted Payments.........................................................29
Section 6.13 Minimum Net Worth...........................................................30
ARTICLE 7 DEFAULT.......................................................................................30
Section 7.1 Events of Default...........................................................30
Section 7.2 Remedies....................................................................32
ARTICLE 8 MISCELLANEOUS.................................................................................32
Section 8.1 Notices.....................................................................32
Section 8.2 Expenses....................................................................33
Section 8.3 Waivers.....................................................................34
Section 8.4 Set-Off.....................................................................34
Section 8.5 Assignment..................................................................35
Section 8.6 Counterparts................................................................35
Section 8.7 Governing Law...............................................................35
Section 8.8 Severability................................................................35
Section 8.9 Interest and Charges........................................................35
Section 8.10 Headings....................................................................36
Section 8.11 Pronouns....................................................................36
Section 8.12 Entire Agreement; Amendments................................................36
ARTICLE 9 YIELD PROTECTION..............................................................................36
Section 9.1 LIBOR Rate Basis Determination..............................................36
Section 9.2 Illegality..................................................................36
Section 9.3 Increased Costs.............................................................37
Section 9.4 Effect On Other Advances....................................................38
Section 9.5 Capital Adequacy............................................................38
ARTICLE 10 DEFINITIONS...................................................................................39
ARTICLE 11 WAIVER OF JURY TRIAL, ETC.....................................................................49
Section 11.1 Consent to Venue............................................................49
Section 11.2 Waiver of Jury Trial........................................................50
ARTICLE 12 ARBITRATION...................................................................................50
Section 12.1 Arbitration.................................................................50
Section 12.2 Special Rules...............................................................50
Section 12.3 Reservation of Rights.......................................................50
</TABLE>
ii
<PAGE> 4
EXHIBITS
<TABLE>
<S> <C>
Exhibit A - Form of Borrower's Loan Certificate
Exhibit B - Form of Subsidiary Loan Certificate
Exhibit C-1 - Form of Trademark Security Agreement
Exhibit C-2 - Copy of Trademark Security Agreement of Medirisk-MO
Exhibit D - Form of Opinion of Counsel
Exhibit E - Form of Compliance Certificate
Exhibit F-1 - Form of Request for Acquisition Advance
Exhibit F-2 - Form of Request for Advance
Exhibit G - Form of Revolving Note
Exhibit H - Form of Security Agreement
Exhibit I - Form of Stock Pledge Agreement
Exhibit J - Form of Subsidiary Guaranty
Exhibit K - Form of Subsidiary Security Agreement
SCHEDULES
Schedule 1.9(c)(ii) Due Diligence Checklist
Schedule 1.9(c)(iv) Acquisition Financial Information
Schedule 3.1(a) States Not Qualified In
Schedule 3.1(c) Subsidiaries
Schedule 3.1(d) Capital Stock and Shareholders
Schedule 3.1(f) Leased Real Property
Schedule 3.1(h) Owned Real Property
Schedule 3.1(i) Tax Issues
Schedule 3.1(k) Materially Adverse Events
Schedule 3.1(l) Litigation
Schedule 3.1(p) Customer Contracts
Schedule 3.1(t) Name Changes
Schedule 3.1(u) Environmental Matters
Schedule 3.1(v) Patents/Trademarks/Copyrights
Schedule 6.4 Restricted Purchases and Restricted Payments
Schedule 9A Liens of Record
</TABLE>
iii
<PAGE> 5
AMENDED AND RESTATED CREDIT AGREEMENT
DATED AS OF
JUNE 29, 1998
BETWEEN
MEDIRISK, INC., AS BORROWER
AND
NATIONSBANK, N.A., AS LENDER
This Amended and Restated Credit Agreement is dated as of June 29,
1998 and is entered into by and between Medirisk, Inc., a Delaware corporation
(the "Company") and NationsBank, N.A. (the "Lender").
RECITALS
WHEREAS, the Company and the Lender are party to a certain Credit
Agreement dated as of March 28, 1997 pursuant to which the Lender provided to
the Company a revolving credit facility in the amount of $10,000,000 (as
amended, the "Prior Credit Agreement"); and
WHEREAS, the Company desires that the Lender modify the Prior Credit
Agreement to provide a $25,000,000 revolving credit facility to the Company for
acquisitions and general corporate purposes, and the Lender is willing to do so,
all in accordance with and subject to the terms and conditions set forth herein,
and the Company and the Lender have agreed in connection therewith to amend and
restate the Prior Credit Agreement in its entirety, as set forth herein; and
WHEREAS, the Company acknowledges and agrees that the security interest
granted to the Lender pursuant to the Prior Credit Agreement and the Security
Documents (as defined in the Prior Credit Agreement), shall remain outstanding
and in full force and effect in accordance with the Prior Credit Agreement and
shall continue to secure the Obligations (as defined herein); and
WHEREAS, the Company and all other parties hereto acknowledge and agree
that (i) the Obligations (as defined herein) represent, among other things, the
amendment, restatement, renewal, extension, consolidation and modification of
the Obligations (as defined in the Prior Credit Agreement) arising in connection
with the Prior Credit Agreement and the other Loan Documents (as defined in the
Prior Credit Agreement) executed in connection therewith; (ii) the parties
hereto intend that the Prior Credit Agreement and the other Loan Documents (as
defined in the Prior Credit Agreement) executed in connection therewith and the
collateral pledged thereunder shall secure, without interruption or impairment
of any kind, all existing Indebtedness under the Prior Credit Agreement and the
other Loan Documents (as defined in the Prior Credit Agreement) executed in
connection therewith as so amended, restated, renewed, extended, consolidated
and modified hereunder, together with all other obligations hereunder; (iii) all
Liens evidenced by the Prior Credit Agreement and the other Loan Documents (as
defined in the Prior Credit Agreement) executed in connection therewith are
hereby ratified, confirmed and continued; and (iv) the Loan Documents (as
defined herein) are intended to restate, renew, extend, consolidate, amend and
modify the Prior Credit Agreement and the other Loan Documents (as defined in
the Prior Credit Agreement) executed in connection therewith; and
1
<PAGE> 6
WHEREAS, the parties hereto intend that (i) the provisions of the Prior
Credit Agreement and the other Loan Documents (as defined in the Prior Credit
Agreement) executed in connection therewith, to the extent restated, renewed,
extended, consolidated, amended and modified hereby, be hereby superseded and
replaced by the provisions hereof and of the Loan Documents (as defined herein);
(ii) the Revolving Note (as hereinafter defined) amends, renews, extends,
modifies, replaces, be substituted for and supersedes in its entirety, but does
not extinguish, the Indebtedness arising under, the promissory note issued
pursuant to the Prior Credit Agreement; and (iii) entering into, and performing
their respective obligations under, this transaction not constitute a novation;
NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged by each of the parties hereto, the
parties hereby amend and restate the Prior Credit Agreement as follows as of the
29th day of June, 1998:
ARTICLE 1
THE LOANS
Section 1.1 Extension of Credit.
(a) Revolving Loans. Subject to the terms and conditions of, and
in reliance upon the representations and warranties made in, this Agreement and
the other Loan Documents, the Lender agrees to lend and relend to the Company,
prior to the Maturity Date, amounts which in the aggregate at any one time
outstanding do not exceed the lesser of (i) the Advance Rate and (ii) the
Commitment. Subject to the terms and conditions hereof and prior to the Maturity
Date, Advances under the Commitment may be repaid and reborrowed from time to
time on a revolving basis.
(b) Overadvances. If at any time, the Revolving Loans exceed the
Advance Rate, the Commitment or any other applicable limitation set forth in
this Agreement, such Revolving Loans shall nevertheless constitute Obligations
that are secured by the Collateral and are entitled to all benefits thereof. In
no event, however, shall the Company have the right whatsoever to receive any
Revolving Loan if, before or after giving effect thereto, there shall exist a
Default or an overadvance. In the event that the Lender, in its sole and
absolute discretion, shall make any Revolving Loan which in such case gives rise
to an overadvance, the Revolving Loans in an aggregate principal amount equal to
such overadvance shall be payable on demand.
2
<PAGE> 7
(c) Extension of Maturity Date. The Company may request the
Lender to extend the Maturity Date for an additional one year period by giving
notice of such request to the Lender in writing, not less than sixty (60) days
prior to the Maturity Date. The Lender shall respond to the Company as to its
approval or refusal to agree to so extend the Maturity Date not later than
thirty (30) days prior to the Maturity Date. The Lender is entitled to exercise
its sole, absolute and unconditional discretion in deciding whether or not to
agree to extend the Maturity Date.
Section 1.2 Revolving Loan Borrowing Mechanics and Disbursement.
(a) Choice of Interest Rate, etc. Any Advance under the
Commitment shall, at the option of the Company, be made as a Base Rate Advance
or a LIBOR Advance; provided, however, that (i) at such time as there shall have
occurred and be continuing a Default or an Event of Default hereunder, the
Company shall not have the right to reborrow any LIBOR Advance, and all
subsequent Advances during the period such Default or Event of Default continues
shall be made as Base Rate Advances and (ii) if the Company fails to give the
Lender written notice specifying whether an Advance is to be repaid or
reborrowed on a Payment Date, such Advance shall be deemed to be repaid and then
reborrowed as a Base Rate Advance on the Payment Date. Any notice given to the
Lender in connection with a requested Advance hereunder shall be given to the
Lender prior to 11:00 a.m. (Atlanta, Georgia time) in order for such Business
Day to count toward the minimum number of Business Days required. The Lender
shall, upon the reasonable request of the Company from time to time, provide to
the Company such information with regard to the LIBOR Basis as may be so
requested.
(b) Base Rate Advances.
(i) Initial and Subsequent Advances. The Company
shall give the Lender in the case of Base Rate Advances not later than 11:00
a.m. (Atlanta, Georgia time) on the Business Day of the date of a proposed
Advance, irrevocable prior notice by telephone or telecopy and shall confirm any
notice by telephone or telecopy with a written Request for Advance or, as
applicable, a written Request for Acquisition Advance.
(ii) Repayments and Reborrowings. The Company may
repay or prepay a Base Rate Advance and (a) at any time reborrow all or a
portion of the principal amount thereof as one or more Base Rate Advances, (b)
upon at least two (2) Business Days' irrevocable prior written notice to the
Lender, reborrow all or a portion of the principal thereof as one or more LIBOR
Advances, or (c) not reborrow all or any portion of such Base Rate Advance. Upon
the date indicated by the Company, such Base Rate Advance shall be so repaid
and, as applicable, reborrowed.
(iii) Miscellaneous. Notwithstanding any term or
provision of this Agreement which may be construed to the contrary, each Base
Rate Advance shall be in a principal amount of not less than $250,000 and in an
integral multiple of $5,000.
3
<PAGE> 8
(c) LIBOR Advances.
(i) Initial and Subsequent Advances. The Company
shall give the Lender in the case of LIBOR Advances at least two (2) Business
Days' irrevocable prior notice by telephone or telecopy and shall immediately
confirm any such notice with a written Request for Advance or, as applicable, a
written Request for Acquisition Advance.
(ii) Repayments and Reborrowings. At least two (2)
days prior to each Payment Date for a LIBOR Advance, the Company shall give the
Lender written notice specifying whether all or a portion of any LIBOR Advance
outstanding on the Payment Date (a) is to be repaid and then reborrowed in whole
or in part as a new LIBOR Advance, in which case such notice shall also specify
the LIBOR Advance Period which the Company shall have selected for such new
LIBOR Advance, (b) is to be repaid and then reborrowed in whole or in part as a
Base Rate Advance or (c) is to be repaid and not reborrowed. Upon such Payment
Date, such LIBOR Advance will, subject to the provisions hereof, be so repaid
and, as applicable, reborrowed.
(iii) Miscellaneous. Notwithstanding any term or
provision of this Agreement which may be construed to the contrary, (a) each
LIBOR Advance shall be in a principal amount of not less than $500,000 and in an
integral multiple of $100,000 and (b) at no time shall the aggregate number of
all LIBOR Advances then outstanding exceed five (5).
(d) Telephonic Notice. The failure by the Company to confirm any
notice by telephone or telecopy with a Request for Advance, or a Request for
Acquisition Advance, as applicable, shall not invalidate any notice so given.
The Lender may rely upon telephonic instructions reasonably believed given by
any Authorized Signatory of the Company and shall have no obligation to inquire
into the propriety of any such instructions.
(e) Disbursement. Prior to 3:00 p.m. (Atlanta, Georgia time) on
the date of an Advance hereunder, the Lender shall, subject to the satisfaction
of the conditions set forth in Section 2.2 hereof disburse the Advance by
depositing such amount in same day funds into the Company's account maintained
with the Lender or by wire transfer pursuant to the Company's instructions.
Section 1.3 Interest. Interest on Advances under the Revolving
Loans shall be payable as follows:
(a) On Base Rate Advances. Interest on Base Rate Advances shall
be computed for the actual number of days elapsed on the basis of a hypothetical
year of 360 days and shall be payable in arrears on the first day of each
calendar month, commencing on August 1, 1998. Interest on Base Rate Advances
outstanding on the Maturity Date shall also be due and payable on the Maturity
Date. Interest shall accrue and be payable on each Base Rate Advance at the
simple per annum interest rate equal to the sum of (A) the Base Rate, plus (B)
the Applicable Interest Rate Margin in effect from time to time and as more
fully set forth in Section 1.3(c) below.
4
<PAGE> 9
(b) On LIBOR Advances. Interest on each LIBOR Advance shall be
computed on the basis of a hypothetical year of 360 days for the actual number
of days elapsed and shall be payable in arrears on (x) the Payment Date for such
Advance, and (y) if the LIBOR Advance Period for such Advance is greater than
three (3) months, each three month anniversary of such Advance. Interest on
LIBOR Advances outstanding on the Maturity Date shall also be due and payable on
the Maturity Date. Interest shall accrue and be payable on each LIBOR Advance at
the per annum interest rate equal to (A) the LIBOR Basis applicable to such
LIBOR Advance, plus (B) the Applicable Interest Rate Margin in effect from time
to time and as more fully set forth in Section 1.3(c) below.
(c) Applicable Interest Rate Margin. The Applicable Interest
Rate Margin for Base Rate Advances shall be zero (0) percent per annum. The
Applicable Interest Rate Margin for LIBOR Advances shall be the interest rate
margin determined by the Lender based upon the Company's Total Funded Debt to
EBITDA ratio for the four quarter period ending on the last day of the most
recent fiscal quarter end, effective as of the second Business Day after the
financial statements referred to in Section 5.1 hereof, and an accompanying
certificate of an Authorized Signatory certifying the calculations of such ratio
as set forth in Section 5.3 hereof, are delivered by the Company to the Lender
for the fiscal quarter most recently ended, expressed as a per annum rate of
interest as follows:
<TABLE>
<CAPTION>
TOTAL FUNDED DEBT/EBITDA APPLICABLE INTEREST RATE
RATIO MARGIN
============================================ ===========================================
<S> <C>
Less than or equal to 1.00:1.00 1.50%
Less than or equal to 2.00:1.00 1.75%
and greater than 1.00:1.00
Less than or equal to 3.00:1.00 2.10%
and greater than 2.00:1.00
-------------------------------------------- -------------------------------------------
</TABLE>
In the event that the Company fails to timely provide the financial statements
and certificate referred to above in accordance with the terms of Sections 5.1
and 5.3 hereof, and without prejudice to any additional rights under Section 7.2
hereof, no downward adjustment of the Applicable Interest Rate Margin in effect
for the preceding fiscal quarter shall occur until the actual delivery of such
financial statements and certificate.
(d) Upon Default. Upon the occurrence of an Event of Default,
interest on the outstanding Obligations shall accrue at the Default Rate from
the date of such Event of Default. Interest accruing at the Default Rate shall
be payable on demand and in any event on the Maturity Date and shall accrue
until the earliest to occur of (i) waiver in writing by the Lender of the
applicable Event of Default, (ii) agreement by the Lender to rescind the
charging of interest at the Default Rate or (iii) payment in full of the
Obligations. The Lender shall not be required to (i) accelerate the maturity of
the Revolving Loans or (ii) exercise any other rights or remedies under the Loan
Documents in order to charge interest hereunder at the Default Rate.
5
<PAGE> 10
(e) Computation of Interest. In computing interest on any
Advance, the date of making the Advance shall be included and the date of
payment shall be excluded; provided, however, that if an Advance is repaid on
the date that it is made, one (1) day's interest shall be due with respect to
such Advance.
Section 1.4 Fees.
(a) Loan Fee. The Company shall cause to be paid to the Lender
on or before the Agreement Date a fee with respect to the Revolving Loans in
amount equal to $30,000. Such fee shall be fully earned when due and
non-refundable when paid.
(b) Commitment Fee. The Company shall pay an unused line fee to
the Lender for the period beginning on the Agreement Date to and including the
Maturity Date at a rate equal to two fifths of one percent (2/5%) per annum on
the amount by which the Commitment exceeds the aggregate outstanding principal
amount of the Revolving Loans. Such fees shall accrue daily but shall be payable
monthly in arrears on the last Business Day of each month and on the Maturity
Date. Such fee shall be fully earned when due and non-refundable when paid.
Section 1.5 Repayment and Prepayment.
(a) Prepayment. The principal amount of any Base Rate Advance
may be prepaid in full or in part at any time, upon written notice to the Lender
on the date of such prepayment, without penalty. LIBOR Advances may be prepaid
prior to the applicable Payment Date, upon at least three (3) Business Days'
prior written notice to the Lender, provided that the Company shall reimburse
the Lender, on the earlier of demand or the Maturity Date, for any loss
(excluding loss of anticipated profit other than loss resulting from any
interest rate differential) or out-of-pocket expense incurred by the Lender in
connection with such prepayment, as set forth in Section 1.8 hereof. Each notice
of prepayment shall be irrevocable, and all amounts prepaid on the Revolving
Loans shall be applied first to interest and fees and other amounts due and
payable hereunder as of such date, and then to principal.
(b) Repayment. The principal balance of all Revolving Loans then
outstanding shall be due and payable in full on the Maturity Date.
Notwithstanding the foregoing, however, in the event that at any time and for
any reason there shall exist an overadvance, the Company shall immediately pay
to the Lender an amount equal to such overadvance pursuant to Section 1.1(b)
hereof, which payment shall constitute a mandatory payment of the Revolving
Loans hereunder.
Section 1.6 Notes and Loan Accounts.
(a) The Revolving Loans shall be payable in accordance with the
terms and provisions of this Agreement and shall be evidenced by the Revolving
Note. The Revolving Note shall be issued by the Company to the Lender and shall
be duly executed and delivered by the Authorized Signatories.
6
<PAGE> 11
(b) The Lender shall open and maintain on its books in the name
of the Company a loan account with respect to the Revolving Loans and interest
thereon. The Lender shall debit such loan account for the principal amount of
each Advance and accrued interest thereon, and shall credit such loan account
for each payment on account of principal of or interest on the Revolving Loans.
The records of the Lender with respect to the loan account shall be prima facie
evidence of the Revolving Loans and accrued interest thereon but the failure to
maintain such records shall not impair the obligation of the Company to repay
Indebtedness hereunder.
Section 1.7 Manner of Payment.
(a) Each payment (including any prepayment) by the Company on
account of the principal of or interest on the Revolving Loans and any other
amount owed to the Lender under this Agreement or the Revolving Note shall be
made not later than 1:00 p.m. (Atlanta, Georgia time) on the date specified for
payment under this Agreement to the Lender in lawful money of the United States
of America in immediately available funds. Any payment received by the Lender
after 1:00 p.m. (Atlanta, Georgia time) shall be deemed received on the next
Business Day.
(b) If any payment under this Agreement or the Revolving Note
shall be specified to be made upon a day which is not a Business Day, it shall
be deemed made on the next succeeding day which is a Business Day, and such
extension of time shall in such case be included in computing interest and fees,
if any, in connection with such payment.
(c) The Company agrees to pay principal, interest, fees and all
other amounts due hereunder or under the Revolving Note without set-off or
counterclaim or any deduction whatsoever.
Section 1.8 Reimbursement. Whenever the Lender shall sustain or
incur any losses (excluding loss of anticipated profit other than loss resulting
from any interest rate differential) or out-of-pocket expenses in connection
with (i) failure by the Company to borrow or reborrow any LIBOR Advance, or
reborrow any Advance as a LIBOR Advance, in each case, after having given notice
of its intention to borrow in accordance with Section 1.2 hereof (whether by
reason of the election of the Company not to proceed or the non-fulfillment of
any of the conditions set forth in Article 3), or (ii) prepayment of any LIBOR
Advance in whole or in part, or (iii) the failure by the Company to prepay any
Advance after notice of prepayment has been given by the Company to the Lender
in accordance with Section 1.5(a) hereof, the Company agrees to pay to the
Lender, upon the earlier of the Lender's demand or the Maturity Date, an amount
sufficient to compensate the Lender for all such losses and out-of-pocket
expenses. The Lender's good faith determination of the amount of such losses and
out-of-pocket expenses, absent manifest error, shall be binding and conclusive.
The obligations of the Company under this Section shall survive the termination
of this Agreement and the payment of the Revolving Note.
Section 1.9 Acquisition Advances.
(a) Acquisition Advance. An Acquisition Advance shall be
available only to finance a Material Acquisition pursuant to the terms and
conditions of this Section 1.9.
7
<PAGE> 12
The proceeds of any Acquisition Advance shall be limited to an amount not to
exceed one hundred percent (100%) of the cash portion of the purchase price of
the Acquisition to be financed thereby. An Acquisition Advance may be made
either as a Base Rate Advance or a LIBOR Advance in accordance with the terms
and conditions of Section 1.2 hereof with respect to such Advances.
(b) Consent of the Lender. In the event that the aggregate
purchase price of all Acquisitions made after the date hereof through June 30,
1999, and, thereafter, during the immediately preceding twelve (12) calendar
months shall exceed $15,000,000 after giving effect to a requested Acquisition
Advance, the consent of the Lender shall be required in connection with such
Acquisition Advance. Such consent shall be within the sole discretion of the
Lender.
(c) Request for Acquisition Advance. In connection with any
Acquisition Advance requiring the consent of the Lender pursuant to Section
1.9(b), the Company shall submit to the Lender not later than ten (10) days
prior to the date of such Acquisition, a duly executed Request for Acquisition
Advance which shall be accompanied by:
(i) a summary overview of the Counterparty proposed to be
acquired, which shall include (i) the location of such
Counterparty, (ii) the number of employees of such Counterparty,
(iii) a description of such Counterparty's business; (iv) the
number of customers of such Counterparty; (v) a list and
description of such Counterparty's products; (vi) a description
of the type of Acquisition (acquisition of assets or stock,
merger or other); (vii) a description of the ownership of such
Counterparty; (viii) a description of the Company's
consolidation plan; and (ix) a description of any synergy
opportunities identified by the Company;
(ii) copies of the following documents, if then in
existence, with respect to the Acquisition: (x) all letters of
intent, or similar agreements between the Company and each
Counterparty; (y) due diligence checklists provided by the
Company to each Counterparty, the current form of which is
attached hereto as Schedule 1.9(c)(ii); and (z) the most current
draft of the acquisition agreement, or similar agreement,
governing the Acquisition, together with all schedules and
exhibits thereto;
(iii) summary of findings with respect to the information
received by the Company in response to each diligence checklist
provided by the Company, which summary shall set forth a
complete description of any findings which, in the reasonable
business judgment of the Company, warrant senior management
concern and which might have a materially
adverse effect on the business or operations (x) of the
Counterparty proposed to be acquired or (y) of the Company its
Subsidiaries on a consolidated basis, as a result of the
Acquisition, and which summary the Lender agrees to return to
the Company upon written notice that the Company does not intend
to proceed with the subject Acquisition;
(iv) financial information relating to each Counterparty
proposed to be acquired by the Acquisition, which information
shall include, without
8
<PAGE> 13
limitation, that information which is more fully described on
Schedule 1.9(c)(iv) attached hereto; and
(v) a statement (v) that Company is in compliance with
Sections 6.9, 6.10, 6.11, 6.12 and 6.13 hereof before and after
giving effect to the transactions contemplated by such
Acquisition, (w) that no Default or Event of Default then exists
or would be caused thereby, or is reasonably foreseeable as a
result of the transactions contemplated in connection with such
Acquisition; (x) that any documents provided to the Lender in
connection with such Request for Advance shall be in
substantially final form and shall not be subject to subsequent
material revisions without the prior consent of the Lender; (y)
of the total purchase price with respect to the Acquisition,
both in terms of cash and other consideration paid and other
indebtedness and liabilities assumed; and (z) of the full name,
state of organization, federal tax identification number and
chief business address of any new Subsidiary created for the
purpose of effecting such Acquisition or resulting therefrom.
In addition to the foregoing, upon the reasonable request of the
Lender, the Company shall make available to the Lender for review, at the
Company's offices located in Atlanta, Georgia, copies of all information
provided by each Counterparty in response to the due diligence checklist, or any
other diligence request, of the Company.
The Company understands that the purpose of delivering a Request
for Acquisition Advance hereunder and making information available hereunder is
to provide the Lender with a full, complete and correct set of information
regarding the Acquisition so that the Lender may provide its informed consent
pursuant to Section 1.9(b) hereof.
To request any Acquisition Advance not requiring the consent of
the Lender under Section 1.9(b), the Company shall submit a Request for Advance.
Section 1.10 Collateral. The Revolving Loans shall be secured by a
perfected first priority security interest, subject only to Permitted Liens, in
substantially all of the assets of the Company and its Subsidiaries and any
assets acquired in connection with an Acquisition, including, without
limitation, accounts, inventory, equipment, furniture, fixtures and intangibles,
as more fully set forth in the Security Documents.
ARTICLE 2
CONDITIONS PRECEDENT
Section 2.1 Conditions Precedent to Initial Advance. The obligation of
the Lender to make the initial Advance under the Commitment is subject to the
fulfillment of each of the following conditions prior to or contemporaneously
with the making of the initial Advance:
(a) The Lender shall have received each of the following, in
form and substance satisfactory to the Lender and its counsel:
(i) a loan certificate of the Company signed by an
Authorized
9
<PAGE> 14
Signatory of the Company in substantially the form of Exhibit A
attached hereto, including a certificate of incumbency with
respect to each Authorized Signatory of the Company, together
with appropriate attachments which shall include, without
limitation, the following: (A) a copy of the Certificate of
Incorporation of the Company certified to be true, complete and
correct by the Secretary of State for the State of Delaware, (B)
a true, complete and correct copy of the By-Laws of the Company,
(C) a true, complete and correct copy of the resolutions of the
Company authorizing the borrowing hereunder and the execution,
delivery and performance by the Company of the Loan Documents,
(D) certificates of good standing, or the equivalent thereof,
from each jurisdiction in which the Company does business, (E)
copies of employment contracts for key management level
employees of the Company, and (F) a copy of any shareholders' or
voting trust or other similar agreement among the shareholders
of the Company certified to be true, complete and correct by an
Authorized Signatory of the Company; or, in lieu of the items
set forth in (A), (B), (E) and (F) above, certification by an
Authorized Signatory of the Company that such attachments
delivered in connection with the Prior Loan Agreement are still
in full force and effect and have not been modified, amended, or
supplemented;
(ii) a loan certificate of each Subsidiary of the
Company on the Agreement Date, in substantially the form of
Exhibit B attached hereto, including a certificate of incumbency
with respect to each Authorized Signatory, together with
appropriate attachments which shall include, without limitation,
the following: (A) a copy of the Certificate of Incorporation of
the Subsidiary certified to be true, complete and correct by the
Secretary of State of its state of incorporation, (B) a true,
complete and correct copy of the By-Laws of such Subsidiary, (C)
a true, complete and correct copy of the resolutions of such
Subsidiary authorizing such Subsidiary with respect to the
execution, delivery and performance by such Subsidiary of each
of the Loan Documents to which it is a party and (D)
certificates of good standing, or the equivalent thereof, from
each jurisdiction in which such Subsidiary does business; or, in
lieu of the items set forth in (A) and (B) above, certification
by an Authorized Signatory of such Subsidiary that such
attachments delivered in connection with the Prior Loan
Agreement or in connection with the addition of such Subsidiary
as a party to certain of the Loan Documents (as defined in the
Prior Credit Agreement) are still in full force and effect and
have not been modified, amended or supplemented;
(iii) the duly executed Revolving Note;
(iv) the duly executed Security Agreement;
(v) the duly executed Stock Pledge Agreement;
(vi) the duly executed Subsidiary Security Agreement;
(vii) the duly executed Subsidiary Guaranty;
10
<PAGE> 15
[(viii) a duly executed Trademark Security Agreement in
substantially the form of Exhibit C-1 attached hereto from
___________;] [delete if all trademarks have been pledged]
(ix) the opinion of Alston & Bird LLP, counsel to the
Company, addressed to the Lender, in substantially the form of
Exhibit D attached hereto;
(x) a duly executed Request for Advance, or Request for
Acquisition Advance, as applicable, covering the initial
Advances on the Revolving Loans;
(xi) copies of a lien search and report conducted with
respect to the Company and its Subsidiaries, which search and
report shall include a review of all Uniform Commercial Code
indices, tax lien records, general execution dockets and
plaintiff/defendant pending case tables as filed and recorded in
the records of all appropriate jurisdictions;
[(xii) acknowledgment copies evidencing the appropriate
filing of all Uniform Commercial Code financing statements
required to be filed in connection with the perfection of the
Lender's security interest in and security title to the
Collateral;][identify additional filings to be made, if any]
(xiii) copies of insurance binders or certificates
covering the Collateral, naming the Lender as loss payee and
meeting the requirements of Section 4.4 hereof;
(xiv) audited financial statements for the Company for
the most recently ended fiscal year for which audited financial
statements are available, and unaudited financial statements for
the Company for the fiscal period ended March 31, 1998;
(xv) [a waiver agreement executed in favor of the Lender
by each landlord, warehouseman, bailee, tenant or owner of
premises used by the Company or its Subsidiaries; and]
(xvi) evidence reasonably satisfactory to the Lender that
all Necessary Authorizations have been obtained or made, are in
full force and effect, and are not subject to any pending or
threatened reversal or cancellation.
(b) All of the representations and warranties of the Company
under this Agreement shall be true and correct in all material
respects, both before and after giving effect to the application of the
proceeds of the initial Advance.
(c) The Lender shall have received evidence, satisfactory to the
Lender and its counsel, with respect to a secondary offering of the
capital stock of the Company showing that the net proceeds of the
Company from such secondary offering shall have been at least
$25,000,000.
11
<PAGE> 16
(d) The Lender shall have received all such other certificates,
reports, statements, opinions of counsel or other documents, and shall
have performed such additional diligence, including, without
limitation, discussions with customers of the Company, as the Lender
may reasonably deem necessary.
Section 2.2 Conditions Precedent to Each Advance Subsequent to the
Agreement Date. The obligation of the Lender to make each Advance which will
increase the principal amount of the Revolving Loans outstanding is subject to
the fulfillment of each of the following conditions immediately prior to or
contemporaneously with such Advance:
(a) All of the representations and warranties of the Company
under this Agreement, which, pursuant to Section 3.2 hereof (as the
same shall have been amended by a report delivered to the Lender
pursuant to Section 5.5(e) hereof which report shall not contain any
information of a materially adverse nature with respect to the Company
or any of its Subsidiaries) are made at and as of the time of such
Advance, shall be true and correct at such time, both before and after
giving effect to the Advance, and the Lender shall have received a
certificate to that effect from an Authorized Signatory of the Company;
(b) The incumbency of the Authorized Signatories shall be as
stated in the Request for Advance, or Request for Acquisition Advance,
as applicable, delivered pursuant to Section 1.2 or as subsequently
modified and reflected in a more recent Request for Advance or Request
for Acquisition Advance;
(c) There shall not exist, as of the date of the making of the
Advance and after giving effect thereto, a Default or an Event of
Default hereunder, and the Lender shall have received a Request for
Advance, or Request for Acquisition Advance, as applicable, so stating;
(d) With respect to an Acquisition Advance, the Company shall
have complied with the terms and conditions of Sections 1.9 and 4.9
hereof, and the Lender shall have given its prior consent to the
Acquisition, as applicable;
(e) The Lender shall have received all other reports,
certificates, statements or opinions in connection with the Advance as
the Lender may reasonably request.
ARTICLE 3
REPRESENTATIONS AND WARRANTIES.
Section 3.1 Representations and Warranties. The Company hereby
represents and warrants as follows and agrees that the following representations
and warranties shall survive the execution and delivery hereof by the Lender or
the making of the Revolving Loans under this Agreement:
12
<PAGE> 17
(a) Organization: Power: Qualification.
(i) The Company is a corporation duly organized, validly
existing and in good standing under the laws of the State of Delaware,
has the power and authority, to own or lease and operate its properties
and to carry on its business as now being and hereafter proposed to be
conducted, and, except as set forth on Schedule 3.1(a), is duly
qualified and is in good standing as a foreign corporation and
authorized to do business in each jurisdiction in which the character
of its properties or the nature of its business requires such
qualification or authorization.
(ii) Each Subsidiary of the Company is a corporation duly
organized, validly existing and in good standing under the laws of its
state of incorporation, having the Company as its sole shareholder.
Each Subsidiary of the Company has the power and authority, to own or
lease and operate its properties and to carry on its business as now
being and hereafter proposed to be conducted, and, except as set forth
on Schedule 3.1(a), is duly qualified and is in good standing as a
foreign corporation and authorized to do business in each jurisdiction
in which the character of its properties or the nature of its business
requires such qualification or authorization.
(b) Authorization: Enforceability. Each of the Company and its
Subsidiaries has the power and has taken all necessary action to authorize it to
execute, deliver and perform this Agreement and each of the other Loan Documents
to which it is a party in accordance with the terms thereof and to consummate
the transactions contemplated hereby and thereby. This Agreement has been duly
executed and delivered by the Company, and is, and each of the other Loan
Documents to which the Company or any of its Subsidiaries is a party is, a
legal, valid and binding obligation of the Company or such Subsidiary,
enforceable in accordance with its terms.
(c) Subsidiaries. Except as set forth on Schedule 3.1(c)
attached hereto, the Company has no Subsidiaries. With respect to each
Subsidiary of the Company, Schedule 3.1(c) also sets forth (i) the state of its
incorporation, (ii) all jurisdictions in which the Subsidiary is qualified to do
business as a foreign corporation and (iii) the address of the principal place
of business of such Subsidiary.
(d) Capital Stock and Related Matters. The authorized capital
stock of the Company together with the number of shares that are currently
issued and outstanding is as set forth on Schedule 3.1(d) attached hereto and
all such shares are fully paid and non-assessable. All Persons known to the
Company to be the holders of more than five percent (5%) of such capital stock,
together with a description of such capital stock held by such Person, are
listed on Schedule 3.1(d) attached hereto.
(e) Compliance with Laws, Other Loan Documents and Contemplated
Transactions. The execution, delivery and performance of this Agreement and each
of the other Loan Documents in accordance with their respective terms and the
consummation of the transactions contemplated hereby and thereby do not and will
not (i) violate any Applicable Law, (ii) conflict with, result in a breach of or
constitute a default under the Articles of Incorporation or By-Laws of the
Company, or under any indenture, agreement or other instrument to which the
Company or any of its Subsidiaries is a party or by which it or any of its
properties may be bound or (iii) result in or require the
13
<PAGE> 18
creation or imposition of any Lien upon or with respect to any property now
owned or hereafter acquired by the Company except Permitted Liens.
(f) Real Property. All real property presently leased by the
Company and its Subsidiaries and the name of the lessor of such real property,
is set forth in Schedule 3.1(f). The leases of the Company and each of its
Subsidiaries are valid, enforceable and in full force and effect, and have not
been modified or amended, except as otherwise set forth in Schedule 3.1(f). The
Company, or the appropriate Subsidiary, is the sole holder of the lessee's
interests under each such lease, and has the right to pledge and assign the same
except as qualified in Schedule 3.1(f). Neither the Company or any of its
Subsidiaries has made any pledge or assignment (other than to the Lender) of any
of its rights under such leases except as set forth in Schedule 3.1(f) and, so
far as is known to the Company, except as set forth in Schedule 3.1(f), there is
no default or condition which, with the passage of time or the giving of notice,
or both, would constitute a material default on the part of any party under such
leases. All real property presently owned by the Company is set forth in
Schedule 3.1(h). The Company presently does not own, lease or use any real
property other than as set forth on Schedule 3.1(f) or Schedule 3.1(h).
(g) Necessary Authorizations. The Company has secured all
Necessary Authorizations, and all such Necessary Authorizations are in full
force and effect and not subject to any pending attack or revocation.
(h) Title to Properties. Each of the Company and its
Subsidiaries has good, marketable and legal title to, or a valid leasehold
interest in, all of their respective material properties and assets (including,
without limitation, the Accounts), and none of such properties or assets is
subject to any Liens, other than Permitted Liens, which materially detract from
the value of such properties or assets or materially interferes with the
respective business or operations of the Company and its Subsidiaries as
presently conducted or proposed to be conducted. Neither Company nor any of its
Subsidiaries owns any real property other than that listed on Schedule 3.1(h)
attached hereto.
(i) Taxes. Except as detailed on Schedule 3.1(i) attached
hereto, all federal, state and other tax returns of the Company and each of its
Subsidiaries required by law to be filed have been duly filed, and all federal,
state and other taxes, assessments and other governmental charges or levies upon
the Company and each of its Subsidiaries and any of their respective properties,
income, profits and assets, which are due and payable, have been paid, except
any such sums the payment of which the Company or its Subsidiary is contesting
in good faith by appropriate proceedings and for which adequate reserves have
been provided on the books of the Company or its Subsidiary, as applicable.
(j) Financial Statements. The Company has furnished, or caused
to be furnished, to the Lender financial statements for the Company and its
Subsidiaries which are complete and correct in all material respects and present
fairly in accordance with GAAP the financial position of the Company as at
September 30, 1996, and the results of operations for the period then ended.
Except as disclosed in such financial statements, the Company has had no
material liabilities required to be reflected in financial statements prepared
in accordance with GAAP, contingent or otherwise, and there are no
14
<PAGE> 19
material unrealized or anticipated losses of the Company which have not been
heretofore disclosed in writing to the Lender.
(k) No Adverse Change. Except as set forth on Schedule 3.1(k),
since [March 31, 1998], there has occurred no event which would have a
Materially Adverse Effect.
(l) Liabilities, Litigation, etc. Except for liabilities
incurred in the normal course of business, neither the Company nor any of its
Subsidiaries has had any material (individually or in the aggregate)
liabilities, direct or contingent, nor any litigation (pending or threatened)
except as disclosed or referred to in the financial statements referred to in
Section 3.1(j) above. Except as disclosed on Schedule 3.1(l), there is no
litigation, legal or administrative proceeding, investigation or other action of
any nature pending or, to the knowledge of the Company, threatened against or
affecting the Company, any of its Subsidiaries or any of its or their respective
properties which involves the possibility of any judgment or liability not fully
covered by insurance that, singly or in the aggregate, could reasonably be
expected to have a Materially Adverse Effect.
(m) ERISA. The Company and each ERISA Affiliate and each of
their respective Plans are in substantial compliance with ERISA and the Code,
and neither the Company nor any of its ERISA Affiliates has incurred any
accumulated funding deficiency with respect to any such Plan within the meaning
of ERISA or the Code. The Company and each of its ERISA Affiliates have complied
with all requirements of ERISA Sections 601 through 608 and Code Section 4980B.
Neither the Company nor any of its ERISA Affiliates has made any promises of
retirement or other benefits to employees, except as set forth in the Plans. The
Company has not incurred any material liability to the Pension Benefit Guaranty
Corporation in connection with any such Plan. The assets of each such Plan which
is subject to Title IV of ERISA are sufficient to provide the benefits under
such Plan, the payment of which the Pension Benefit Guaranty Corporation would
guarantee if such Plan were terminated, and such assets are also sufficient to
provide all other "benefit liabilities" (as defined in ERISA Section 4001(a)(16)
due under the Plan upon termination. No Reportable Event has occurred and is
continuing with respect to any such Plan. No such Plan or trust created
thereunder, or party in interest (as defined in Section 3(14) of ERISA), or any
fiduciary (as defined in Section 3(21) of ERISA), has engaged in a "prohibited
transaction" (as such term is defined in Section 406 of ERISA or Section 4975 of
the Code) which would subject such Plan or any other Plan of the Company or any
of its ERISA Affiliates, any trust created thereunder, or any such party in
interest or fiduciary, or any party dealing with any such Plan or any such trust
to the penalty or tax on "prohibited transactions" imposed by Section 502 of
ERISA or Section 4975 of the Code. Neither the Company nor any of its ERISA
Affiliates is a participant in or is obligated to make any payment to a
Multiemployer Plan.
(n) Compliance with Law; Absence of Default. The Company and
each of its Subsidiaries is in compliance with all Applicable Laws the
non-compliance with which would have a Materially Adverse Effect, and no event
has occurred or has failed to occur which has not been remedied or waived, the
occurrence or non-occurrence of which constitutes (i) a Default or (ii) a
default by the Company or any of its Subsidiaries under any other indenture,
agreement or other instrument, or any judgment, decree or order to
15
<PAGE> 20
which the Company or any of its Subsidiaries is a party or by which the Company
or any of its Subsidiaries or any of its or their properties may be bound, which
default could reasonably be considered to have a Materially Adverse Effect.
(o) Casualties; Taking of Properties, etc. Since the date of the
most recent financial statements provided to the Lender by the Company, neither
the business nor the properties of the Company has been materially and adversely
affected as a result of any fire, explosion, earthquake, flood, drought,
windstorm, accident, strike or other labor disturbance, embargo, requisition or
taking of property or cancellation of contracts, permits or concessions by any
domestic or foreign government or any agency thereof, riot, activities of armed
forces, or acts of God or of any public enemy.
(p) Accuracy and Completeness of Information. None of the
financial statements or any written statements delivered to the Lender pursuant
to this Agreement contains, as at the date of delivery thereof, any untrue
statement of material fact nor do such financial statements, and such written
statements, taken as a whole, omit to state a material fact or any fact
necessary to make the statements contained therein not misleading. As of the
Agreement Date, and as supplemented by the Company from time to time pursuant to
Section 5.4(6), Schedule 3.1(p) hereto lists each Material Customer Contract to
which the Company or any of its Subsidiaries is a party.
(q) Compliance with Regulations G, T, U and X. Neither the
Company nor any of its Subsidiaries is engaged principally or as one of its
important activities in the business of extending credit for the purpose of
purchasing or carrying, and neither the Company nor any of its Subsidiaries own
or presently intend to acquire, any "margin security" or "margin stock" as
defined in Regulations G, T, U, and X (12 C.F.R. Parts 221 and 224) of the Board
of Governors of the Federal Reserve System (herein called "margin stock"). None
of the proceeds of the Revolving Loans will be used, directly or indirectly, for
the purpose of purchasing or carrying any margin stock or for the purpose of
reducing or retiring any Indebtedness which was originally incurred to purchase
or carry margin stock or for any other purpose which might constitute this
transaction a "purpose credit" within the meaning of said Regulations G, T, U
and X.
(r) Solvency. The Company and each of its Subsidiaries is
Solvent.
(s) Business. The Company's business includes providing
proprietary databases and related decision-support software and analytical
services to the United States healthcare industry.
(t) Name of the Company and its Subsidiaries; Principal Place of
Business. Neither the Company nor any of its Subsidiaries has changed its name,
or transacted business under any other name or trade name, within the five (5)
years preceding the Agreement Date, except as disclosed on Schedule 3.1(t)
hereto. The principal place of business of the Company is as set forth in
Section 7.1 hereto.
(u) Environmental Matters. Except as would not, individually or
in the aggregate, have a Materially Adverse Effect, and except as is described
on Schedule 3.1(u) attached hereto with respect to each of the Properties:
16
<PAGE> 21
(i) To the knowledge of the Company, the Properties do
not contain, in, on or under, including, without limitation, the soil
and groundwater thereunder, any Hazardous Materials in violation of
Environmental Laws or in amounts that could give rise to liability
under Environmental Laws;
(ii) To the knowledge of the Company, the Properties and
all operations and facilities at the Properties are in compliance with
all Environmental Laws, and to the knowledge of the Company, there is
no contamination or violation of any Environmental Law which could
interfere with the continued operation of any of the Properties or
impair the financial condition of the Company;
(iii) The Company has not received from any governmental
authority any complaint, notice of violation, alleged violation,
investigation or advisory action or notice of potential liability
regarding matters of environmental protection or permit compliance
under applicable Environmental Laws with regard to the Properties, nor
is the Company aware that any governmental authority is contemplating
delivering to the Company or any of its Subsidiaries any such notice.
To the knowledge of the Company, there has been no pending or
threatened complaint, notice of violation, alleged violation,
investigation or notice of potential liability under Environmental Laws
with regard to any of the Properties;
(iv) Neither the Company nor any of its Subsidiaries has
generated, treated, stored, or disposed of any Hazardous Materials at,
on or under any of the Properties in violation of any Environmental
Laws or in a manner that could give rise to liability under
Environmental Laws nor has the Company or any of its Subsidiaries
transported or disposed of any Hazardous Materials from any of
the Properties to any other location in violation of any Environmental
Laws or in a manner that could give rise to liability under
Environmental Laws;
(v) There are no governmental administrative actions or
judicial proceedings pending under any Environmental Law to which the
Company or any of its Subsidiaries is a party with respect to any of
the Properties, nor to the knowledge of the Company, are there any
consent decrees or other decrees, consent orders, administrative orders
or other orders or other administrative or judicial requirements
outstanding under any Environmental Law with respect to any of the
Properties; and
(vi) To the knowledge of the Company, there has been no
release or threat of release by the Company or any of its Subsidiaries
of Hazardous Materials into the environment at or from any of the
Properties, or arising from or relating to the operations of the
Company, in violation of Environmental Laws or in amounts that could
give rise to liability under Environmental Laws.
(v) Patents, Trademarks, Franchises, etc. Except as set forth on
Schedule 3.1(v) attached hereto, neither the Company nor any of its Subsidiaries
owns any registered patents, trademarks, service marks or registered copyrights
and has no pending registration applications with respect to patents,
trademarks, service marks or copyrights. Except as set forth on Schedule 3.1(v),
no other patents, trademarks, service marks or
17
<PAGE> 22
registered copyrights are necessary for the operation of the business of the
Company or any of its Subsidiaries.
(w) OSHA. All of the operations of each of the Company and its
Subsidiaries are conducted in material compliance with all applicable rules and
regulations promulgated by the Occupational Safety and Health Administration of
the United States Department of Labor.
(x) Investment Company Act. Neither the Company nor any of its
Subsidiaries is required to register under the provisions of the Investment
Company Act of 1940, as amended, and neither the entering into or performance by
the Company of this Agreement nor the issuance of the Revolving Note violates
any provision of such Act or requires any consent, approval, or authorization
of, or registration with, any governmental or public body or authority pursuant
to any of the provisions of such Act.
(y) Year 2000.
(i) The Company has (A) begun analyzing the operations of
the Company and its Subsidiaries that could be adversely affected by
failure to become Year 2000 compliant (that is, that computer
applications, imbedded microchips and other systems will be able to
perform date-sensitive functions prior to and after December 31, 1999),
and (B) developed a plan for becoming Year 2000 compliant in a timely
manner, the implementation of which is on schedule in all material
respects. The Company reasonably believes that it will become Year 2000
compliant for its operations and those of its Subsidiaries on a timely
basis except to the extent that a failure to do so could not reasonably
be expected to have a Material Adverse Effect.
(ii) The Company is in the process of canvassing its
suppliers and vendors that are material to the operations of the
Company or its Subsidiaries to determine whether each of them will be
Year 2000 compliant for their own computer applications.
(iii) The Company will promptly notify the Lender in the
event the Company determines that any computer application which is
material to the operations of the Company, its Subsidiaries or any of
its material vendors or suppliers will not be fully Year 2000 compliant
on a timely basis, except to the extent that such failure could not
reasonably be expected to have a Material Adverse Effect.
Section 3.2 Survival of Representations and Warranties. All
representations or warranties made under this Agreement shall be deemed to be
made, and shall be true and correct, at and as of the Agreement Date and the
date of each Advance, except to the extent previously fulfilled in accordance
with the terms hereof and to the extent subsequently inapplicable or modified as
a result of activities of the Company and its Subsidiaries or changes in
circumstances, in any case as permitted hereunder or consented to in accordance
with the provisions hereof.
18
<PAGE> 23
ARTICLE 4
GENERAL COVENANTS
So long as any of the Obligations is outstanding and unpaid, or the
Lender has an obligation to make Advances hereunder, and unless the Lender shall
otherwise consent in writing:
Section 4.1 Preservation of Existence and Similar Matters. Except as
provided in Section 6.6 hereof, the Company will, and will cause each of its
Subsidiaries to, (a) preserve and maintain its existence, licenses and
privileges in its jurisdiction of incorporation including, without limitation,
all Necessary Authorizations and (b) qualify and remain qualified and authorized
to do business in each jurisdiction in which the character of its properties or
the nature of its businesses requires such qualification or authorization.
Section 4.2 Compliance with Applicable Law. The Company will comply,
and will cause each of its Subsidiaries to comply, with the requirements of all
Applicable Laws.
Section 4.3 Maintenance of Properties. The Company will maintain, and
will cause each of its Subsidiaries to maintain, or cause to be maintained in
the ordinary course of business in good repair, working order and condition all
properties (including, without limitation, the Equipment) used or useful in its
business (whether owned or held under lease), and from time to time to make or
cause to be made all needed and appropriate repairs, renewals, replacements,
additions, betterments and improvements thereto.
Section 4.4 Insurance. The Company will:
(a) Maintain insurance including, but not limited to, public
liability, product and manufacturer's liability and fidelity coverage
insurance from responsible companies in such amounts and against such
risks as shall be generally insured against by companies engaging in
businesses similar to that of the Company;
(b) Keep the Collateral insured by insurers on terms and in a
manner based on industry standards for companies engaged in businesses
similar to that of the Company against loss or damage by fire, theft,
burglary, pilferage, loss in transit, explosions, and hazards insured
against by extended coverage, and, with respect to any properties and
assets located in a designated flood plain, flood insurance, all in
amounts reasonably satisfactory to the Lender and all premiums thereon
to be paid by the Company; and
(c) Require that copies of each such insurance policy referred
to in Section 4.4(b) above shall be provided to the Lender, shall name
the Lender as an additional loss payee, or additional insured, if
appropriate, to the extent of the Obligations, and shall provide for at
least thirty (30) days' prior written notice to the Lender of any
default under, termination of or proposed cancellation of any such
policy and provide confirmation thereof to the Lender on each July 1
and
19
<PAGE> 24
December 31 during the term hereof. All such amounts paid in excess
of $25,000 in respect of any such policy shall be paid directly to the
Lender and shall be applied by it to the payment of any of the
Obligations at the time due and payable.
Section 4.5 Payment of Taxes and Claims. The Company will pay and
discharge, and will cause each of its Subsidiaries to pay and discharge, all
taxes, assessments and governmental charges or levies imposed upon it or upon
its income or profits or upon any properties belonging to it and all lawful
claims for labor, materials and supplies which, if unpaid, might become a Lien
upon any of its properties; except that, no such tax, assessment, charge, levy
or claim need be paid which is being contested in good faith by appropriate
proceedings and for which adequate reserves shall have been set aside on the
appropriate books. The Company shall timely file all information returns
required by federal, state or local tax authorities.
Section 4.6 Visits and Inspections. Upon twenty-four (24) hours'
telephonic notice, the Company shall permit, and will cause each of its
Subsidiaries to permit, representatives of the Lender to visit and inspect the
properties, books and records of the Company during normal business hours and
discuss with its principal officers its businesses, financial positions and
results of operations.
Section 4.7 ERISA. The Company shall at all times make, or cause to be
made, prompt payment of contributions required to meet the minimum funding
standards set forth in ERISA with respect to its and its ERISA Affiliates'
Plans; promptly after the filing thereof, furnish to the Lender copies of any
annual report required to be filed pursuant to ERISA in connection with each
such Plan of it and its ERISA Affiliates; notify the Lenders as soon as
practicable of any Reportable Event and of any additional act or condition
arising in connection with any such Plan which the Company believes might
constitute grounds for the termination thereof by the Pension Benefit Guaranty
Corporation or for the appointment by the appropriate United States District
Court of a trustee to administer such Plan; and furnish to the Lender, promptly
upon the Lender's request therefor, such additional information concerning any
such Plan as may be reasonably requested by the Lender.
Section 4.8 Further Assurances. The Company will promptly cure, or
cause to be cured, defects in the creation and issuance of the Revolving Note
and the execution and delivery of the Loan Documents resulting from any act or
failure to act by the Company or any employee or officer thereof, including this
Agreement and the perfection of any Liens in favor of the Lender.
Section 4.9 Covenants Regarding Formation of New Subsidiaries and
Acquisitions.
(a) As soon as available, but not later than the date of
Acquisition, whether or not such Acquisition constitutes a Material Acquisition,
or the formation of any new Subsidiary of the Company or any of its Subsidiaries
as permitted by this Agreement, the Company and its Subsidiaries, as applicable,
shall:
(i) provide to the Lender copies of a lien search
and report conducted with respect to each
Counterparty proposed to be acquired, which
search and report shall include a review of all
20
<PAGE> 25
Uniform Commercial Code indices, tax lien
records, general execution dockets and
plaintiff/defendant pending case tables as
filed and recorded in the records of all
appropriate jurisdictions;
(ii) execute and deliver to the Lender a certificate
with respect to each Counterparty proposed to
be acquired, or new Subsidiary, substantially
in the form of Exhibit B attached hereto,
together with appropriate attachments thereto;
(iii) with respect to each Counterparty proposed to
be acquired, or any new Subsidiary, execute or
cause the applicable Subsidiary to execute and
deliver to the Lender such collateral documents,
including, without limitation, a supplement to
the Subsidiary Security Agreement, a supplement
to the Subsidiary Guaranty, a trademark security
agreement in the form of Exhibit C-1 hereto, if
applicable, financing statements and such other
documentation for such pledge and assignment as,
in the reasonable opinion of the Lender, is
appropriate, and all of which in such form and
substance as shall be acceptable to the Lender;
(iv) in the case of a new Subsidiary, execute and
deliver to the Lender a supplement to the Stock
Pledge Agreement, in form and substance
satisfactory to Lender, together with original
stock certificates representing all issued and
outstanding shares of capital stock of the new
Subsidiary and stock powers executed in blank;
(v) provide to the Lender a duly executed
certificate signed by an Authorized Signatory
of the Company, or the applicable Subsidiary,
certifying that upon the delivery and proper
filing of each of the documents contemplated
under this Section, the Lender shall have a
first priority perfected security interest,
subject only to Permitted Liens, in all
Collateral acquired as a result of the
Acquisition, or held by the new Subsidiary;
(vi) provide all other documentation, including,
without limitation, to the extent available,
financial statements and information with
respect to such new Subsidiary for the most
recent period ending immediately prior to the
date of such formation and other financial
information, to the extent available, which in
the reasonable opinion of the Lender is
appropriate with respect to such new Subsidiary
to confirm the Company's compliance with the
terms and conditions of this Agreement; and
(vii) at the request of the Lender, provide evidence
of all Necessary Authorizations relating to
such new Subsidiary.
21
<PAGE> 26
(b) In addition to the requirements of Section 4.9(a), with
respect to any Material Acquisition, as soon as available, but not in any event
later than ten (10) days after the date of such Acquisition, the Company, and
its Subsidiaries, as applicable, shall:
(i) provide to the Lender a summary overview of the
Counterparty proposed to be acquired, which shall
include (i) the location of such Counterparty,
(ii) the number of employees of such Counterparty,
(iii) a description of such Counterparty's
business; (iv) the number of customers of such
Counterparty; (v) a list and description of such
Counterparty's products; (vi) a description of the
type of Acquisition (acquisition of assets or
stock, merger or other); (vii) a description of
the ownership of such Counterparty; (viii) a
description of the Company's short- and
intermediate-term consolidation plan; and (ix) a
description of any synergy opportunities
identified by the Company;
(ii) provide the Lender with final, executed, if
applicable, copies of the following documents with
respect to such Acquisition: (x) all letters of
intent, if any, between the Company and each
Counterparty; (y) due diligence checklists
provided by the Company to each Counterparty
substantially in the form of Schedule 1.9(c)(ii)
attached hereto; and (z) the acquisition
agreement, or similar agreement, governing the
Acquisition, together with all schedules and
exhibits thereto;
(iii) provide to the Lender financial information
relating to each Counterparty proposed to be
acquired by the Acquisition, which information
shall include that information more fully set
forth on Schedule 1.9(c)(iv) attached hereto;
(iv) execute and deliver to the Lender an assignment of
each acquisition document from the Company, or the
applicable Subsidiary, to the Lender, in such form
and substance as shall be acceptable to the Lender
and its counsel; and
(v) with respect to any Acquisition the purchase price
of which Acquisition shall be in excess of
$5,000,000, shall use its best efforts to cause
the Lender to be a co-addressee with respect to
the legal opinion delivered to the Company from
the counsel for the seller, or sellers.
(c) In addition to the requirements of Section 4.9(a), with
respect to each Acquisition which shall not constitute a Material Acquisition,
not later than ten (10) days following the date of such Acquisition, the
Company, and its Subsidiaries, as applicable, shall:
(i) provide to the Lender a summary overview of the
Counterparty proposed to be acquired, which shall
include (i) the location of such Counterparty,
(ii) the number of
22
<PAGE> 27
employees of such Counterparty, (iii) a
description of such Counterparty's business;
(iv) the number of customers of such
Counterparty; (v) a list and description of
such Counterparty's products; (vi) a
description of the type of Acquisition
(acquisition of assets or stock, merger or
other); (vii) a description of the ownership of
such Counterparty; (viii) a description of the
Company's short- and intermediate-term
consolidation plan; and (ix) a description of
any synergy opportunities identified by the
Company;
(ii) provide to the Lender financial information
relating to each Counterparty proposed to be
acquired by the Acquisition, which information
shall include that information more fully set
forth on Schedule 1.9(c)(iv) attached hereto;
and
(iii) execute and deliver to the Lender an assignment
of each acquisition documents from the Company,
or the applicable Subsidiary, to the Lender, in
such form and substance as shall be acceptable
to the Lender and its counsel together with
copies of all material documents executed in
connection with the Acquisition certified by an
Authorized Signatory of the Company to be true,
correct and complete copies thereof.
Any document, agreement or instrument executed or issued pursuant to
this Section 4.9 shall be and constitute a "Loan Document" for purposes of this
Agreement.
The requirements of this Section 4.9 shall be separate from and in
addition to the requirements regarding certain Acquisition Advances, including,
without limitation, the requirement that a Request for Acquisition Advance,
together with appropriate attachments, be delivered to the Lender, pursuant to
Section 1.9(c) hereof.
Section 4.10 Indemnity. The Company will indemnify and hold harmless
the Lender and each of its employees, representatives, officers and directors
(collectively, the "Indemnified Parties") from and against any and all claims,
liabilities, losses, damages, actions, and demands by any party (other than with
respect to any claims, actions or demands made by other such indemnified parties
or any liabilities, losses or damages caused thereby) against the Lender,
resulting from any breach or alleged breach by the Company or any of its
Subsidiaries of any representation or warranty made hereunder, or otherwise
arising out of the Commitment or the making, administration or enforcement of
the Loan Documents and the Revolving Loans; unless, with respect to any of the
above, the Lender is finally judicially determined to have acted or failed to
act with gross negligence or willful misconduct. This Section shall survive
termination of this Agreement.
Section 4.11 Use of Proceeds. The Company shall use the proceeds of
Advances hereunder to fund Acquisitions made in compliance with the terms of
this Agreement, for working capital needs and general corporate purposes.
23
<PAGE> 28
ARTICLE 5
INFORMATION COVENANTS
So long as any of the Obligations is outstanding and unpaid or the
Lender has any obligation to make Advances hereunder, and unless the Lender
shall otherwise consent in writing, the Company shall furnish or cause to be
furnished to the Lender:
Section 5.1 Quarterly Financial Statements and Information. Within
sixty (60) days after the last day of each fiscal quarter of the Company, the
balance sheet of the Company as at the end of such quarter, and the related
statement of income and retained earnings and related statement of cash flows of
the Company and for such quarter and for the elapsed portion of the year ended
with the last day of such quarter, which financial statements shall set forth in
comparative form such figures for the same period for the prior calendar year
(all of which shall be on a consolidated basis with the Company's Subsidiaries)
and certified by an Authorized Signatory of the Company to, in his or her
opinion, present fairly, in accordance with GAAP, the financial position of the
Company and its Subsidiaries as at the end of such period, and the results of
operations for such period, and for the elapsed portion of the year ended with
the last day of such period, subject only to normal year-end adjustments,
together with the Form 10-Q Quarterly Report filed by the Company with the
Securities and Exchange Commission with respect to such period.
Section 5.2 Audited Annual Financial Statements and Information:
Certificate of No Default. Within one hundred and twenty (120) days after the
end of each fiscal year of the Company, the balance sheet of the Company as at
the end of such fiscal year and the related statements of income, retained
earnings and cash flow of the Company for such fiscal year and on a consolidated
and a consolidating basis with the Company's Subsidiaries, setting forth in
comparative form the figures as at the end of and for the previous fiscal year
and certified by independent certified public accountants of recognized national
standing whose opinion shall not be qualified as to the scope of audit or as to
the status of the Company or any of the Subsidiaries as a going concern,
together in any event with a certificate of such accounting firm stating that in
the course of its regular audit of the business of the Company and the
Subsidiaries, which audit was conducted in accordance with generally accepted
auditing standards, such accounting firm has obtained no knowledge of any
Default or Event of Default relating to Sections 6.9, 6.10, 6.11, 6.12 and 6.13
that has occurred and is continuing or, if in the opinion of such accounting
firm such a Default or Event of Default has occurred and is continuing, a
statement as to the nature thereof, and who shall have authorized the Company to
deliver such financial statements and opinion thereon to the Lender pursuant to
this Agreement.
Section 5.3 Covenant Compliance Certificates. At the time financial
statements are required to be provided under Sections 5.1 and 5.2, a
certificate, substantially in the form of Exhibit E attached hereto, of an
Authorized Signatory of the Company (i) setting forth as at the end of such
quarter or calendar year, as the case may be, the arithmetical calculations
required to establish whether or not the Company was in compliance with the
requirements of Sections 6.9, 6.10, 6.11, 6.12 and 6.13 hereof, (ii) setting
forth as at the end of such quarter the arithmetical calculations required to
establish the Advance Rate of the Company to be applied with respect to Advances
made during the succeeding quarter; (iii) stating that, to the best of his or
her knowledge, no Default or Event of Default has occurred as at the end of such
quarter or year, as the case may be, or, if a Default or an Event of Default has
occurred, disclosing each such Default or Event of Default and its nature, when
it occurred, whether it is continuing, and the steps being taken by the Company
with respect to such Default or Event of Default and (iv) setting forth a list
and description of, together with applicable financial statements, if available,
with respect to each Acquisition by the Company or any of its Subsidiaries
during the period for which such Compliance Certificate is being given.
24
<PAGE> 29
Section 5.4 Copies of Other Reports. The Company shall deliver, or
cause to be delivered, to the Lender:
(1) As soon as available, but not in any event, without the
prior written consent of the Lender, later than March 31 of each fiscal year of
the Company, an annual business and financial plan with respect to the Company's
business for the current fiscal year;
(2) Promptly upon receipt thereof, copies of all reports, if
any, submitted to the Company by the Company's independent public accountants
regarding the Company, including, without limitation, any management report
prepared in connection with the annual audit referred to in Section 5.2 hereof;
(3) Promptly after the sending thereof, copies of all
statements, reports and other material financial information which the Company
or any of its Subsidiaries shall send to its respective shareholders;
(4) Promptly after the preparation of the same, copies of all
material reports or financial information filed with any governmental agency,
department, bureau, division or other governmental authority or regulatory body,
or evidencing facts or containing information which could have a Materially
Adverse Effect; and
(5) At the time financial statements are required to be provided
under Section 5.1, a written list of each Material Customer Contract then in
effect (noting any Material Customer Contracts that have been either added or
deleted with respect to the prior quarter).
(6) From time to time and promptly upon each request, such data,
certificates, reports, statements, opinions of counsel, documents, or further
information regarding the Collateral or the business, assets, liabilities,
financial position, projections, results of operations or business prospects of
the Company and its Subsidiaries, as the Lender reasonably may request.
Section 5.5 Notice of Litigation and Other Matters. Prompt notice of
the following events after the Company has, or in the exercise of reasonable
diligence should have, received notice thereof:
(a) The commencement of all proceedings and investigations by or
before any governmental body and all actions and proceedings in any
court or before any arbitrator (i) against, or (ii) (to the extent
known to the Company) in any other way relating adversely to, the
Company or any of its Subsidiaries or any of their respective assets or
businesses which, if adversely determined, would singly or when
aggregated with all other such proceedings, investigations, and
actions, if adversely determined, have a Materially Adverse Effect;
25
<PAGE> 30
(b) Any material adverse change with respect to the business,
assets, liabilities, financial position, results of operations or
business prospects of the Company or any of its Subsidiaries other than
changes in the ordinary course of business the effects of which have
not had, and are not reasonably expected to have, a Materially Adverse
Effect;
(c) Any Default or Event of Default or the occurrence or
non-occurrence of any event which constitutes, or which with the
passage of time or giving of notice (or both) would constitute a
default by the Company or any of its Subsidiaries under any material
agreement other than this Agreement to which the Company or any of its
Subsidiaries is a party or by which its respective properties may be
bound, giving in each case the details thereof and specifying the
action proposed to be taken with respect thereto;
(d) The occurrence of any Reportable Event or a "prohibited
transaction" (as such term is defined in Section 406 of ERISA or
Section 4975 of the Code) with respect to any Plan of the Company or
any of its ERISA Affiliates or the institution or threatened
institution by the Pension Benefit Guaranty Corporation of proceedings
under ERISA to terminate or to partially terminate any such Plan or the
commencement or threatened commencement of any litigation regarding any
such Plan or naming it or the Trustee of any such Plan with respect to
such Plan; and
(e) The occurrence of any event subsequent to the Agreement Date
which, if such event had occurred prior to the Agreement Date, would
have constituted an exception to the representations and warranties in
Sections 3.1(c), (d), (f), (h), (i), (k), (l) or (u) of this Agreement.
ARTICLE 6
NEGATIVE COVENANTS
So long as any of the Obligations is outstanding and unpaid or the
Lender have an obligation to make Advances hereunder, and unless the Lender
shall otherwise consent in writing, the Company hereby agrees that:
Section 6.1 Indebtedness. The Company shall not create, assume, incur
or otherwise become or remain obligated in respect of, or permit to be
outstanding, and shall not permit any of its Subsidiaries to create, assume,
incur, or otherwise become obligated in respect of, or permit to be outstanding,
any Indebtedness except:
(a) Indebtedness under this Agreement and the other Loan
Documents;
(b) Trade or accounts payable and/or similar obligations, and
accrued expenses, incurred in the ordinary course of
business, other than for borrowed money;
(c) Indebtedness incurred in connection with any Acquisition in
favor of any Counterparty, including, without limitation,
under any hold-back note, which Indebtedness is expressly
subordinated to Indebtedness
26
<PAGE> 31
under this Agreement and the other Loan Documents by
language to which the Lender has given its prior approval;
(d) Intercompany Indebtedness among the Company and its
Subsidiaries; provided, that the repayment of any such
Indebtedness owed by the Company or any of its Subsidiary
to any Subsidiary not a Credit Party pursuant to the terms
of this Agreement shall be subordinated to the prior
payment in full of the Obligations;
(e) Indebtedness owed by any Counterparty proposed to be
acquired in an Acquisition which Indebtedness is
outstanding as at the date of such Acquisition; provided,
however, that Indebtedness for money borrowed assumed in
connection with all Acquisitions shall not be in excess of
$1,000,000 in the aggregate; and
(f) Indebtedness secured by Permitted Liens.
Section 6.2 Guaranties. The Company shall not, and shall not permit any
of its Subsidiaries to, at any time enter into or Guaranty, or assume, be
obligated with respect to, or permit to be outstanding, any Guaranty, other than
(a) obligations under repurchase agreements of the Company entered into in
connection with the sale of products in the ordinary course of business of the
Company, (b) obligations under agreements to indemnify persons or entities which
have issued bid or performance bonds or letters of credit in the ordinary course
of business of the Company securing performance by the Company of activities
permissible hereunder, (c) obligations under agreements of the Company entered
into in connection with the acquisition of services, supplies and equipment in
the ordinary course of business of the Company, (d) obligations of any
Subsidiary under agreements entered into by such Subsidiary in the ordinary
course of business, (e) Indebtedness of the Company and any of its Subsidiaries
permitted to be incurred pursuant to Section 6.1 hereof; and (f) any Guaranty in
favor of the Lender.
Section 6.3 Liens. The Company shall not create, assume, incur, or
permit to exist or to be created, assumed, or permitted to exist, directly or
indirectly, and shall not permit any of its Subsidiaries to create, assume,
incur, or permit to exist or to be created, assumed, or permitted to exist,
directly or indirectly, any Lien on any of its property, real or personal, now
owned or hereafter acquired, except for Permitted Liens.
Section 6.4 Restricted Payments and Purchases. The Company shall not,
and shall not permit any of its Subsidiaries to, directly or indirectly declare
or make any Restricted Payment or Restricted Purchase, or set aside any funds
for any such purpose, other than the Restricted Payments and Restricted
Purchases described on Schedule 6.4 attached hereto.
Section 6.5 Investments. Except for Acquisitions not prohibited by the
terms of this Agreement, the Company shall not, and shall not permit any of its
Subsidiaries to, make any loan, advance, or otherwise acquire for consideration
evidences of Indebtedness, capital stock, partnership interests or other
securities of or equity interests in any third party, except that the Company
and its Subsidiaries may purchase or otherwise acquire, own, (a) marketable,
direct obligations of the United States of America
27
<PAGE> 32
and its agencies maturing within three hundred sixty-five (365) days of the date
of purchase, (b) commercial paper issued by corporations, each of which shall
(i) have a consolidated net worth of at least $250,000,000 and (ii) will mature
within one hundred eighty (180) days from the date of the original issue thereof
and is rated "P-2" or better by Moody's Investors Service, Inc., or "A-2" or
better by Standard & Poor's Corporation, (c) certificates of deposit maturing
within three hundred sixty-five (365) days of the date of purchase and issued by
a United States national or state bank having deposits totaling more than
$250,000,000, and whose short-term debt is rated "P-2" or better by Moody's
Investors Service, Inc. or "A-2" or better by Standard & Poor's Corporation and
(d) up to $100,000 per institution and up to $1,000,000 in the aggregate in (i)
short-term obligations issued by any local commercial bank or trust company
located in those areas where the Company or any of its Subsidiaries conducts its
business, whose deposits are insured by the Federal Deposit Insurance
Corporation, or (ii) commercial bank-insured money market funds, or any
combination of investments described in clauses (i) and (ii).
Section 6.6 Liquidation; Disposition or Acquisition of Assets. Except
with respect to Acquisitions otherwise governed by the terms of this Agreement,
the Company shall not, and shall not permit any of its Subsidiaries to, at any
time:
(a) (i) liquidate or dissolve itself (or suffer any
liquidation or dissolution) or otherwise wind up, or (ii) sell, lease,
abandon, transfer or otherwise dispose of any assets or business (other
than obsolete equipment and inventory or other property in the ordinary
course of business) or (iii) enter into any merger or consolidation,
except that Subsidiaries may merge with each other or the Company or
(iv) convey, pledge, encumber or otherwise transfer any of its shares
or issue any new shares of any existing Subsidiaries to any Person
other than the Company or any other Subsidiary;
(b) except for Capital Expenditures in the ordinary course
of the Company's business, acquire the assets, property, stock or
business of any other Person, except that so long as no Event of
Default then exists or would be caused thereby, the Company and its
Subsidiaries may make Acquisitions subject to compliance with the terms
and conditions of Sections 1.9 and 4.9 hereof as applicable.
Section 6.7 Change of Name or Year. The Company shall not, and shall
not permit any of its Subsidiaries to, at any time:
(a) Change its corporate name without giving the Lender
thirty (30) days prior written notice of its intention to do so
and complying with all reasonable requirements of the Lender in
regard thereto; or
(b) Change its fiscal year-end for accounting purposes from
a calendar year-end.
Section 6.8 Affiliate Transactions. The Company shall not at any time
engage in any transaction with an Affiliate (except an Affiliate which
constitutes a Credit Party pursuant to the terms of this Agreement) on terms
generally less advantageous to the Company than would be the case if such
transaction had been effected with a non-Affiliate.
28
<PAGE> 33
Section 6.9 Debt/Capitalization Ratio. The Company shall not, at any
time, permit its ratio of (i) Debt to (ii) Capitalization to exceed 1.0 to 1.0.
If, in connection with a Material Acquisition, the Company determines
that the accounting treatment for "acquired in-process research and development
expense, and similar expense," might result in a default under this Section 6.9,
the Company may request the Lender to modify the Debt/Capitalization Ratio so
that no default shall occur as a result of such acquisition and accounting
treatment. Upon such request, the Lender agrees to consider such request in the
exercise of its reasonable business and financial judgment; provided that, any
decision with respect to such request shall be in the sole and absolute
discretion of the Lender.
Section 6.10 Cash Flow Leverage Ratio. The Company shall not, at any
time, permit its ratio of (i) Total Funded Debt to (ii) EBITDA to exceed 3.0 to
1.0.
Section 6.11 Debt Service Coverage Ratio. The Company shall not, at any
time during the term of this Agreement, permit its Debt Service Coverage Ratio
to be less than 1.25 to 1.0.
Section 6.12 Restricted Payments. The Company shall not apply any sums
to the redemption, retirement or purchase or any warrant, option or share of its
capital stock, or to the payment of any dividend or other distributions thereon,
if after such application shall have been made, the aggregate of the sums so
applied since the Agreement Date exceed ten percent (10%) of the Net Income of
the Company determined on a cumulative basis as of the end of each fiscal year
commencing December 31, 1997.
Section 6.13 Minimum Net Worth. The Company shall not, at any time
during the term of this Agreement, permit the sum of (i) the Company's Net Worth
plus (ii) any non-cash charges and expenses related to Acquisitions or research
and development, including, without limitation, acquired in-process research and
development expense and similar expenses, to be less than $16,000,000.
ARTICLE 7
DEFAULT
Section 7.1 Events of Default. Each of the following shall constitute
an Event of Default, whatever the reason for such event and whether it shall be
voluntary or involuntary or be effected by operation of law or pursuant to any
judgment or order of any court or any order, rule or regulation of any
governmental or non-governmental body:
(a) Any representation or warranty made under this Agreement or
any other Loan Document shall prove incorrect or misleading in any
material respect when made;
(b) The Company shall default in the payment of any fees due
hereunder or of any principal or interest under the Revolving Note
within five (5) days from when any such payment is due;
29
<PAGE> 34
(c) The Company shall default in the performance or observance
of any agreement or covenant contained in Article 6 hereof;
(d) The Company shall default in the performance or observance
of any other agreement or covenant contained in this Agreement not
specifically referred to elsewhere in this Section 7.1, and such
Default shall not be cured to the Lender's satisfaction within a period
of thirty (30) days after notice thereof by the Lender to the Company;
(e) There shall occur any default in the performance or
observance of any agreement or covenant or breach of any representation
or warranty contained in any of the Loan Documents (other than this
Agreement), which shall not be cured within any applicable grace period
set forth therein, or the Company or any Affiliate shall in any way
challenge, or any proceedings shall in any way be brought to challenge
(and, in the case of a proceeding brought by someone other than the
Company or any Affiliate, shall continue unstayed for a period of
thirty (30) days), the prior (subject to Permitted Liens) and perfected
status of the Lender's security interest with respect to the Collateral
or the validity or enforceability of such security interest;
(f) There shall be entered a decree or order by a court having
jurisdiction in the premises constituting an order for relief in
respect of the Company or any of its Subsidiaries under Title 11 of the
United States Code, as now constituted or hereafter amended, or any
other applicable federal or state bankruptcy law or other similar law,
or appointing a receiver, liquidator, assignee, trustee, custodian,
sequestrator or similar official of the Company or any of its
Subsidiaries or of any substantial part of the properties of the
Company and its Subsidiaries on a consolidated basis, or ordering the
winding-up or liquidation of the affairs of the Company or any of its
Subsidiaries and any such decree or order shall continue in effect for
a period of forty-five (45) consecutive days;
(g) The Company or any of its Subsidiaries shall file a
petition, answer or consent seeking relief under Title 11 of the United
States Code, as now constituted or hereafter amended, or any other
applicable federal or state bankruptcy law or other similar law, or the
Company or any of its Subsidiaries shall consent to the institution of
proceedings thereunder or to the filing of any such petition or to the
appointment or taking of possession of a receiver, liquidator,
assignee, trustee, custodian, sequestrator or other similar official of
the Company or any of its Subsidiaries or of any substantial part of
properties, or the Company or any of its Subsidiaries shall fail
generally to pay its debts as such debts become due, or the Company or
any of its Subsidiaries shall take any corporate action in furtherance
of any such action;
(h) A final judgment shall be entered by any court against the
Company for the payment of money which is not covered in whole by
insurance and exceeds $100,000, or a warrant of attachment or execution
or similar process shall be issued or levied against property of the
Company which, together with all other such property of the Company
subject to other such process, exceeds in value $100,000 in the
aggregate, and if, within thirty (30) days after the entry, issue or
levy thereof, such judgment, warrant or process shall not have been
paid or
30
<PAGE> 35
discharged or stayed pending appeal, or if, after the expiration of any
such stay, such judgment, warrant or process shall not have been paid
or discharged;
(i) There shall occur a Change of Control;
(j) Any event shall occur which has a Materially Adverse Effect;
(k) There shall be at any time any "accumulated funding
deficiency," as defined in ERISA or in Section 412 of the Code, with
respect to any Plan maintained by the Company or any of its ERISA
Affiliates, or to which the Company or any of its ERISA Affiliates has
any liabilities, or any trust created thereunder; or a trustee shall be
appointed by a United States District Court to administer any such
Plan; or the Pension Benefit Guaranty Corporation shall institute
proceedings to terminate any such Plan; or the Company or any of its
ERISA Affiliates shall incur any liability to the Pension Benefit
Guaranty Corporation in connection with the termination of any such
Plan; or any Plan or trust created under any Plan of the Company or any
of its ERISA Affiliates shall engage in a "prohibited transaction" (as
such term is defined in Section 406 of ERISA or Section 4975 of the
Code) which would subject any such Plan, any trust created thereunder,
any trustee or administrator thereof, or any party dealing with any
such Plan or trust to the tax or penalty on "prohibited transactions"
imposed by Section 502 of ERISA or Section 4975 of the Code; or the
Company or any of its ERISA Affiliates shall enter into or become
obligated to contribute to a Multiemployer Plan;
(l) There shall occur any default under any indenture, agreement
or instrument evidencing any Indebtedness of the Company or any of its
Subsidiaries, which default is not cured or waived within any
applicable cure period; or
(m) Any Loan Document or provision thereof shall at any time and
for any reason be declared by a court of competent jurisdiction to be
null and void, or a proceeding shall be commenced by the Company or any
Affiliate or by any governmental authority having jurisdiction over the
Company or any Affiliate seeking to establish the invalidity or
unenforceability thereof (exclusive of questions of interpretation of
any provision thereof), or the Company or any Affiliate shall deny that
it has any liability or any obligation for the payment of principal or
interest purported to be created under any Loan Document.
Section 7.2 Remedies. If an Event of Default shall have occurred and
shall be continuing, the Lender shall have the right and option, in its sole
discretion, to do any one or more of the following:
(a) Not make any further Advances;
(b) Declare the principal of and interest on the Revolving
Loans and the Revolving Note, all other amounts owed under this
Agreement or the Revolving Note, and all other Obligations to be
forthwith due and payable, whereupon all such amounts shall immediately
become absolute and due and payable, without presentment, demand,
protest or notice of any kind, all of which are hereby
31
<PAGE> 36
expressly waived, anything in this Agreement or in the Revolving Note
to the contrary notwithstanding, whereupon all such amounts shall be
due;
(c) Exercise all of the post-default rights granted to it under
the Loan Documents; and
(d) Exercise all rights and remedies available to it at law or
in equity.
ARTICLE 8
MISCELLANEOUS.
Section 8.1 Notices.
(1) Any notices required or permitted to be sent hereunder shall be
delivered personally or mailed, certified mail, return receipt requested or
delivered by overnight courier service to the following addresses, or such other
address as any party hereto designates by written notice to the Company, the
Lender, and shall be deemed to have been given upon delivery, if delivered
personally, three (3) days after mailing, if mailed, or one (1) Business Day
after delivery to the courier, if delivered by overnight courier service:
(i) If to the Company, to it at:
Two Piedmont Center, Suite 400
3565 Piedmont Road, N.E.
Atlanta, Georgia 30305-1502
Attn: Chief Financial Officer
Telecopy No.: (404) 364-6703
with a copy (which shall not constitute notice) to:
Douglas B. Chappell, Esq.
Alston & Bird LLP
One Atlantic Center
1201 West Peachtree Street
Atlanta, Georgia 30309-3424
Telecopy No.: (404) 881-7777
(ii) If to the Lender, to it at:
Deborah Levin, Senior Vice President
NationsBank, N.A.
High Tech, 18th Floor
600 Peachtree Street
Atlanta, GA 30308-2213
Telecopy No.: (404) 607-6338
32
<PAGE> 37
with a copy (which shall not constitute notice) to:
Wayne Shortridge, Esq.
Paul, Hastings, Janofsky & Walker LLP
600 Peachtree Street
Suite 2400
Atlanta, GA 30308-2222
Telecopy No.: (404) 815-2424
(b) Any party hereto may change the address to which notices shall be
directed under this Section 8.1 by giving ten (10) days' written notice of such
change to the other parties.
Section 8.2 Expenses. The Company will promptly pay:
(a) Upon closing of this Agreement, all out-of-pocket expenses of the
Lender in connection with the preparation, negotiation, execution and delivery
of this Agreement, the Revolving Note and the other Loan Documents, including
all post-closing matters, and the transactions contemplated hereunder and
thereunder and the making of the Revolving Loans hereunder including, but not
limited to, outside auditor costs, title and other insurance premiums, recording
fees, and intangible, documentary stamp and other taxes and the reasonable
attorneys' fees and disbursements of counsel for the Lender and the reasonable,
allocated costs for services of internal counsel for the Lender;
(b) All out-of-pocket expenses of the Lender in connection with the
administration of the Revolving Loans and the Loan Documents in accordance with
the provisions thereof, the restructuring, refinancing and "work-out" of the
transaction herein contemplated, and the preparation, negotiation, execution and
delivery of any waiver, amendment or consent by the Lender relating to this
Agreement or the other Loan Documents, including, but not limited to, the
reasonable attorneys' fees and disbursements of counsel for the Lender and the
reasonable, allocated costs for services of internal counsel for the Lender and
post-closing filing fees; and
(c) All costs and out-of-pocket expenses of obtaining performance under
this Agreement or the other Loan Documents and all costs and out-of-pocket
expenses of collection if default is made in the payment of the Revolving Note,
which in each case shall include reasonable fees and expenses of counsel for the
Lender and the reasonable allocated costs for services of internal counsel for
the Lender.
Section 8.3 Waivers. The rights and remedies of the Lender under this
Agreement and the other Loan Documents shall be cumulative and not exclusive of
any rights or remedies which it would otherwise have. No failure or delay by the
Lender in exercising any right shall operate as a waiver of such right. Any
waiver or indulgence granted by the Lender shall not constitute a modification
of this Agreement, except to the extent expressly provided in such waiver or
indulgence, or constitute a course of dealing by the Lender at variance with the
terms of this Agreement such as to require further notice by the Lender of the
Lender's intent to require strict adherence to the terms of this Agreement in
the future.
33
<PAGE> 38
Section 8.4 Set-Off. In addition to any rights now or hereafter granted
under Applicable Law and not by way of limitation of any such rights, upon the
occurrence of a Default or an Event of Default, the Lender and any subsequent
holder of the Revolving Note are hereby authorized by the Company at any time or
from time to time, without notice to the Company, or to any other Person, any
such notice being hereby expressly waived, to set-off, to appropriate and to
apply any and all deposits (general or special, time or demand, including, but
not limited to, Indebtedness evidenced by certificates of deposit, in each case
whether matured or unmatured) and any other Indebtedness at any time held or
owing by the Lender or such holder to or for the credit or the account of the
Company, as the case may be, against and on account of the obligations and
liabilities of the Company, as the case may be, to the Lender or such holder
under this Agreement, the Revolving Note, and any other Loan Document,
including, but not limited to, all claims of any nature or description arising
out of or connected with this Agreement, the Revolving Note, or any other Loan
Document, irrespective of whether or not (a) the Lender or the holder of the
Revolving Note shall have made any demand hereunder or (b) the Lender shall have
declared the principal of and interest on the Revolving Loans and the Revolving
Note and other amounts due hereunder to be due and payable as permitted by
Section 7.2 hereof and although said obligations and liabilities, or any of
them, shall be contingent or unmatured.
Section 8.5 Assignment.
(a) The Company may not assign or transfer any of its rights or
obligations hereunder or under the Revolving Note without the prior written
consent of the Lender.
(b) The Lender may at any time grant participations in, or sell,
assign, transfer or otherwise dispose of, all or any portion of the Indebtedness
of the Company outstanding pursuant to this Agreement and the Revolving Note
upon prior written notice to the Company. The Company hereby agrees that any
holder of a participation in, and any assignee or transferee of, all or any
portion of any amount owed by the Company under this Agreement and the Revolving
Note (i) shall be entitled to the benefits of the provisions of this Agreement
as a lender hereunder and (ii) may exercise any and all rights of banker's lien,
set-off or counterclaim with respect to any and all amounts owed by the Company
to such assignee, transferee or holder as fully as if such assignee, transferee
or holder had made the Revolving Loans in the amount of the obligation in which
it holds a participation or which is assigned or transferred to it.
(c) Except as specifically set forth in Section 8.5(b) hereof, nothing
in this Agreement or the Revolving Note, expressed or implied, is intended to or
shall confer on any person other than the respective parties hereto and thereto
and their successors and assignees permitted hereunder and thereunder any
benefit or any legal or equitable right, remedy or other claim under this
Agreement or the Revolving Note.
Section 8.6 Counterparts. This Agreement may be executed in any number
of counterparts, each of which shall be deemed to be an original, but all such
separate counterparts shall together constitute but one and the same instrument.
Section 8.7 Governing Law. This Agreement and the Revolving Note shall
be construed in accordance with and governed by the law of the State of Georgia.
34
<PAGE> 39
Section 8.8 Severability. Any provision of this Agreement which is
prohibited or unenforceable shall be ineffective to the extent of such
prohibition or unenforceability without invalidating the remaining provisions
hereof in that jurisdiction or affecting the validity or enforceability of such
provision in any other jurisdiction.
Section 8.9 Interest and Charges. The Company and the Lender hereby
agree that (a) the only charge imposed by the Lender upon the Company for the
use of money in connection with the Revolving Loans is and shall be the interest
expressed herein, as provided in the Revolving Note and the loan fees described
in Section 1.6 hereof and (b) all other charges imposed by the Lender upon the
Company in connection with the Revolving Loans, including, without limitation,
any loan fee, default and late charges and charges for taxes and reserve
requirements, are and shall be deemed to be charges made to compensate the
Lender for administrative services and costs and other services and costs
performed and incurred, and to be performed and incurred, by the Lender in
connection with the Revolving Loans, and shall under no circumstances be deemed
to be charges for the use of money. All charges referred to herein shall be
fully earned when due and non-refundable when paid.
Section 8.10 Headings. Headings used in this Agreement are for
convenience only and shall not be used in connection with the interpretation of
any provision hereof.
Section 8.11 Pronouns. The pronouns used herein shall include, when
appropriate, either gender and both singular and plural, and the grammatical
construction of sentences shall conform thereto.
Section 8.12 Entire Agreement; Amendments. This Agreement and the other
Loan Documents represent the entire agreement between the Company and the Lender
with respect to the subject matter of this transaction. No amendment or
modification of the terms and provisions of this Agreement shall be effective
unless in writing and signed by the Lender and the Company.
ARTICLE 9
YIELD PROTECTION
Section 9.1 LIBOR Rate Basis Determination. Notwithstanding anything
contained herein which may be construed to the contrary, if with respect to any
proposed LIBOR Rate Advance for any LIBOR Advance Period, the Lender determines
that deposits in dollars (in the applicable amount) are not being offered to the
Lender in the relevant market for such LIBOR Advance Period, the Lender shall
forthwith give notice thereof to the Company, whereupon until the Lender
notifies the Company that the circumstances giving rise to such situation no
longer exist, the obligations of the Lender to make such types of LIBOR Rate
Advances shall be suspended.
Section 9.2 Illegality. If any applicable law, rule or regulation, or
any change therein, or any interpretation or change in interpretation or
administration thereof by any governmental authority, central bank or comparable
agency charged with the interpretation or administration thereof, or compliance
by the Lender with any request or directive (whether or not having the force of
law) of any such authority, central bank or
35
<PAGE> 40
comparable agency, shall make it unlawful or impossible for the Lender to make,
maintain or fund its LIBOR Rate Advances, the Lender shall so notify the
Company. Before giving any notice to the Company pursuant to this Section 9.2,
the Lender shall designate a different lending office if such designation will
avoid the need for giving such notice and will not, in the judgment of the
Lender, be otherwise disadvantageous to the Lender. Upon receipt of such notice,
notwithstanding anything contained in Article 1 hereof, the Company shall repay
in full the then outstanding principal amount of each affected LIBOR Rate
Advance, together with accrued interest thereon, either (a) on the last day of
the then current LIBOR Advance Period applicable to such LIBOR Rate Advance if
the Lender may lawfully continue to maintain and fund such LIBOR Rate Advance to
such day or (b) immediately if the Lender may not lawfully continue to fund and
maintain such LIBOR Rate Advance to such day; provided, however, that
notwithstanding any provision contained in this Agreement to the contrary, the
Company shall not be required to compensate the Lender for any losses, including
any loss or expenses incurred by reason of the liquidation, reemployment of
deposits or other funds acquired to obtain the LIBOR Rate Advance, incurred as a
consequence of any required conversion of a LIBOR Rate Advance to a Base Rate
Advance as hereinafter provided, as a result of the events described in this
Section. Concurrently with repaying each affected LIBOR Rate Advance,
notwithstanding anything contained in Article 1 hereof, the Company shall borrow
a Base Rate Advance (or the other type of LIBOR Rate Advance, if available) from
the Lender, and the Lender shall make such Advance in an amount such that the
outstanding principal amount of the Revolving Note shall equal the outstanding
principal amount of the Revolving Note immediately prior to such repayment.
Section 9.3 Increased Costs.
(a) If any Applicable Law, rule or regulation, or any change
therein, or any interpretation or change in interpretation or administration
thereof by any governmental authority, central bank or comparable agency charged
with the interpretation or administration thereof or compliance by the Lender
with any request or directive (whether or not having the any such authority,
central bank or comparable agency:
(i) Shall subject the Lender to any tax, duty or other charge
with respect to its obligation to make LIBOR Rate Advances, or its
LIBOR Rate Advances, or shall change the basis of taxation of payments
to the Lender of the principal of or interest on its LIBOR Rate
Advances or in respect of any other amounts due under this Agreement in
respect of its LIBOR Rate Advances or its obligation to make LIBOR Rate
Advances (except for changes in the rate of tax on the overall net
income of the Lender imposed by the jurisdiction in which the Lender's
principal executive office is located); or
(ii) Shall impose, modify, or deem applicable any reserve
(including, without limitation, any imposed by the Board of Governors
of the Federal Reserve System, but excluding any included in an
applicable LIBOR Reserve Percentage), special deposit, capital
adequacy, assessment or other requirement or condition against assets
of, deposits with or for the account of, or commitments or credit
extended by the Lender, or shall impose on the Lender or the eurodollar
interbank borrowing market any other condition affecting its obligation
to make such
36
<PAGE> 41
LIBOR Rate Advances or its LIBOR Rate Advances; and the result of any
of the foregoing is to increase the cost to the Lender of making or
maintaining any such LIBOR Rate Advances, or to reduce the amount of
any sum received or receivable by the Lender under this Agreement or
under the Revolving Note with respect thereto, and such increase is not
given effect in the determination of the LIBOR Rate then,
on the earlier of demand by the Lender or the Maturity Date, the Company agrees
to pay to the Lender such additional amount or amounts as will compensate the
Lender for such increased costs. The Lender will promptly notify the Company of
any event of which it has knowledge, occurring after the date hereof, which will
entitle the Lender to compensation pursuant to this Section 9.3 and will
designate a different lending office if such designation will avoid the need
for, or reduce the amount of, such compensation and will not, in the sole
judgment of the Lender, be otherwise disadvantageous to the Lender.
(b) A certificate of the Lender claiming compensation under this
Section 11.9 and setting forth the additional amount or amounts to be paid to it
hereunder and calculations therefor shall be conclusive in the absence of
manifest error. In determining such amount, the Lender may use any reasonable
averaging and attribution methods. If the Lender demands compensation under this
Section 9.3, the Company may at any time, upon at least five (5) Business Days'
prior notice to the Lender, prepay in full the then outstanding affected LIBOR
Rate Advances of the Lender, together with accrued interest thereon to the date
of prepayment, along with any reimbursement required under Section 1.8 hereof.
Concurrently with prepaying such LIBOR Rate Advances, the Company shall borrow a
Base Rate Advance, or a LIBOR Rate Advance not so affected, from the Lender, and
the Lender shall make such Advance in an amount such that the outstanding
principal amount of the Revolving Note shall equal the outstanding principal
amount of the Revolving Note immediately prior to such prepayment.
Section 9.4 Effect On Other Advances. If notice has been given pursuant
to Section 9.1, 9.2 or 9.3 suspending the obligation of the Lender to make any
type of LIBOR Rate Advance, or requiring LIBOR Rate Advances of the Lender to be
repaid or prepaid, then, unless and until such Lender notifies the Company that
the circumstances giving rise to such repayment no longer apply, all Advances
which would otherwise be made by the Lender as to the type of LIBOR Rate
Advances affected shall, at the option of the Company, be made instead as Base
Rate Advances.
Section 9.5 Capital Adequacy. If after the date hereof, the Lender (or
any Affiliate of the Lender) shall have reasonably determined that the adoption
of any applicable law, governmental rule, regulation or order regarding the
capital adequacy of banks or bank holding companies, or any change therein, or
any change in the interpretation or administration thereof by any governmental
authority, central bank or comparable agency charged with the interpretation or
administration thereof, or compliance by the Lender (or any Affiliate of the
Lender) with any request or directive regarding capital adequacy (whether or not
having the force of law) of any such governmental authority, central bank or
comparable agency, has or would have the effect of reducing the rate of return
on the Lender's (or any Affiliate of the Lender) capital as a consequence of the
Lender's Commitment or Obligations hereunder to a level below that which it
could have achieved but for such adoption, change or compliance (taking into
consideration the Lender's (or any Affiliate of the Lender) policies with
respect to capital adequacy immediately before such adoption, change or
compliance and assuming that the Lender's (or any Affiliate of the Lender)
capital was fully utilized prior to such adoption,
37
<PAGE> 42
change or compliance), then, upon demand by the Lender, the Company shall
immediately pay to the Lender such additional amounts as shall be sufficient to
compensate the Lender for any such reduction actually suffered; provided,
however, that there shall be no duplication of amounts paid to the Lender
pursuant to this sentence and Section 9.3 hereof. A certificate of the Lender
setting forth the amount to be paid to it by the Company as a result of any
event referred to in this paragraph shall, absent manifest error, be conclusive.
ARTICLE 10
DEFINITIONS
For the purposes of this Agreement:
"Accounts" shall mean all accounts, contract rights, chattel paper,
notes receivable, drafts, acceptances, instruments and documents and similar
instruments and documents of the Company arising from the sale of goods or the
rendering of services by the Company in the ordinary course of its business,
whether secured or unsecured, and whether now existing or hereafter created or
arising.
"Acquisition" shall mean any business combination, by acquisition of
assets, stock, merger or otherwise, by the Company or any of its Subsidiaries
with any other Person, which Person shall then become part of the consolidated
group with the Company or any such Subsidiary in accordance with GAAP. The
surviving entity of any Acquisition (if not the Company or any existing
Subsidiary of the Company) shall thereafter be deemed a Subsidiary for all
purposes under this Agreement.
"Acquisition Advance" shall mean an Advance the proceeds of which shall
be used to fund the purchase price of a Material Acquisition, in whole or in
part, and advanced subject to the terms and conditions of Section 1.9 hereof.
"Advance" shall mean the amounts of the Revolving Loans advanced by the
Lender to the Company pursuant to the terms hereof on the occasion of any
borrowing, which amounts shall include, without limitation, those amounts
advanced pursuant to any Acquisition Advance subject to Section 1.9 hereof.
"Advance Rate" shall mean, at any particular time, the product of (a)
EBITDA times (b) three (3). The Advance Rate in effect as of the last date of
any quarter shall remain in effect until delivery of the financial statements
under Section 5.1 hereof.
"Affiliate" shall mean any Person directly or indirectly controlling,
controlled by or under common control with the Company, and any Person who is a
director, officer or shareholder owning, or having the right to acquire, more
than ten percent (10%) of the issued and outstanding voting capital stock of the
Company. For purposes of this definition, "control", when used with respect to
any Person, includes, without limitation, the direct or indirect beneficial
ownership of ten percent (10%) or more of the outstanding voting securities or
voting equity of such Person or the power to direct or cause the direction of
the management and policies of such Person whether by contract or otherwise.
38
<PAGE> 43
"Agreement" shall mean this Agreement.
"Agreement Date" shall mean the date as of which this Agreement is
dated.
"Applicable Interest Rate Margin" shall have the meaning set forth in
Section 1.3(c) hereof.
"Applicable Law" shall mean in respect of any Person, all provisions of
constitutions, statutes, rules, regulations and orders of governmental bodies or
regulatory agencies applicable to such Person, and all orders and decrees of all
courts and arbitrators in proceedings or actions to which the Person in question
is a party or by which it or its properties are bound.
"Authorized Signatory" shall mean such senior personnel of the Company
as may be duly authorized and designated in writing by the Company to execute
documents, agreements and instruments on behalf of the Company.
"Base Rate" shall mean, at any time, the rate of interest adopted by
the Lender as its reference rate for the determination of interest rates for
loans of varying maturities in United States dollars to United States residents
of varying degrees of creditworthiness and being quoted at such time by the
Lender as its "prime rate". The prime rate is not necessarily the lowest rate of
interest charged to borrowers of the Lender. Each change in the Base Rate shall
take effect simultaneously with the change in the Lender's "prime rate".
"Base Rate Advance" shall mean an Advance which the Company requests to
be made as a Base Rate Advance or which is reborrowed as a Base Rate Advance, in
accordance with the provision of Section 1.2 hereof and which bears interest at
a per annum rate equal to the sum of (i) the Base Rate plus (ii) the Applicable
Interest Rate Margin in effect from time to time.
"Business Day" shall mean a day on which the Lender is open for the
transaction of the business required for this Agreement in Atlanta, Georgia.
"Capital Expenditures" shall mean, for any period, the aggregate of all
expenditures made by the Company during such period that, in conformity with
GAAP, are required to be included or reflected on the balance sheet as a capital
asset of the Company.
"Capitalization" shall mean an amount equal to the amount of the total
assets of the Company less the sum of its total liabilities, both determined in
accordance with GAAP.
"Capitalized Lease Obligation" shall mean that portion of any
obligation of the Company as lessee under a lease which at the time would be
required to be capitalized on the balance sheet of the Company in accordance
with GAAP.
"Change of Control" shall mean and be deemed to have occurred if (a)(i)
the persons who are stockholders of the Company on the Agreement Date shall at
any time not own, in the aggregate, directly or indirectly, beneficially and of
record, at least fifty
39
<PAGE> 44
percent (50%) of the outstanding shares of securities which generally entitle
the holder thereof to vote for the election of directors (the "Voting Stock") of
the Company (other than as the result of one or more widely distributed
offerings of common stock of the Company, in each case whether by the Company or
by one or more stockholders of the Company and/or (ii) any Person, entity or
"group" (within the meaning of Section 13(d) or 14(d) of the Securities Exchange
Act of 1934, as amended) shall at any time have acquired direct or indirect
beneficial ownership of a percentage of the outstanding Voting Stock of the
Company representing in excess of thirty percent (30%) of the Voting Stock of
the Company, unless, in the case of either clause (i) or (ii) above; and/or (b)
at any time Continuing Directors shall not constitute a majority of the Board of
Directors of the Company.
"Code" shall mean the Internal Revenue Code of 1986, as amended from
time to time.
"Collateral" shall mean and include all real and personal property of
the Company and its Subsidiaries, whether now owned or hereafter acquired by the
Company or any of its Subsidiaries or in which the Company or such Subsidiary
has or hereafter acquires any interest with respect to which the Lender have, or
are entitled or intended to have, a security interest, assignment, lien, trust
title or security title pursuant to the terms of this Agreement, any Security
Document or any other instrument or agreement now or hereafter effective between
the Lender and the Company as security for the payment and performance of all or
any portion of the Obligations.
"Commitment" shall mean the obligation of the Lender to advance the
aggregate sum of $25,000,000 to the Company pursuant to the terms hereof.
"Company" shall mean Medirisk, Inc., a Delaware corporation.
"Continuing Director" shall mean, at any date, an individual (a) who is
a member of the Board of Directors of the Company on the date hereof, (b) who,
as at such date, has been a member of such Board of Directors for at least the
twelve (12) preceding months, (c) who has been nominated to be a member of such
Board of Directors, directly or indirectly, by management of the Company or
Persons nominated by management of the Company, [(d) who has been nominated to
be a member of the Board of Directors pursuant to the terms of that certain
Stock Purchase Agreement, dated January 8, 1996, between the Company and
HealthPlan Services Corporation,] or (e) who has been nominated to be a member
of such Board of Directors by a majority of the other Continuing Directors then
in office.
"Counterparty" shall mean, with respect to any Acquisition, any Person
party to such Acquisition, other than the Company and any Subsidiary of the
Company.
"Credit Party" shall mean, with respect to the Company and its
Subsidiaries, each Person that is, or shall in the future, be a party to the
Loan Documents required to executed by such Person hereunder.
"Debt" shall mean all Indebtedness of the Company.
40
<PAGE> 45
"Debt Service" shall mean, for any period, payments of principal of,
interest on and other amounts payable with respect to, Debt.
"Debt Service Coverage Ratio" shall mean, for any period, a ratio of
which the numerator is EBITDA for the previous four quarters less the sum of
taxes paid in cash, less dividends paid in cash, less Maintenance Capital
Expenditures; and the denominator is the sum of Debt Service plus Imputed
Amortization.
"Default" shall mean any of the events specified in Section 7.1 hereof,
regardless of whether there shall have occurred any passage of time or giving of
notice, or both, that would be necessary in order to constitute such event an
Event of Default.
"Default Rate" shall mean a simple per annum interest rate equal to the
sum of (i) (x) the Base Rate or the LIBOR Basis, as applicable, plus (y) the
Applicable Interest Rate Margin as then in effect, plus (ii) two percent (2%).
"EBITDA" shall mean, for any period, the Net Income of the Company for
such period, plus, without duplication and to the extent reflected as charges in
the statement of Net Income for such period, the sum of (a) taxes measured by
income, (b) interest expense, (c) depreciation and amortization expense, (d)
amortization (or accelerated amortization) of original issue discount and (e)
non-cash charges and expenses related to Acquisitions or research and
development, including, without limitation, acquired in- process research and
development expense and similar expenses, all as determined in accordance with
GAAP; provided, however, that all cash items of gain or loss for such fiscal
period which are not ordinary by GAAP shall be included in the computation of
EBITDA and; provided further, that all non-cash items of gain or loss for such
fiscal period which are not ordinary by GAAP shall be excluded from the
computation of EBITDA.
"Environmental Laws" shall mean any and all federal, state, local or
municipal laws, rules, orders, regulations, statutes, ordinances, codes, decrees
or requirements of any governmental authority regulating, relating to or
imposing liability or standards of conduct concerning environmental protection
matters, including without limitation, Hazardous Materials, as now or may at any
time hereafter be in effect.
"ERISA" shall mean the Employee Retirement Income Security Act of 1974,
as in effect on the Agreement Date and as such Act may be amended thereafter
from time to time.
"ERISA Affiliate" shall mean any "affiliate" of the Company within the
meaning of Section 414 of the Code.
"Event of Default" shall mean any of the events specified in Section
7.1 hereof, provided that any requirement for notice or lapse of time, or both,
has been satisfied.
"Funding Date" shall mean the business day on which an Advance is to be
made by the Lender to the Company.
"GAAP" shall mean, as in effect from time to time, generally accepted
accounting principles set forth in opinions and pronouncements of the Accounting
Principles Board
41
<PAGE> 46
of the American Institute of Certified Public Accountants and of the Financial
Accounting Standards Board in the United States on the Agreement Date
consistently applied.
"Guaranty" or "Guarantee", as applied to an obligation (each a "primary
obligation"), shall mean and include (a) any guaranty, direct or indirect, in
any manner, of any part or all of such primary obligation, and (b) any
agreement, direct or indirect, contingent or otherwise, the practical effect of
which is to assure in any way the payment or performance (or payment of damages
in the event of non-performance) of any part or all of such primary obligation,
including, without limiting the foregoing, any reimbursement obligations as to
amounts drawn down by beneficiaries of outstanding letters of credit, and any
obligation of such Person (the "primary obligor"), whether or not contingent,
(i) to purchase any such primary obligation or any property or asset
constituting direct or indirect security therefor, (ii) to advance or supply
funds (1) for the purchase or payment of such primary obligation or (2) to
maintain working capital, equity capital or the net worth, cash flow, solvency
or other balance sheet or income statement condition of any other Person, (iii)
to purchase property, assets, securities or services primarily for the purpose
of assuring the owner or holder of any primary obligation of the ability of the
primary obligor with respect to such primary obligation to make payment thereof
or (iv) otherwise to assure or hold harmless the owner or holder of such primary
obligation against loss in respect thereof.
"Hazardous Materials" shall mean any hazardous materials, hazardous
wastes, hazardous constituents, hazardous or toxic substances, petroleum
products (including crude oil or any fraction thereof) or friable asbestos
containing materials defined or regulated as such in or under any Environmental
Law.
"Imputed Amortization" shall mean, for any period, the average
outstanding principal balance of the Revolving Loans during such period
calculated based on a hypothetical amortization of the Revolving Loans over a
five (5) year period.
"Indebtedness" of any Person shall mean (a) all indebtedness of such
Person for borrowed money, (b) the deferred purchase price of assets or services
that in accordance with GAAP would be shown on the liability side of the balance
sheet of such Person, (c) the face amount of all letters of credit issued for
the account of such Person and, without duplication, all drafts drawn
thereunder, (d) all Indebtedness of a second Person secured by any Lien on any
property owned by such first Person, whether or not such Indebtedness has been
assumed, and (e) all Capitalized Lease Obligations of such Person.
"Lender" shall mean NationsBank, N.A., and its successors and assigns.
"LIBOR" shall mean, for any LIBOR Advance Period, the average (rounded
upward to the nearest one sixteenth of one percent (1/16%)) of the interest
rates per annum which appear on Telerate Page 3750 as of approximately 11:00
a.m. (London time), or, if unavailable, any generally accepted successor rate
selected by the Lender, two (2) Business Days before the first day of such LIBOR
Advance Period, with respect to an Advance in an amount approximately equal to
the principal amount of, and for a length of time approximately equal to the
LIBOR Advance Period for, the LIBOR Advance sought by the Company.
42
<PAGE> 47
"LIBOR Advance" shall mean an Advance which the Company requests to be
made as a LIBOR Advance or which is reborrowed as a LIBOR Advance, in accordance
with the provisions of Section 1.2 hereof and which bears interest at a per
annum rate equal to the LIBOR Basis plus the Applicable Interest Rate Margin in
effect from time to time.
"LIBOR Advance Period" shall mean, for each LIBOR Advance, each one,
two, three or six month period, as selected by the Company and made available by
the Lender pursuant to Section 1.2 hereof, during which the applicable LIBOR
(but not the Applicable Interest Rate Margin) shall remain unchanged.
Notwithstanding the foregoing, however: (i) any applicable LIBOR Advance Period
which would otherwise end on a day which is not a Business Day shall be extended
to the next succeeding Business Day, unless such Business Day falls in another
calendar month, in which case such LIBOR Advance Period shall end on the next
preceding Business Day; (ii) any applicable LIBOR Advance Period which begins on
a day for which there is no numerically corresponding day in the calendar month
during which such LIBOR Advance Period is to end shall (subject to clause (i)
above) end on the last Business Day of such calendar month; and (iii) no LIBOR
Advance Period shall extend beyond the Maturity Date. Interest shall be due and
payable with respect to any LIBOR Advance as provided in Section 1.3 hereof.
"LIBOR Basis" shall mean a simple per annum interest rate equal to the
quotient of (i) LIBOR divided by (ii) one minus the LIBOR Reserve Percentage,
stated as a decimal. The LIBOR Basis shall be rounded upward to the nearest one
sixteenth of one percent (1/16%) and, once determined, shall remain unchanged
during the applicable LIBOR Advance Period, except for changes to reflect
adjustments in the LIBOR Reserve Percentage.
"LIBOR Reserve Percentage" shall mean the percentage which is in effect
from time to time under Regulation D of the Board of Governors of the Federal
Reserve System, as such regulation may be amended from time to time, as the
maximum reserve requirement applicable with respect to Eurocurrency Liabilities
(as that term is defined in Regulation D), whether or not the Lender has any
Eurocurrency Liabilities subject to such reserve requirement at that time. The
LIBOR Basis for any LIBOR Advance shall be adjusted as of the effective date of
any change in the LIBOR Reserve Percentage.
"Lien" shall mean, with respect to any property, any security deed,
mortgage, deed to secure debt, deed of trust, lien, pledge, assignment, charge,
security interest, title retention agreement, negative pledge, levy, execution,
seizure, attachment, garnishment or other encumbrance of any kind in respect of
such property, whether or not choate, vested or perfected.
"Loan Documents" shall mean this Agreement, the Revolving Note, the
Security Documents and all other documents, agreements, certificates, reports
and instruments now or hereafter executed in connection herewith or contemplated
hereby.
"Maintenance Capital Expenditures" shall mean, for any period, the
amount equal to fifty percent (50%) of the sum of (i) depreciation plus (ii) Net
Capitalized Software, as determined in accordance with GAAP for such period.
43
<PAGE> 48
"Material Acquisition" shall mean any Acquisition the purchase price of
which, in terms of cash and other consideration paid and Indebtedness assumed,
shall be in excess of $7,500,000.
"Material Customer Contracts" shall mean those contracts, licenses and
other agreements between the Company, or any of its Subsidiaries, and any
customer of the Company, or any of its Subsidiaries, pursuant to which the
Company, or any of its Subsidiaries, provides database and decision-support
software services and from which the Company expects to receive revenue during
any fiscal year in excess of an amount equal to five percent (5%) of the
Company's total revenue for the immediately preceding fiscal year.
"Materially Adverse Effect" shall mean any materially adverse effect
(a) upon the business, assets, liabilities, financial condition, results of
operations or business prospects of the Company, or (b) upon the ability of the
Company to perform any material obligations under this Agreement or any other
Loan Document, or (c) upon the rights, benefits or interests of the Lender in or
to this Agreement, any other Loan Document or the Collateral, in any case,
whether resulting from any single act, omission, situation, status, event or
undertaking, or taken together with other such acts, omissions, situations,
statuses, events or undertakings.
"Maturity Date" shall mean July 15, 2000, or such earlier date as
payment of the Revolving Loans shall be due (whether by acceleration or
otherwise); provided, however, that the Maturity Date may be subject to
extension pursuant to the terms of Section 1.1(c) hereof.
"Medirisk-IL" shall mean Medirisk of Illinois, Inc., an Indiana
corporation, formerly known as Formations In Health Care, Inc.
"Medirisk-MO" shall mean Medirisk of Missouri, Inc., a Missouri
corporation, formerly known as PracticeMatch, Inc.
"Multiemployer Plan" shall have the meaning set forth in Section
4001(a)(3) of ERISA.
"Necessary Authorizations" shall mean all authorizations, consents,
approvals, permits, licenses and exemptions of, filings and registrations with,
and reports to, all governmental and other regulatory authorities, whether
federal, state or local, and all agencies thereof (including, without
limitation, any specific authorizations, licenses, franchises, etc. that may be
required for the particular industry of the Company).
"Net Assets" shall mean, with respect to the Company and its
Subsidiaries, the aggregate amount of all items categorized as assets on the
consolidated balance sheet of the Company and its Subsidiaries under GAAP.
"Net Capitalized Software" shall mean capitalized software as at the
last date of such period less (y) capitalized software as at the first date of
such period less (z) any capitalized software acquired during such period.
44
<PAGE> 49
"Net Income" shall mean, for any period, the net income (or deficit) of
the Company and its Subsidiaries, on a consolidated basis, for such period,
determined in accordance with GAAP.
"Net Worth" shall mean, with respect to the Company and its
Subsidiaries on a consolidated basis, the excess of Net Assets over
Indebtedness.
"Obligations" shall mean all payment and performance duties,
liabilities and obligations of the Company to the Lender, whether now existing
or hereafter created, incurred or arising, and whether direct or indirect,
absolute or contingent, primary or secondary, due or to become due, including
without limitation, all liabilities now or at any time or times hereafter owing
to the Lender under this Agreement, the Revolving Note and the other Loan
Documents.
"Payment Date" shall mean the last day of each LIBOR Advance Period for
a LIBOR Advance.
"Permitted Liens" shall mean, as applied to any Person:
(a) Any Lien in favor of the Lender given to secure the
Obligations;
(b) (i) Liens on real estate for real estate taxes not yet
delinquent and (ii) Liens for taxes, assessments, judgments, governmental
charges or levies, or claims the non-payment of which are being diligently
contested in good faith by appropriate proceedings and for which adequate
reserves have been set aside on such Person's books;
(c) Liens of landlords and liens of carriers, warehousemen,
mechanics, laborers, suppliers, workers and materialmen incurred in the ordinary
course of business for sums not yet due or being diligently contested in good
faith, if such reserve or appropriate provision, if any, as shall be required by
GAAP shall have been made therefor;
(d) Liens incurred in the ordinary course of business in
connection with worker's compensation and unemployment insurance or other types
of social security benefits;
(e) Easements, rights-of-way, restrictions and other similar
encumbrances on the use of real property which do not interfere with the
ordinary conduct of the business of such Person, or Liens incidental to the
conduct of the business of such Person or to the ownership of its properties
which were not incurred in connection with any Indebtedness or other extensions
of credit and which do not in the aggregate materially detract from the value of
such properties or materially impair their use in the operation of the business
of such Person;
(f) Purchase money security interests, provided that such Lien
attaches only to the asset so purchased by the Company and secures only
Indebtedness incurred by the Company in order to purchase such asset, so long as
the aggregate Indebtedness secured by such liens does not exceed $250,000 for
any twelve (12) month period;
45
<PAGE> 50
(g) Deposits to secure the performance of bids, trade contracts,
tenders, sales, leases, statutory obligations, surety and appeal bonds,
performance bonds and other obligations of a like nature incurred in the
ordinary course of business;
(h) Liens on assets of the Company on the Agreement Date as more
fully set forth on Schedule 9A, attached hereto;
(i) Liens to which any asset is subject at the time of the
Company's purchase thereof, provided that such Lien is not created in
anticipation of such purchase;
(j) Judgment Liens which shall not constitute an Event of
Default;
(k) Interest of any lessor in property leased by the Company or
any Subsidiary; and
(l) Leases and subleases granted to other Persons which shall
not, in any material respect, interfere with the business and operations of the
Company and its Subsidiaries, on a consolidated basis.
"Person" shall mean an individual, corporation, partnership, trust,
joint stock company, limited liability company or unincorporated organization,
or a government or any agency or political subdivision thereof.
"Plan" shall mean an employee benefit plan within the meaning of
Section 3(3) of ERISA or any other employee benefit plan maintained for
employees of any Person or any Affiliate of such Person.
"Properties" shall mean all parcels of real property owned or operated
by the Company or any of its Subsidiaries; and "Property" shall mean any of the
foregoing parcels.
"Reportable Event" shall have the meaning set forth in Title IV of
ERISA.
"Request for Acquisition Advance" shall mean any certificate delivered
pursuant to Section 1.9 hereof and signed by an Authorized Signatory requesting
an Acquisition Advance requiring the consent of the Lender hereunder which will
increase the aggregate amount of the Revolving Loans outstanding, which
certificate shall be denominated a "Request for Acquisition Advance", and shall
be in substantially the form of Exhibit F-1 attached hereto. Each Request for
Acquisition Advance shall, among other things, (a) specify the Funding Date of
the Acquisition Advance, which shall be a Business Day, the amount of the
Acquisition Advance and the type of Acquisition Advance, and (b) state that
there shall not exist, on the date of the requested Acquisition Advance and
after giving effect thereto, a Default or an Event of Default.
"Request for Advance" shall mean any certificate signed by an
Authorized Signatory requesting an Advance hereunder which will increase the
aggregate amount of the Revolving Loans outstanding, which certificate shall be
denominated a "Request for Advance", and shall be in substantially the form of
Exhibit F-2 attached hereto. Each Request for Advance shall, among other things,
(a) specify the Funding Date of the Advance, which shall be a Business Day, the
amount of the Advance and the type of
46
<PAGE> 51
Advance, and (b) state that there shall not exist, on the date of the requested
Advance and after giving effect thereto, a Default or an Event of Default.
"Restricted Payment" shall mean (a) any direct or indirect
distribution, dividend or other payment to any Person on account of any shares
of capital stock or other securities of the Company and (b) any payment of any
management, consulting or similar fees payable by the Company and to any
Affiliate.
"Restricted Purchase" shall mean any payment on account of the
purchase, redemption or other acquisition or retirement of any shares of capital
stock or other securities of the Company.
"Revolving Loans" shall mean, collectively, the amounts advanced by the
Lender to the Company under the Commitment, not to exceed the Commitment, and
evidenced by the Revolving Note, and "Revolving Loan" shall mean one of the
Revolving Loans made by the Lender.
"Revolving Note" shall mean that certain Revolving Loan Promissory Note
in the original principal amount of $25,000,000 issued to the Lender,
substantially in the form of Exhibit G attached hereto, and any amendments,
renewals or extensions thereof.
"Security Agreement" shall mean that certain Security Agreement of even
date herewith between the Company and the Lender, substantially in the form of
Exhibit H attached hereto, as the same may be amended, supplemented or otherwise
modified from time to time.
"Security Documents" shall mean, collectively, the Security Agreement,
the Subsidiary Security Agreement, the Subsidiary Guaranty and any other
agreement, document or instrument granting collateral for the Obligations,
whether now or hereafter in existence, and any filings, instruments, agreements
and other documents related thereto or to this Agreement, and providing the
Lender with Collateral for the Obligations.
"Solvent" shall mean, as to any Person, that such Person has capital
sufficient to carry on its business and transactions in which it is about to
engage and is able to pay its debts as they mature and owns property having a
value, both at fair valuation and at present fair salable value, greater than
the amount required to pay its debts.
"Subsidiary" shall mean, as applied to any Person, (a) any corporation
of which fifty percent (50%) or more of the outstanding stock (other than
directors' qualifying shares) having ordinary voting power to elect a majority
of its board of directors (or other governing body), regardless of the existence
at the time of a right of the holders of any class or classes (however
designated) of securities of such corporation to exercise such voting power by
reason of the happening of any contingency, or any partnership of which fifty
percent (50%) or more of the outstanding partnership interests is, at the time,
owned directly or indirectly by such Person, or by one or more Subsidiaries of
such Person, or by such Person and one or more Subsidiaries of such Person, and
(b) any other entity which is directly or indirectly controlled or capable of
being controlled by such Person, or by one or more Subsidiaries of such Person,
or by such Person and one or more Subsidiaries of such Person.
47
<PAGE> 52
"Stock Pledge Agreement" shall mean that certain Stock Pledge Agreement
of even date herewith between the Company and the Lender, substantially in the
form of Exhibit I attached hereto, as the same may be amended, supplemented or
otherwise modified from time to time.
"Subsidiary Guaranty" shall mean that certain Subsidiary Guaranty of
even date herewith between each of the Subsidiaries of the Company and the
Lender, substantially in the form of Exhibit J attached hereto, as the same may
be amended, supplemented or otherwise modified from time to time.
"Subsidiary Security Agreement" shall mean that certain Subsidiary
Security Agreement of even date herewith between each of the Subsidiaries of the
Company and the Lender, substantially in the form of Exhibit K attached hereto,
as the same may be amended, supplemented or otherwise modified form time to
time.
"Total Funded Debt" shall mean, with respect to the Company, all Debt
issued, incurred, assumed or guaranteed by the Company of for the payment of
which the Company is otherwise liable, directly or indirectly, whether or not
such Debt now exists or shall hereafter be created, and shall include, without
duplication, all Capitalized Lease Obligations.
"Trademark Security Agreement" shall mean, [collectively,] that certain
Trademark Security Agreement dated as of March 28, 1997 executed by Medirisk-MO
in favor of the Lender, a copy of which is attached hereto as Exhibit C-2, [and
that certain Trademark Security Agreement executed by ________ in favor of the
Lender, substantially in the form of Exhibit C-1 attached hereto.]
Each definition of a document in this Article 10 shall include such
document, as amended, modified or supplemented from time to time with the prior
consent of the Lender and, except where the context otherwise requires,
definitions imparting the singular shall include the plural and vice versa.
Except where restricted, reference to a party to a Loan Document includes that
party and its successors and permitted assigns. All accounting terms used herein
without definitions shall be used as defined under GAAP. All calculations with
respect to financial covenants and otherwise shall be made as at the end of each
calendar quarter on the basis of the previous four (4) quarters; provided that,
during the first three (3) quarters of the term hereof, the calculations shall
be based on an annualized basis of the preceding quarters.
ARTICLE 11
WAIVER OF JURY TRIAL, ETC.
Section 11.1 Consent to Venue. The Company (a) hereby irrevocably
waives any objection it would make now or hereafter for the laying of venue of
any suit, action or proceeding arising out of or relating to this Agreement or
any other Loan Document brought in the Northern District of Georgia of the
Federal courts of the United States of America, and (b) hereby irrevocably
waives any claim that any such suit, action or proceeding brought in any such
court has been brought in an incorrect forum.
48
<PAGE> 53
Section 11.2 Waiver of Jury Trial. THE COMPANY AND THE LENDER HEREBY
AGREE TO WAIVE THE RIGHT TO A TRIAL BY JURY IN ANY COURT AND IN ANY ACTION OR
PROCEEDING OF ANY TYPE IN WHICH THE COMPANY, THE LENDER OR ANY OF THEIR
RESPECTIVE SUCCESSORS OR ASSIGNS IS A PARTY, AS TO ALL MATTERS AND THINGS
ARISING DIRECTLY OR INDIRECTLY OUT OF THIS AGREEMENT, THE REVOLVING NOTE OR THE
OTHER LOAN DOCUMENTS AND THE RELATIONS AMONG THE PARTIES LISTED IN THIS ARTICLE
10.
ARTICLE 12
ARBITRATION
Section 12.1 Arbitration. Any controversy or claim between or among the
parties hereto, including but not limited to, those arising out of or relating
to this Agreement and the other Loan Documents, including any claim based on or
arising from an alleged tort, shall be determined by binding arbitration in
accordance with the Federal Arbitration Act (or if not applicable, the
applicable state law), the rules of practice and procedure for the arbitration
of commercial disputes of J.A.M.S./Endispute or any successor thereof
("J.A.M.S."), and the "special rules" set forth below. In the event of any
inconsistency, the "special rules" shall control. Judgment upon any arbitration
award may be entered in any court having jurisdiction. Any party to this
instrument, agreement or document may bring an action, including a summary or
expedited proceeding, to compel arbitration of any controversy or claim to which
this Agreement and the other Loan Documents applies in any court having
jurisdiction over such action.
Section 12.2 Special Rules. The arbitration shall be conducted in
Atlanta, Georgia, and administered by J.A.M.S, who will appoint an arbitrator.
If J.A.M.S. is unable or legally precluded from administering the arbitration,
then the American Arbitration Association will serve as administrator. All
arbitration hearings will be commenced within ninety (90) days of the demand for
arbitration. Further, the arbitrator shall only, upon a showing of cause, be
permitted to extend the commencement of such hearing for up to an additional
sixty (60) days.
Section 12.3 Reservation of Rights. Nothing in this arbitration
provision shall be deemed to (i) limit the applicability of any otherwise
applicable statutes of limitation or repose and any waivers contained in this
Agreement or the other Loan Documents; or (ii) be a waiver by the Lender of the
protection afforded to it, if applicable, by 12 U.S.C. Sec. 91 or any
substantially equivalent state law; or (iii) limit the right of the Lender (a)
to exercise self help remedies such as (but not limited to) setoff, or (b) to
foreclose against any real or personal property collateral, or (c) to obtain
from a court provisional or ancillary remedies such as (but not limited to)
injunctive relief, writ of possession or the appointment of a receiver. The
Lender may exercise such self help rights, foreclose upon such property, or
obtain such provisional or ancillary remedies before, during or after the
pendency of any arbitration proceeding brought pursuant to this Agreement.
Neither this exercise of self help remedies nor the institution or maintenance
of an action for foreclosure or provisional or ancillary remedies shall
constitute a waiver of the right of any party, including the claimant in any
such action, to arbitrate the merits of the controversy or claim occasioning
resort to such remedies.
[Remainder of this page intentionally left blank]
49
<PAGE> 54
IN WITNESS WHEREOF, the parties hereto have executed this Agreement or
caused it to be executed under seal by their duly authorized officers, all as of
the day and year first above written.
COMPANY: MEDIRISK, INC.
By: /s/ Thomas C. Kuhn, III
---------------------------
Name: THOMAS C. KUHN, III
---------------------------
Title: Vice President
---------------------------
LENDER: NATIONSBANK, N.A.
By: /s/ Deborah Levin
----------------------------
Name: DEBORAH LEVIN
--------------------------
Title: Senior Vice President
--------------------------
<PAGE> 55
EXHIBIT B
SUBSIDIARY LOAN CERTIFICATE
The undersigned, who is the Secretary of MEDIRISK OF
MISSOURI, INC., a Missouri corporation (the "Subsidiary"), does hereby certify
on behalf of the Subsidiary that the undersigned is the duly elected and
qualified holder of the office set forth below the undersigned's signature below
and an Authorized Signatory of the Subsidiary. In connection with that certain
Amended and Restated Credit Agreement dated as of June ___, 1998 (as the same
may be amended, restated, supplemented or otherwise modified from time to time,
the "Credit Agreement") between Medirisk, Inc. (the "Company") and NationsBank,
N.A. (the "Lender"), the undersigned hereby certifies to the Lender that:
(a) Except as described on Exhibit A attached hereto, all
of the information provided to the Lender in that certain
Subsidiary Loan Certificate of dated as of _________, provided on
behalf of the Subsidiary in connection with the Prior Credit
Agreement, and all certifications contained therein remain true
and correct as of the date hereof and all documents provided in
connection therewith remain in full force and effect and have not
been modified, amended or supplemented;
(b) Attached hereto as Exhibit B is a true, complete and
correct copy of the resolutions of the Subsidiary, authorizing the
Subsidiary to execute, deliver and perform its obligations under
each of the Loan Documents to which it is a party;
(c) Attached hereto as Exhibit C are good standing
certificates or similar certificates, as the case may be, from the
Secretary of State of the Subsidiary's organization and each other
state where the Subsidiary is authorized to do business;
(d) The following persons are the Authorized Signatories
of the Subsidiary, each of such persons having been duly elected
to the offices set forth opposite their respective names below,
and the signatures set forth opposite their respective names below
are their respective genuine signatures:
<TABLE>
<CAPTION>
NAME TITLE SIGNATURE
- ---- ----- ---------
<S> <C> <C>
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
</TABLE>
Capitalized terms used herein and not otherwise defined
are used as defined in the Credit Agreement.
<PAGE> 56
IN WITNESS WHEREOF, I have signed this Certificate this
____ day of ________, 19__.
MEDIRISK OF MISSOURI, INC.
By:
------------------------------------
Name:
-------------------------------
Secretary
Its:
Attachments
Exhibit A Prior Certifications
Exhibit B Authorizing Resolutions
Exhibit C Good Standing Certificates
<PAGE> 57
SUBSIDIARY LOAN CERTIFICATE
The undersigned, who is the Secretary of MEDIRISK OF
ILLINOIS, INC., an Indiana corporation (the "Subsidiary"), does hereby certify
on behalf of the Subsidiary that the undersigned is the duly elected and
qualified holder of the office set forth below the undersigned's signature below
and an Authorized Signatory of the Subsidiary. In connection with that certain
Amended and Restated Credit Agreement dated as of June ___, 1998 (as the same
may be amended, restated, supplemented or otherwise modified from time to time,
the "Credit Agreement") between Medirisk, Inc. (the "Company") and NationsBank,
N.A. (the "Lender"), the undersigned hereby certifies to the Lender that:
(e) Except as described on Exhibit A attached hereto, all
of the information provided to the Lender in that certain
Subsidiary Loan Certificate of dated as of ________, provided on
behalf of the Subsidiary in connection with the Prior Credit
Agreement, and all certifications contained therein remain true
and correct as of the date hereof and all documents provided in
connection therewith remain in full force and effect and have not
been modified, amended or supplemented;
(f) Attached hereto as Exhibit B is a true, complete and
correct copy of the resolutions of the Subsidiary, authorizing the
Subsidiary to execute, deliver and perform its obligations under
each of the Loan Documents to which it is a party;
(g) Attached hereto as Exhibit C are good standing
certificates or similar certificates, as the case may be, from the
Secretary of State of the Subsidiary's organization and each other
state where the Subsidiary is authorized to do business;
(h) The following persons are the Authorized Signatories
of the Subsidiary, each of such persons having been duly elected
to the offices set forth opposite their respective names below,
and the signatures set forth opposite their respective names below
are their respective genuine signatures:
<TABLE>
<CAPTION>
NAME TITLE SIGNATURE
- ---- ----- ---------
<S> <C> <C>
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
</TABLE>
Capitalized terms used herein and not otherwise defined
are used as defined in the Credit Agreement.
<PAGE> 58
IN WITNESS WHEREOF, I have signed this Certificate this
____ day of ________, 19__.
MEDIRISK OF MISSOURI, INC.
By:
------------------------------------
Name:
-------------------------------
Secretary
Its:
Attachments
Exhibit A Prior Certifications
Exhibit B Authorizing Resolutions
Exhibit C Good Standing Certificates
<PAGE> 59
SUBSIDIARY LOAN CERTIFICATE
The undersigned, who is the Secretary of CIVS, INC., a
Maryland corporation (the "Subsidiary"), does hereby certify on behalf of the
Subsidiary that the undersigned is the duly elected and qualified holder of the
office set forth below the undersigned's signature below and an Authorized
Signatory of the Subsidiary. In connection with that certain Amended and
Restated Credit Agreement dated as of June ___, 1998 (as the same may be
amended, restated, supplemented or otherwise modified from time to time, the
"Credit Agreement") between Medirisk, Inc. (the "Company") and NationsBank, N.A.
(the "Lender"), the undersigned hereby certifies to the Lender that:
(i) Except as described on Exhibit A attached hereto, all
of the information provided to the Lender in that certain
Subsidiary Loan Certificate of dated as of ______, provided on
behalf of the Subsidiary in connection with the Prior Credit
Agreement, and all certifications contained therein remain true
and correct as of the date hereof and all documents provided in
connection therewith remain in full force and effect and have not
been modified, amended or supplemented;
(j) Attached hereto as Exhibit B is a true, complete and
correct copy of the resolutions of the Subsidiary, authorizing the
Subsidiary to execute, deliver and perform its obligations under
each of the Loan Documents to which it is a party;
(k) Attached hereto as Exhibit C are good standing
certificates or similar certificates, as the case may be, from the
Secretary of State of the Subsidiary's organization and each other
state where the Subsidiary is authorized to do business;
(l) The following persons are the Authorized Signatories
of the Subsidiary, each of such persons having been duly elected
to the offices set forth opposite their respective names below,
and the signatures set forth opposite their respective names below
are their respective genuine signatures:
<TABLE>
<CAPTION>
NAME TITLE SIGNATURE
- ---- ----- ---------
<S> <C> <C>
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
</TABLE>
Capitalized terms used herein and not otherwise defined
are used as defined in the Credit Agreement.
<PAGE> 60
IN WITNESS WHEREOF, I have signed this Certificate this
____ day of ________, 19__.
CIVS, INC.
By:
-----------------------------------
Name:
------------------------------
Its: Secretary
Attachments
Exhibit A Prior Certifications
Exhibit B Authorizing Resolutions
Exhibit C Good Standing Certificates
<PAGE> 61
SUBSIDIARY LOAN CERTIFICATE
The undersigned, who is the Secretary of CAREDATA REPORTS,
INC., a New York corporation (the "Subsidiary"), does hereby certify on behalf
of the Subsidiary that the undersigned is the duly elected and qualified holder
of the office set forth below the undersigned's signature below and an
Authorized Signatory of the Subsidiary. In connection with that certain Amended
and Restated Credit Agreement dated as of June ___, 1998 (as the same may be
amended, restated, supplemented or otherwise modified from time to time, the
"Credit Agreement") between Medirisk, Inc. (the "Company") and NationsBank, N.A.
(the "Lender"), the undersigned hereby certifies to the Lender that:
(m) Except as described on Exhibit A attached hereto, all
of the information provided to the Lender in that certain
Subsidiary Loan Certificate of dated as of ______, provided on
behalf of the Subsidiary in connection with the Prior Credit
Agreement, and all certifications contained therein remain true
and correct as of the date hereof and all documents provided in
connection therewith remain in full force and effect and have not
been modified, amended or supplemented;
(n) Attached hereto as Exhibit B is a true, complete and
correct copy of the resolutions of the Subsidiary, authorizing the
Subsidiary to execute, deliver and perform its obligations under
each of the Loan Documents to which it is a party;
(o) Attached hereto as Exhibit C are good standing
certificates or similar certificates, as the case may be, from the
Secretary of State of the Subsidiary's organization and each other
state where the Subsidiary is authorized to do business;
(p) The following persons are the Authorized Signatories
of the Subsidiary, each of such persons having been duly elected
to the offices set forth opposite their respective names below,
and the signatures set forth opposite their respective names below
are their respective genuine signatures:
<TABLE>
<CAPTION>
NAME TITLE SIGNATURE
- ---- ----- ---------
<S> <C> <C>
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
</TABLE>
Capitalized terms used herein and not otherwise defined
are used as defined in the Credit Agreement.
<PAGE> 62
IN WITNESS WHEREOF, I have signed this Certificate this
____ day of ________, 19__.
CAREDATA REPORTS, INC.
By:
-----------------------------------
Name:
-------------------------------
Secretary
Its:
Attachments
Exhibit A Prior Certifications
Exhibit B Authorizing Resolutions
Exhibit C Good Standing Certificates
<PAGE> 63
SUBSIDIARY LOAN CERTIFICATE
The undersigned, who is the Secretary of MEDSOURCE, INC.,
a Minnesota corporation (the "Subsidiary"), does hereby certify on behalf of the
Subsidiary that the undersigned is the duly elected and qualified holder of the
office set forth below the undersigned's signature below and an Authorized
Signatory of the Subsidiary. In connection with that certain Amended and
Restated Credit Agreement dated as of June ___, 1998 (as the same may be
amended, restated, supplemented or otherwise modified from time to time, the
"Credit Agreement") between Medirisk, Inc. (the "Company") and NationsBank, N.A.
(the "Lender"), the undersigned hereby certifies to the Lender that:
(q) Except as described on Exhibit A attached hereto, all
of the information provided to the Lender in that certain
Subsidiary Loan Certificate of dated as of ______, provided on
behalf of the Subsidiary in connection with the Prior Credit
Agreement, and all certifications contained therein remain true
and correct as of the date hereof and all documents provided in
connection therewith remain in full force and effect and have not
been modified, amended or supplemented;
(r) Attached hereto as Exhibit B is a true, complete and
correct copy of the resolutions of the Subsidiary, authorizing the
Subsidiary to execute, deliver and perform its obligations under
each of the Loan Documents to which it is a party;
(s) Attached hereto as Exhibit C are good standing
certificates or similar certificates, as the case may be, from the
Secretary of State of the Subsidiary's organization and each other
state where the Subsidiary is authorized to do business;
(t) The following persons are the Authorized Signatories
of the Subsidiary, each of such persons having been duly elected
to the offices set forth opposite their respective names below,
and the signatures set forth opposite their respective names below
are their respective genuine signatures:
<TABLE>
<CAPTION>
NAME TITLE SIGNATURE
- ---- ----- ---------
<S> <C> <C>
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
</TABLE>
Capitalized terms used herein and not otherwise defined
are used as defined in the Credit Agreement.
<PAGE> 64
IN WITNESS WHEREOF, I have signed this Certificate this
____ day of ________, 19__.
MEDSOURCE, INC.
By:
-----------------------------------
Name:
------------------------------
Its: Secretary
Attachments
Exhibit A Prior Certifications
Exhibit B Authorizing Resolutions
Exhibit C Good Standing Certificates
<PAGE> 65
SUBSIDIARY LOAN CERTIFICATE
The undersigned, who is the Secretary of
HEALTHDEMOGRAPHICS, INC., a Delaware corporation (the "Subsidiary"), does hereby
certify on behalf of the Subsidiary that the undersigned is the duly elected and
qualified holder of the office set forth below the undersigned's signature below
and an Authorized Signatory of the Subsidiary. In connection with that certain
Amended and Restated Credit Agreement dated as of June ___, 1998 (as the same
may be amended, restated, supplemented or otherwise modified from time to time,
the "Credit Agreement") between Medirisk, Inc. (the "Company") and NationsBank,
N.A. (the "Lender"), the undersigned hereby certifies to the Lender that:
(u) Except as described on Exhibit A attached hereto, all
of the information provided to the Lender in that certain
Subsidiary Loan Certificate of dated as of ______, provided on
behalf of the Subsidiary in connection with the Prior Credit
Agreement, and all certifications contained therein remain true
and correct as of the date hereof and all documents provided in
connection therewith remain in full force and effect and have not
been modified, amended or supplemented;
(v) Attached hereto as Exhibit B is a true, complete and
correct copy of the resolutions of the Subsidiary, authorizing the
Subsidiary to execute, deliver and perform its obligations under
each of the Loan Documents to which it is a party;
(w) Attached hereto as Exhibit C are good standing
certificates or similar certificates, as the case may be, from the
Secretary of State of the Subsidiary's organization and each other
state where the Subsidiary is authorized to do business;
(x) The following persons are the Authorized Signatories
of the Subsidiary, each of such persons having been duly elected
to the offices set forth opposite their respective names below,
and the signatures set forth opposite their respective names below
are their respective genuine signatures:
<TABLE>
<CAPTION>
NAME TITLE SIGNATURE
- ---- ----- ---------
<S> <C> <C>
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
</TABLE>
Capitalized terms used herein and not otherwise defined
are used as defined in the Credit Agreement.
<PAGE> 66
IN WITNESS WHEREOF, I have signed this Certificate this
____ day of ________, 19__.
HEALTHDEMOGRAPHICS, INC.
By:
-----------------------------------
Name:
------------------------------
Its: Secretary
Attachments
Exhibit A Prior Certifications
Exhibit B Authorizing Resolutions
Exhibit C Good Standing Certificates
<PAGE> 67
SUBSIDIARY LOAN CERTIFICATE
The undersigned, who is the Secretary of SUCCESSFUL
SOLUTIONS, INC., a Delaware corporation (the "Subsidiary"), does hereby certify
on behalf of the Subsidiary that the undersigned is the duly elected and
qualified holder of the office set forth below the undersigned's signature below
and an Authorized Signatory of the Subsidiary. In connection with that certain
Amended and Restated Credit Agreement dated as of June ___, 1998 (as the same
may be amended, restated, supplemented or otherwise modified from time to time,
the "Credit Agreement") between Medirisk, Inc. (the "Company") and NationsBank,
N.A. (the "Lender"), the undersigned hereby certifies to the Lender that:
(y) Except as described on Exhibit A attached hereto, all
of the information provided to the Lender in that certain
Subsidiary Loan Certificate of dated as of _______, provided on
behalf of the Subsidiary in connection with the Prior Credit
Agreement, and all certifications contained therein remain true
and correct as of the date hereof and all documents provided in
connection therewith remain in full force and effect and have not
been modified, amended or supplemented;
(z) Attached hereto as Exhibit B is a true, complete and
correct copy of the resolutions of the Subsidiary, authorizing the
Subsidiary to execute, deliver and perform its obligations under
each of the Loan Documents to which it is a party;
(aa) Attached hereto as Exhibit C are good standing
certificates or similar certificates, as the case may be, from the
Secretary of State of the Subsidiary's organization and each other
state where the Subsidiary is authorized to do business;
(bb) The following persons are the Authorized Signatories
of the Subsidiary, each of such persons having been duly elected
to the offices set forth opposite their respective names below,
and the signatures set forth opposite their respective names below
are their respective genuine signatures:
<TABLE>
<CAPTION>
NAME TITLE SIGNATURE
- ---- ----- ---------
<S> <C> <C>
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
</TABLE>
Capitalized terms used herein and not otherwise defined
are used as defined in the Credit Agreement.
<PAGE> 68
IN WITNESS WHEREOF, I have signed this Certificate this
____ day of ________, 19__.
SUCCESSFUL SOLUTIONS, INC.
By:
-----------------------------------
Name:
------------------------------
Its: Secretary
Attachments
Exhibit A Prior Certifications
Exhibit B Authorizing Resolutions
Exhibit C Good Standing Certificates
<PAGE> 69
SUBSIDIARY LOAN CERTIFICATE
The undersigned, who is the Secretary of SWEETWATER HEALTH
ENTERPRISES, INC., a Texas corporation (the "Subsidiary"), does hereby certify
on behalf of the Subsidiary that the undersigned is the duly elected and
qualified holder of the office set forth below the undersigned's signature below
and an Authorized Signatory of the Subsidiary. In connection with that certain
Amended and Restated Credit Agreement dated as of June ___, 1998 (as the same
may be amended, restated, supplemented or otherwise modified from time to time,
the "Credit Agreement") between Medirisk, Inc. (the "Company") and NationsBank,
N.A. (the "Lender"), the undersigned hereby certifies to the Lender that:
(cc) Except as described on Exhibit A attached hereto, all
of the information provided to the Lender in that certain
Subsidiary Loan Certificate of dated as of _______, provided on
behalf of the Subsidiary in connection with the Prior Credit
Agreement, and all certifications contained therein remain true
and correct as of the date hereof and all documents provided in
connection therewith remain in full force and effect and have not
been modified, amended or supplemented;
(dd) Attached hereto as Exhibit B is a true, complete and
correct copy of the resolutions of the Subsidiary, authorizing the
Subsidiary to execute, deliver and perform its obligations under
each of the Loan Documents to which it is a party;
(ee) Attached hereto as Exhibit C are good standing
certificates or similar certificates, as the case may be, from the
Secretary of State of the Subsidiary's organization and each other
state where the Subsidiary is authorized to do business;
(ff) The following persons are the Authorized Signatories
of the Subsidiary, each of such persons having been duly elected
to the offices set forth opposite their respective names below,
and the signatures set forth opposite their respective names below
are their respective genuine signatures:
<TABLE>
<CAPTION>
NAME TITLE SIGNATURE
- ---- ----- ---------
<S> <C> <C>
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
- -------------------------- ----------------------- -------------------
</TABLE>
Capitalized terms used herein and not otherwise defined
are used as defined in the Credit Agreement.
<PAGE> 70
IN WITNESS WHEREOF, I have signed this Certificate this
____ day of ________, 19__.
SWEETWATER HEALTH ENTERPRISES, INC.
By:
-----------------------------------
Name:
-------------------------------
Secretary
Its:
Attachments
Exhibit A Prior Certifications
Exhibit B Authorizing Resolutions
Exhibit C Good Standing Certificates
<PAGE> 71
EXHIBIT C-1
TRADEMARK SECURITY AGREEMENT
This TRADEMARK SECURITY AGREEMENT (this "Agreement"), made as
of this day _______of ______, ,__ by SWEETWATER HEALTH ENTERPRISES, INC., a
Texas corporation, having its chief executive office at Two Piedmont Center,
Suite 400, 3565 Piedmont Road, N.E., Atlanta, Georgia 30305 ("Assignor"), in
favor of NATIONSBANK, N.A., having an office located at 600 Peachtree Street,
N.E., Atlanta, Georgia 30308 (the "Lender", and sometimes herein "Assignee").
RECITALS
WHEREAS, Medirisk, Inc., a Delaware corporation (the
"Borrower") and the Lender have entered into an Amended and Restated Credit
Agreement, dated as of June , 1998 (as the same may be amended, restated,
supplemented or otherwise modified or refinanced or refunded from time to time,
the "Credit Agreement"); and
WHEREAS, Assignor is a wholly-owned Subsidiary of the
Borrower, and as such will realize substantial direct and indirect benefits from
the continued extension of credit to the Borrower under the Credit Agreement;
and
WHEREAS, it is a condition to the continued extension of
credit under the Credit Agreement that Assignor shall have granted to the
Lender, a security interest in Assignor's assets, including, without limitation,
common law and statutory trademarks, service marks, trade names, trademark and
service mark registrations, applications for trademark or service mark
registrations and any other indicia of origin, and licenses thereunder, as well
as all goodwill associated therewith (all such trademarks, service marks, trade
names, registrations, applications and other indicia, licenses thereunder and
goodwill associated therewith being, collectively, the "Trademarks");
NOW, THEREFORE, in consideration of the premises set forth
herein and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, Assignor agrees as follows:
1. Incorporation of Credit Agreement. The Credit Agreement and
the definitions, terms and provisions thereof are hereby incorporated herein in
their entirety by this reference thereto. Terms used herein which are defined in
the Credit Agreement shall have the respective meanings set forth in the Credit
Agreement unless otherwise defined herein.
2. Grant of Security. To secure the complete and timely
payment of all of the obligations of Assignor to the Lender now or hereafter
existing from time to
<PAGE> 72
time, Assignor hereby grants to Assignee a security interest in, the entire
right, title and interest, in the United States and throughout the world, in and
to the following, whether now owned or hereafter acquired (the "Collateral"):
(a) Each of the Trademarks which are presently, or in
the future may be from time to time, owned, held (whether pursuant to a
license or otherwise) or used by Assignor, in whole or in part, in
conducting its business (including, without limitation, the United
States trademark and service mark registrations, and applications for
registration, specifically identified on Schedule A attached hereto);
(b) all proceeds of the Trademarks (such as, by way
of example and not by way of limitation, license royalties and proceeds
of infringement suits);
(c) the right (but not the obligation) to sue or
bring opposition or cancellation proceedings in the name of Assignor or
in the name of Assignee for past, present and future infringements of
the Trademarks and all rights (but not obligations) corresponding
thereto; and
(d) all documents and things in Assignor's
possession, or subject to its demand for possession, related to the
production and sale by Assignor, or any Subsidiary, licensee or
subcontractor of Assignor, of products or services sold by or under the
authority of Assignor in connection with the Trademarks, including by
way of example, without limitation: (i) all lists and ancillary
documents which identify and describe any of Assignor's customers, or
those of its Subsidiaries or licensees, for products sold under or in
connection with the Trademarks, including without limitation, such
existing lists and ancillary documents which contain each customer's
full name and address, the identity of the person or persons having the
principal responsibility on each customer's behalf for ordering
products or services of the kind supplied by Assignor, the credit,
payment, discount, delivery and other sale terms applicable to such
customer, together with detailed information setting forth the total
purchases, by brand, product, style and size and the patterns of such
purchases; (ii) all product and service specification documents and
production and quality control manuals used in the manufacture of
products or provision of services sold under or in connection with the
Trademarks; (iii) all documents which reveal the name and address of
all sources of supply, and all terms of purchase and delivery, for all
materials and components used in the production of products or
provision of service, sold under or in connection with the Trademarks;
and (iv) all documents constituting or concerning the then current or
proposed advertising and promotion by Assignor or its Subsidiaries or
licensees of products sold under or in connection with the Trademarks
including, by way of example and
-2-
<PAGE> 73
not in limitation, all documents which reveal the media used or to be
used and the cost for all such advertising conducted within the
described period or planned for such products;
it being understood and agreed that the Collateral hereunder shall include,
without limitation, rights and interests pursuant to licensing or other
contracts in favor of Assignor pertaining to common law and statutory
trademarks, service marks, trade names, trademark and service mark
registrations, applications for trademark or service mark registrations and any
other indicia of origin presently or in the future owned or used by third
parties, but in the case of third parties which are not Subsidiaries of
Assignor, only to the extent permitted by such licensing or other contracts and,
if not so permitted, only with the consent of such third parties.
3. Inspection Rights. Assignor hereby grants to Assignee and
all employees, representatives and agents the right to visit Assignor and any of
its Subsidiaries' or subcontractor's plants and facilities which manufacture,
inspect or store products or provide services (or which have done so during the
prior six-month period) sold under any of the Trademarks, and to inspect the
products of and services and quality control records relating thereto upon
reasonable notice to Assignor and as often as may be reasonably requested.
4. Representations and Warranties. Assignor covenants and
warrants as follows:
(a) A true and complete list of all United States
trademark and service mark registrations and applications for
registration (the "U.S. Registrations") owned, held (whether pursuant
to a license or otherwise) or used by Assignor, in whole or in part, in
conducting its business is set forth on Schedule A hereto as such
schedule may be supplemented and amended from time to time.
(b) The Trademarks are subsisting and have not been
adjudged invalid or unenforceable and Assignor is not aware of any
claim by any third party that the Trademarks are invalid or
unenforceable.
(c) To the best of Assignor's knowledge, each of the
Trademarks is valid and enforceable.
(d) No claim has been made that the practice of any
of the Trademarks does or may violate the rights of any third person.
(e) Assignor is the legal and beneficial owner of the
Collateral free and clear of any lien, security interest, charge or
encumbrance, including,
-3-
<PAGE> 74
without limitation, pledges, assignments, licenses, shop rights and
covenants by Assignor not to sue third persons, except for (i) the
security interest and assignment created by this Agreement and (ii)
Permitted Liens. No effective financing statement or other instrument
similar in effect covering all or any part of the Collateral is on file
in any recording office, except such as may have been filed in favor of
Assignee relating to this Agreement or for which duly executed
termination statements have been recorded or delivered to Assignee.
(f) This Agreement will create in favor of Assignee a
valid and perfected first priority security interest in the Collateral
upon making the filings referred to in clause (g) below.
(g) Except for the filing of financing statements
with the appropriate officer in Fulton County, Georgia under the UCC
and filings with the United States Patent and Trademark Office, no
authorization, approval or other action by, and no notice to or filing
with, any governmental authority or regulatory body is required either
(i) for the grant by Assignor of the security interest granted hereby
or for the execution, delivery or performance of this Agreement by
Assignor or (ii) for the perfection of or the exercise by Assignee of
its rights and remedies hereunder to the U.S. Registrations.
(h) The chief executive office of Assignor is located
at the address set forth above for Assignor.
(i) Except as disclosed on Schedule B attached
hereto, none of Assignor's Affiliates or Subsidiaries has any right,
title or interest in any Trademarks.
5. New Trademarks and Applications. If, during the term of the
Credit Agreement, Assignor shall obtain rights to any new Trademarks, the
provisions of this Agreement shall automatically apply thereto. With respect to
any new U.S. Registrations, Assignor shall give to Assignee prompt notice
thereof in writing.
6. Assignor's Covenants. On a continuing basis and at the
request of Assignee, Assignor shall make, execute, acknowledge and deliver, and
file and record in the proper filing and recording places, all such instruments,
including, without limitation, appropriate financing and continuation statements
and security agreements, and take all such action as may be deemed necessary or
advisable by Assignee to carry out the intent and purposes of this Agreement, or
for assuring and confirming to Assignee the grant or perfection of a security
interest in all Collateral. Without limiting the generality of the foregoing
sentence, Assignor (i) shall not enter into any agreement which would or might
in any way impair or conflict with Assignor's obligations hereunder without
Assignee's prior written consent; (ii) upon the written request of
-4-
<PAGE> 75
Assignee, shall use its best efforts to obtain any necessary consents of third
parties to the grant or perfection of a security interest to Assignee with
respect to the Collateral; (iii) authorizes Assignee in its sole discretion to
modify this Agreement without first obtaining Assignor's approval of or
signature to such modification by amending Schedule A thereof to include a
reference to any right, title or interest in any existing U.S. Registration and
any U.S. Registration acquired by Assignor after the execution hereof or to
delete any reference to any right, title or interest in any U.S. Registration in
which Assignor no longer has or claims any right, title or interest; (iv) shall,
from time to time upon Assignee's request, cause its books and records to be
marked with such legends or segregated in such manner as Assignee may reasonably
specify, and take or cause to be taken such other action and adopt such
procedures as Assignee may reasonably specify to give notice of or to perfect
the security interest in the Collateral intended to be created hereby; (v) shall
at all times keep at least one complete set of its records concerning
substantially all of the Trademarks at its chief executive office as set forth
above and will not change the location of its chief executive office or such
records without giving Assignee at least thirty (30) days' prior written notice
thereof; (vi) shall promptly, following its becoming aware thereof, notify
Assignee of the institution of, or any adverse determination in, any proceeding
in the United States Patent and Trademark Office or any United States or foreign
court regarding Assignee's claim of ownership in any of the Collateral; (vii)
shall promptly notify Assignee of the filing of an application for registration
of any trademark; (viii) shall not permit the inclusion in any contract to which
it becomes a party of any provisions which could or might in any way impair or
prevent the creation of a security interest in Assignor's rights and interest in
any property included within the definition of the Collateral acquired under
such contracts; (ix) shall properly maintain and care for the Collateral; (x)
shall not grant any security interest in any Collateral (other than Permitted
Liens) except in the name of Assignee; (xi) shall not sell, license, or contract
for sale or otherwise dispose of any Collateral except as may be permitted by
the Credit Agreement; (xii) upon any officer of Assignor obtaining knowledge
thereof, shall promptly notify Assignee of any event which materially adversely
affects the value of any Collateral, the ability of Assignor or Assignee to
dispose of any of the Trademarks or the rights and remedies of Assignee in
relation thereto including, without limitation, the levy of any legal process
against any of the Collateral; (xiii) until Assignee exercises its rights to
make collection, shall diligently keep reasonable records respecting the
Collateral; (xiv) shall promptly notify Assignee of any suspected infringement
of any of the Trademarks by any third party and of all steps, including the
commencement and course of litigation, taken to remedy such infringement; and
(xv) shall use proper statutory notice in conjunction with each of the U.S.
Registrations.
7. Amounts Payable in Respect of the Trademarks. Except as
otherwise provided in this Section 7 or in the Credit Agreement, Assignor shall
continue to collect, at its own expense, all amounts due or to become due to
Assignor in respect of the Trademarks. Upon the occurrence and during the
continuance of an Event of
-5-
<PAGE> 76
Default, Assignee is hereby given full power and authority, without notice or
demand, (i) to notify any and all obligors of Assignor with respect to any
Trademark obligation which Assignor, except for the execution hereof, could ask
for, and (ii) to demand, take, collect, sue for and receive for its own use all
amounts due or to become due Assignor in respect of the Trademarks, and in
connection therewith to enforce all rights and remedies with respect to any
Trademark which Assignor could enforce if this Agreement had not been made; and
Assignor hereby ratifies any action which Assignee shall lawfully take to
enforce Assignee's rights hereunder. Whether or not Assignee shall have so
notified any obligors, Assignor shall at its expense render all reasonable
assistance to Assignee in enforcing claims against such obligors.
8. Trademark Applications, Renewal and Litigation. Assignor
shall have the duty to prosecute diligently any application for trademark
registration of the U.S. Registrations specifically identified in Schedule A
annexed hereto pending as of the date of this Agreement or thereafter during the
term of the Credit Agreement, to make U.S. application on any existing or future
unregistered but registrable Trademark (except those having negligible
commercial value) and to preserve, renew and maintain all Trademarks as to which
a security interest has been granted pursuant to this Agreement. Any expenses
incurred in connection with such an application, or in protecting, maintaining
or preserving the Trademarks, shall be borne by Assignor.
Assignor shall have the right and obligation to commence and
diligently prosecute in its own name, as real party in interest, for its own
benefit and at its own expense, such suits, proceedings or other actions for
infringement, or other damage or opposition or cancellation proceedings as are
reasonable to protect any of the Trademarks. However, no such suit, proceeding
or other action shall be settled or voluntarily dismissed, nor shall any party
be released or excused of any claims of or liability for infringement, without
the prior written consent of Assignee. Assignor shall indemnify and hold
harmless Assignee for any and all liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, costs, expenses or disbursements
(including reasonable attorneys' fees) of any kind whatsoever which may be
imposed on, incurred by or asserted against Assignee in connection with or in
any way arising out of such suits, proceedings or other actions other than
actions caused by Assignee's gross negligence or willful misconduct.
9. Certain Remedies. If any Event of Default shall have
occurred and be continuing:
(a) Assignee may exercise in respect of the
Collateral, in addition to other rights and remedies provided for
herein or otherwise available to it, all the rights and remedies of a
secured party in default under the UCC in effect in the State of
Georgia at that time (whether or not the UCC applies to the affected
Collateral) and also may (i) require Assignor to, and Assignor hereby
agrees
-6-
<PAGE> 77
that it will at its expense and upon request of Assignee forthwith,
assemble all or part of the Collateral as directed by Assignee and make
it available to Assignee at a place to be designated by Assignee which
is reasonably convenient to both parties; (ii) without notice except as
specified below, sell the Collateral or any part thereof in one or more
parcels at public or private sale, at any of Assignee's offices or
elsewhere, for cash, on credit or for future delivery, and upon such
other terms as Assignee may deem commercially reasonable; (iii) occupy
any premises owned or leased by Assignor where the Collateral or any
part thereof is located for a reasonable period in order to effectuate
its rights and remedies hereunder or under law, without obligation to
Assignor in respect of such occupation; and (iv) exercise any and all
rights and remedies of Assignor under or in connection with the
contracts related to Collateral or otherwise in respect of the
Collateral, including, without limitation, any and all rights of
Assignor to demand or otherwise require payment of any amount under, or
performance of any provision of, such contracts. Assignor agrees that,
to the extent notice of sale shall be required by law, at least ten
(10) days' written notice to Assignor of the time and place of any
public sale or the time after which any private sale is to be made
shall constitute reasonable notification. Assignee shall not be
obligated to make any sale of Collateral regardless of notice of sale
having been given. Assignee may adjourn any public or private sale from
time to time by announcement at the time and place fixed therefor, and
such sale may, without further notice, be made at the time and place to
which it was so adjourned.
(b) Any cash held by Assignee as Collateral and all
cash proceeds received by Assignee in respect of any sale of,
collection from, or other realization upon all or any part of the
Collateral may, in the discretion of Assignee, be held by Assignee as
collateral for, and then or at any time thereafter applied in whole or
in part by Assignee against, all or any part of the obligations of
Assignor to the Lender in such order as is provided in the Credit
Agreement. Any surplus of such cash or cash proceeds held by Assignee
and remaining after payment in full of all such Obligations shall be
paid over to Assignor or to whomsoever may be lawfully entitled to
receive such surplus.
10. Power of Attorney. Assignor hereby authorizes and empowers
Assignee, upon the occurrence and during the continuation of an Event of
Default, to make, constitute and appoint any officer or agent of Assignee as
Assignor's true and lawful attorney-in-fact, with power (i) to endorse
Assignor's name on all applications, documents, papers and instruments necessary
for Assignee in the use or maintenance of the Collateral, (ii) to take any other
actions with respect to the Collateral, including without limitation,
commencement or continuation of any litigation or administrative proceeding, as
Assignee deems in its best interest, (iii) to grant or issue an exclusive or
-7-
<PAGE> 78
non-exclusive license to the Trademarks to anyone, or (iv) to assign, pledge,
convey or otherwise transfer title in or dispose of the Collateral to anyone.
11. Amendments, etc. No amendment or waiver of any provision
of this Agreement nor consent to any departure by Assignor herefrom, shall in
any event be effective unless the same shall be in writing and signed by the
parties hereto, and then such waiver or consent shall be effective only in the
specific instance and for the specific purpose for which given, except as
provided in Section 6, in which case the writing need only be signed by
Assignee.
12. Address for Notices. All notices and other communications
to any party provided for hereunder shall be in writing (including
telecommunications) and mailed or transmitted or delivered to such party,
addressed to it at the address first stated herein for such party, or as to
either party at such other address as shall be designated by such party in a
written notice to each other party complying as to delivery with the terms of
this Section. All such notices and other communications shall, when mailed,
telegraphed, telexed or cabled, be effective as provided in Section 8.1 of the
Credit Agreement.
13. Continuing Security Interest; Transfers by the Lender.
This Agreement shall create a continuing security interest in the Collateral and
shall (i) remain in full force and effect until the indefeasible payment in full
of all of the obligations of Assignor to the Lender, (ii) be binding upon
Assignor, its successors and assigns and (iii) inure to the benefit of Assignee,
and its successors, transferees and assigns. Without limiting the generality of
the foregoing clause (iii), Assignee may assign or otherwise transfer any
obligations held by it, and such other benefits in respect thereof granted to it
herein or otherwise, to any other person or entity, subject, however, to the
provisions of Section 8.5 of the Credit Agreement. Upon the indefeasible payment
in full of all of the obligations of Assignor to the Lender, the security
interest granted hereby shall terminate and all rights to the Collateral shall
revert to Assignor, subject to any disposition thereof which may have been made
by Assignee pursuant hereto or pursuant to the Credit Agreement. Upon any such
termination, Assignee shall, at Assignor's expense, execute and deliver to
Assignor such documents as Assignor shall reasonably request to evidence such
termination.
14. Cumulative Remedies; Effect on Credit Agreement. All of
Assignee's rights and remedies with respect to the Collateral, whether
established hereby or by the Credit Agreement, or by any other agreements or by
law shall be cumulative and may be exercised singularly or concurrently.
Assignor hereby acknowledges and agrees that this Agreement is not intended to
limit or restrict in any way the rights and remedies of Assignee under the
Credit Agreement and the other Loan Documents, but rather is intended to
facilitate the exercise of such rights and remedies.
-8-
<PAGE> 79
15. Counterparts. This Agreement may be executed in any number
of counterparts, each of which when so executed and delivered shall be deemed an
original, but all such counterparts together shall constitute but one and the
same instrument.
16. Severability. The provisions of this Agreement are
severable, and if any clause or provision shall be held invalid or unenforceable
in whole or in part in any jurisdiction, then such invalidity or
unenforceability shall affect only such clause or provision, or part thereof, in
such jurisdiction, and shall not in any manner affect such clause or provision
in any other jurisdiction, or any other clause or provision of this Agreement in
any jurisdiction.
17. Governing Law; Terms. THIS AGREEMENT SHALL BE GOVERNED BY
AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF GEORGIA (DETERMINED
WITHOUT REFERENCE TO PRINCIPLES OF CONFLICTS OF LAWS).
IN WITNESS WHEREOF, the parties hereto have caused this
Agreement to be executed by their respective officers thereunder duly
authorized, as of the date first above written.
SWEETWATER HEALTH ENTERPRISES, INC.
By:
----------------------------------
Name:
-----------------------------
Title:
----------------------------
(CORPORATE SEAL)
ATTEST:
- ---------------------------------
Secretary
Agreed and Accepted as of
this ______ day of _________,_____:
NATIONSBANK, N.A., Assignee
By:
-------------------------------
Name:
Title:
-9-
<PAGE> 80
STATE OF GEORGIA )
) ss.:
COUNTY OF FULTON )
The foregoing Trademark Security Agreement was executed and acknowledged before
me this ____ day of _________, __________, by ____________ and
_________________, personally known to me to be the ________________ and the
Secretary, respectively, of ________________, a ___________ corporation, on
behalf of such corporation.
(SEAL)
-----------------------------
Notary Public
My Commission expires:
<PAGE> 81
SCHEDULE A
United States Trademark and Service Mark
Registrations and Applications for Registration
Trademark Application No.
<PAGE> 82
SCHEDULE B
Rights of Affiliates of Subsidiaries
<PAGE> 83
EXHIBIT E
COMPLIANCE CERTIFICATE
This Certificate is delivered pursuant to that certain
Amended and Restated Credit Agreement, dated as of June __, 1998 (as the same
may be amended, supplemented or otherwise modified from time to time, the
"Credit Agreement"), by and between Medirisk, Inc. (the "Company") and
NationsBank, N.A.(the "Lender"). All capitalized terms used herein which are
defined in the Credit Agreement are used herein with the same meanings given
such terms in the Credit Agreement.
The undersigned ______________________________________
hereby certifies in his/her representative capacity on behalf of the Company to
the Lender as follows:
1. ____________________________ is the duly elected
and acting ____________________ of the Company.
2. The undersigned has had prepared under his/her
supervision and has reviewed the financial statements of the
Company as of and for the quarter ending __________________,
199__, true, complete and correct copies of which have been
previously furnished to the Lender (collectively, the "Financial
Statements").
3. The Financial Statements were prepared in accordance
with GAAP and fairly present the financial position and results of
operations of the Company as of and for the quarter ending on the
date of the Financial Statements.
4. As of ______ __, 19__, after giving effect to the
transactions contemplated by the Credit Agreement:
(a) To the best of his/her knowledge, no Default
or Event of Default has occurred and is continuing;
(b) No material adverse change in the financial
condition or operations of the business of the Company has
occurred since ___________________;
(c) The representations and warranties of the Company
set forth in Article 3 of the Credit Agreement are true
and correct in all material respects as of this date, as
the same have been supplemented by delivery of a report by
the Company to the Lender pursuant to Section 5.5(e) of
the Credit Agreement; and
(d) The Company is in compliance with all of the
terms and provisions set forth in the Credit Agreement and
the other Loan Documents and their respective parts to be
observed and performed, including, without limitation, the
following (calculated on a four quarter trailing basis,
other than during the first three (3) quarters after the
Agreement Date, when such calculations shall be based on
an annualized basis of the preceding quarters):
<PAGE> 84
<TABLE>
<S> <C>
(1) Section 6.9 - Debt/Capitalization
Ratio. The Company shall not, at any time, permit its
ratio of (i) Debt to (ii) Capitalization to exceed 1.0 to
1.0.
Debt
(a) Indebtedness of the Company $___________________
Capitalization
(b) Total assets $___________________
(c) Minus total liabilities $___________________
(d) Capitalization = (b) - (c) $___________________
Ratio = (a)/(d) ____________________
(2) Section 6.10 - Cash Flow Leverage
Ratio. The Company shall not, at any time, permit its
ratio of (i) Total Funded Debt to (ii) EBITDA to exceed
3.0 to 1.0.
Total Funded Debt
(a) Indebtedness of the Company $___________________
EBIDTA
(b) Net Income $___________________
(c) Interest and Taxes for such periods $___________________
(d) Depreciation and Amortization
for such periods $___________________
(e) Amortization for original issue discount $___________________
(f) Acquired in-process research and
development expense and similar
expense $___________________
(g) EBITDA = (b) + (c) + (d) + (e) + (f) $___________________
Ratio = (a)/(g) _____________________
</TABLE>
<PAGE> 85
(3) Section 6.11 - Debt Service Coverage
Ratio. The Company shall not, at any time, permit its Debt
Service Coverage Ratio to be less than 1.25 to 1.0.
<TABLE>
<S> <C>
Debt Service Coverage Ratio
(a) Net Income $__________________
(b) Interest and Taxes for such periods $__________________
(c) Depreciation and Amortization
for such periods $__________________
(d) Amortization for original issue discount $__________________
(e) Acquired in-process research and
development expense and similar
expense $__________________
(f) EBITDA = (a) + (b) + (c) + (d) + (e) $__________________
(g) Minus cash taxes and dividends $__________________
(h) Minus Maintenance Capital Expenditures $__________________
(i) Numerator = (f) - (g) - (h) $__________________
(j) Interest Expense for the period $__________________
(k) Current Portion of Long-term Debt $__________________
(l) Imputed Amortization Amount (amount
outstanding on the revolver divided
by five years) $__________________
(m) Denominator = (j) + (k) + (l) $__________________
Ratio = (i)/(m) __________________
</TABLE>
<PAGE> 86
(4) Section 6.12 - Restricted Payments.
The Company shall not apply any sums to the redemption,
retirement or purchase of any warrant, option or share of
its capital stock, or to the payment of any dividend or
other distributions thereon, if after such application
shall have been made, the aggregate of the sums so applied
since the Agreement Date exceed ten percent (10%) of the
Net Income of the Company determined on a cumulative basis
as of the end of the fiscal year commencing December 31,
1997.
<TABLE>
<S> <C>
Restricted Payments
(a) Distributions, dividends or other payments
in respect of capital stock $_________________
(b) Management, consulting or similar fees
payable to an Affiliate of the Company $_________________
(c) Restricted Payments = (a) + (b) $_________________
Net Income Threshold
(d) Net Income for the period $_________________
(e) 10% of Net Income $_________________
</TABLE>
Covenant = (c) shall be less than or equal to (e)
(5) Section 6.13 - Minimum Net Worth.
The Company shall not at any time during the term of the
Agreement, permit the sum of (i) the Company's Net Worth
plus (ii) any non-cash charges and expenses related to
Acquisitions or research and development, including,
without limitation, acquired in-process research and
development expense and similar expenses, to be less than
$16,000,000.
<TABLE>
<S> <C>
Net Worth
(a) Net Assets $_________________
(b) Minus Indebtedness of the Company $__________________
(c) Net Worth = (a) - (b) $__________________
Non-cash Charges and Expenses
(d) Non-cash charges and expenses related
to Acquisitions or research and
development $__________________
Covenant = (c) + (d) $__________________
</TABLE>
<PAGE> 87
The undersigned represents the foregoing information to be
true and correct to the best of his/her knowledge and belief and executes this
Certificate in his/her representative capacity on behalf of the Company as of
this ___ day of _______, 199_.
--------------------------
[NAME]
<PAGE> 88
EXHIBIT F-1
FORM OF REQUEST FOR ACQUISITION ADVANCE
I, ________________________________, as _______________ of
Medirisk, Inc., Delaware corporation (the "Company"), and as an Authorized
Signatory, do hereby certify, pursuant to the provisions of that certain Amended
and Restated Credit Agreement dated as of June _____, 1998 (as the same may be
amended, restated, supplemented or otherwise modified from time to time, the
"Credit Agreement") dated as of June _____, 1998, between the Company and
NationsBank, N.A. (the "Lender"), that:
1. The Company hereby requests an Acquisition Advance in
the form of [a LIBOR Advance in the amount of $____________ with a
LIBOR Advance Period of _____________ /a Base Rate Advance in the
amount of $______________] to be made on _________________, ______
(the "Funding Date"), under the Commitment. The proceeds of the
Acquisition Advance should be wired on behalf of the Company as
set forth on Schedule 1 attached hereto. The foregoing
instructions shall be irrevocable.
2. The proceeds of the Acquisition Advance requested
hereby shall be used to fund the purchase price of that certain
Acquisition more fully described on Schedule 2 attached hereto
(hereafter referred to as the "Acquisition"). Schedule 2 also sets
forth the total purchase price with respect to the Acquisition,
both in terms of cash and other consideration paid and
indebtedness and liabilities assumed. The proceeds of the
Acquisition Advance requested hereby shall not be in an amount in
excess of one hundred percent (100%) of the cash portion of such
purchase price.
3. Attached hereto as Exhibit A is full, complete and
correct copy of the Letter of Intent, and each similar agreement,
entered into between the Company and the seller, or sellers, of
any interests in the Target.
4. Attached hereto as Exhibit B is a copy of each due
diligence checklist provided by the Company to the seller, or
sellers, of any interests in the Target, and all responses
thereto.
5. Attached hereto as Exhibit C is a copy of the current
draft of the acquisition agreement, and each similar agreement,
governing the terms of the Acquisition, together with all
schedules and exhibits thereto.
6. Attached hereto as Exhibit D are copies of
__________________________ [describe financial information]
relating to the Acquisition. Each adjusting entry which the
Company proposes to make with respect to its books and records,
and the books and records of the Target or of any new Subsidiary
of the Company formed in connection with the Acquisition, is
described in detail on Schedule 3 attached hereto.
<PAGE> 89
7. The full name, state of organization, federal tax
identification number and chief business address of each
Subsidiary formed, or otherwise created, in connection with the
Acquisition are set forth on Schedule 4 attached hereto.
8. Except as disclosed in writing to the Lender, all
representations and warranties of the Company made in Article 3 of
the Credit Agreement are true and correct in all material respects
as of the date hereof, both before and after giving effect to the
application of the proceeds of the Advance in connection with
which this Request is given and all applicable conditions set
forth in Article 2 of the Credit Agreement have been satisfied.
9. Except as disclosed in the Compliance Certificate most
recently delivered to the Lender, as of the Funding Date, the
Company shall be in compliance with each of the covenants
contained in Sections 6.9, 6.10, 6.11, 6.12 and 6.13 of the Credit
Agreement.
10. Each of the agreements and other documents relating to
the Acquisition provided by the Company hereunder are in
substantially final form and shall not subject to any material
revisions subsequent to the date hereof without the prior consent
of the Lender.
11. The incumbency of persons authorized by the Company to
sign documents is as stated in the certificate of incumbency most
recently delivered to the Lender.
12. There shall not exist, as of the Funding Date and
after giving effect to the Advance requested hereunder, any
Default or Event of Default.
Capitalized terms used in this Request for Acquisition
Advance and not otherwise defined herein are used as defined in the Credit
Agreement.
[Remainder of this page intentionally left blank]
<PAGE> 90
Dated as of this ____ day of ________________, ______.
MEDIRISK, INC., a Delaware corporation
By:
-----------------------------------
Name:
---------------------------------
Title:
--------------------------------
Attachments:
Exhibit A - Letter of Intent
Exhibit B - Diligence Checklists
Exhibit C - Acquisition Agreement
Exhibit D - Financial Documentation
Schedule 1 - Wiring Instructions
Schedule 2 - Proposed Acquisition and Purchase Price
Schedule 3 - Adjusting Entries
Schedule 4 - New Subsidiaries
3
<PAGE> 91
SCHEDULE 1 - WIRING INSTRUCTIONS
4
<PAGE> 92
SCHEDULE 2 - PROPOSED ACQUISITION AND PURCHASE PRICE
5
<PAGE> 93
SCHEDULE 3 - ADJUSTING ENTRIES
6
<PAGE> 94
SCHEDULE 4 - NEW SUBSIDIARIES
7
<PAGE> 95
EXHIBIT F-2
FORM OF
REQUEST FOR ADVANCE
[LENDER CONSENT NOT REQUIRED]
I, ________________________________, as _______________ of
Medirisk, Inc., Delaware corporation (the "Company"), and as an Authorized
Signatory, do hereby certify, pursuant to the provisions of that certain Amended
and Restated Credit Agreement (as the same may be amended, modified, restated or
supplemented from time to time, the "Credit Agreement") dated as of June __,
1998, between the Company and NationsBank, N.A. (the "Lender"), that:
1. The Company hereby requests a LIBOR Advance in the
amount of $____________ with a LIBOR Advance Period of
_____________ /a Base Rate Advance in the amount of
$______________ to be made on _________________, 199___ (the
"Funding Date"), under the Commitment. The proceeds of the Advance
should be wired on behalf of the Company as set forth on Schedule
1 attached hereto. The foregoing instructions shall be
irrevocable.
2. Except as disclosed in writing to the Lender, all
representations and warranties of the Company made in Article 3 of
the Credit Agreement are true and correct in all material respects
as of the date hereof, both before and after giving effect to the
application of the proceeds of the Advance in connection with
which this Request is given and all applicable conditions set
forth in Article 2 of the Credit Agreement have been satisfied.
3. The incumbency of persons authorized by the Company to
sign documents is as stated in the certificate of incumbency most
recently delivered to the Lender.
4. There shall not exist, as of the Funding Date and after
giving effect to the Advance requested hereunder, any Default or
Event of Default.
5. The proceeds of the Advance requested hereunder shall
not be used, in whole or in part, to fund any Acquisition
requiring the consent of the Lender pursuant to Section 1.9(d) of
the Credit Agreement.
Capitalized terms used in this Request for Advance and not
otherwise defined herein are used as defined in the Credit Agreement.
<PAGE> 96
Dated as of this ____ day of ________________, 199__.
MEDIRISK, INC.,
a Delaware corporation
By:
--------------------------------
Title:
-----------------------------
<PAGE> 97
SCHEDULE 1 - WIRING INSTRUCTIONS
3
<PAGE> 98
EXHIBIT G
FORM OF
AMENDED AND RESTATED REVOLVING LOAN PROMISSORY NOTE
AS OF JUNE ___, 1998
ATLANTA, GEORGIA
FOR VALUE RECEIVED, the undersigned, MEDIRISK, INC., a
Delaware corporation (the "Borrower"), unconditionally promises to pay to the
order of NATIONSBANK, N.A. (hereinafter, together with its successors and
assigns, called the "Lender"), at the principal office of the Lender located in
Atlanta, Georgia, or such other place as the Lender may designate in writing to
the Borrower, the principal sum of TWENTY-FIVE MILLION AND NO/100s Dollars
($25,000,000.00), or, if less, so much thereof as may from time to time be
advanced by the Lender to the Borrower hereunder, plus interest as hereinafter
provided.
All capitalized terms used herein shall have the meanings
ascribed to them in that certain Credit Agreement (as hereafter amended from
time to time, the "Credit Agreement") of even date herewith between the Borrower
and the Lender, except to the extent such capitalized terms are otherwise
defined or limited herein.
Section 1. Manner of Borrowing Revolving Loans.
(a) Advances. Advances hereunder shall be made in
accordance with Section 1.2 of the Credit Agreement.
(b) Amount of Advance. Notwithstanding any term or
provision of this Note which may be construed to the contrary, each Base Rate
Advance shall be in a principal amount of no less than $250,000 and in integral
multiples of $5,000, and each LIBOR Advance shall be in a principal amount of no
less than $500,000 and in integral multiples of $100,000.
(c) Revolving Loans. Subject to the terms and conditions
hereof and of the Credit Agreement, the Borrower may borrow up to the maximum
principal amount above stated, repay all or any portion thereof, and reborrow up
to such amount on a revolving basis. Such borrowings, to the extent not
evidenced by other notes, shall be evidenced by this Note and shall be subject
to its terms and the terms of the Credit Agreement.
(d) Revolving Loans in Excess of Advance Rate. If at any
time the Revolving Loans outstanding exceed the Advance Rate, or any other
applicable limitation set forth in the Credit Agreement, such Revolving Loans
shall nevertheless
<PAGE> 99
constitute Obligations that are secured by the Collateral and are entitled to
all benefits thereof.
Section 2. Repayment.
(a) The principal balance of the Revolving Loans then
outstanding shall be due and payable in full on the Maturity Date.
Notwithstanding the foregoing, however, in the event the Revolving Loans
outstanding shall at any time and for any reason exceed the Advance Rate, the
Borrower shall immediately pay to the Lender an amount equal to the difference
between the Revolving Loans and the Advance Rate, which payment shall constitute
a pro rata prepayment of the Revolving Loans evidenced by this Note.
(b) Prepayments of this Note may be made only as provided
in the Credit Agreement.
Section 3. Interest. The Borrower shall pay interest on the daily
outstanding principal balance of this Note in accordance with Section 1.3 of the
Credit Agreement. Interest on each Advance hereunder shall be calculated on the
basis of three hundred and sixty days per year for the actual number of days
elapsed, and, to the extent accrued, shall be paid in arrears by the Borrower
monthly on the last day of each month, commencing on August 1, 1998, until the
principal amount of this Note has been paid in full. The entire principal amount
hereof, together with all accrued and unpaid interest hereon, shall be due and
payable on the Maturity Date.
Section 4. Upon Default. If an Event of Default shall have
occurred and shall be continuing, the Lender shall have the option (but shall
not be required to give prior notice thereof to the Borrower, to accelerate the
maturity of this Note, or exercise any other rights or remedies hereunder in
connection with this right) to charge interest on the outstanding principal
balance of this Note at the Default Rate from the date of such Event of Default.
In addition, upon the occurrence and during the continuance of an Event of
Default, the Lender shall have all the rights and remedies set forth in the
Credit Agreement.
Section 5. Manner of Payment. The principal hereof and interest
hereon shall be payable in lawful money of the United States of America, at the
Lender's principal office in Atlanta, Georgia, or at such other place as the
Lender may designate in writing to the Borrower. All payments hereunder received
from the Borrower by the Lender shall be applied to the Obligations as set forth
in the Credit Agreement.
Section 6. Collateral. This Note is secured by Security Documents
of even date herewith between the Lender, the Borrower or its Subsidiaries.
Section 7. Fees. All parties liable for the payment of this Note
agree to pay the Lender reasonable attorneys' fees for the services of counsel
employed to collect this Note, whether or not suit be brought and whether
incurred in connection with collection, trial, appeal or otherwise, and to
indemnify and hold the Lender harmless
-2-
<PAGE> 100
against liability for the payment of state intangible, documentary and recording
taxes, and other taxes (including interest and penalties, if any) which may be
determined to be payable with respect to this transaction.
Section 8. Interest. In no event shall the amount of interest due
or payable hereunder exceed the maximum rate of interest allowed by Applicable
Law, and in the event any such payment is inadvertently paid by the Borrower or
inadvertently received by the Lender, then such excess sum shall be credited as
a payment of principal, unless the Borrower shall notify the Lender, in writing,
that the Borrower elects to have such excess sum returned to it forthwith. It is
the express intent hereof that the Borrower not pay and the Lender not receive,
directly or indirectly, in any manner whatsoever, interest in excess of that
which may be lawfully paid by the Borrower under Applicable Law.
Section 9. Remedies.
(a) The remedies of the Lender as provided herein and in
any Loan Documents or other documents governing or securing repayment hereof
shall be cumulative and concurrent and may be pursued singly, successively or
together, at the sole discretion of the Lender and may be exercised as often as
occasion therefor shall arise.
(b) No act of omission or commission of the Lender,
including specifically (but without limitation) any failure to exercise any
right, remedy or recourse, shall be effective unless set forth in a written
document executed by the Lender, and then only to the extent specifically
recited therein. A waiver or release with reference to one event shall not be
construed as continuing, as a bar to, or as a waiver or release of any
subsequent right, remedy or recourse as to any subsequent event.
(c) The Borrower hereby (a) waives demand, presentment of
payment, notice of nonpayment, protest, notice of protest and all other notice,
filing of suit and diligence in collecting this Note, or in enforcing any of its
rights under any guaranties securing the repayment hereof; (b) agrees to any
substitution, addition, or release of any party or Person primarily or
secondarily liable hereon; (c) agrees that the Lender shall not be required
first to institute any suit, or to exhaust its remedies against the Borrower or
any other Person or party to become liable hereunder, or against any Collateral
in order to enforce payment of this Note; (d) consents to any extension,
rearrangement, renewal or postponement of time of payment of this Note and to
any other indulgence with respect hereto without notice, consent or
consideration to any of them; and (e) agrees that, notwithstanding the
occurrence of any of the foregoing (except with the express written release by
the Lender or any such Person), the Borrower shall be and remain directly and
primarily liable for all sums due under this Note.
Section 10. Borrower and Lender. Whenever used in this Note, the
words "Borrower" and "Lender" shall be deemed to include the Borrower and the
Lender
-3-
<PAGE> 101
named in the opening paragraph of this Note, and their respective successors
and assigns. It is expressly understood and agreed that the Lender shall never
be construed for any purpose as a partner, joint venturer, co-principal or
associate of the Borrower, or of any Person or party claiming by, through or
under the Borrower in the conduct of their respective businesses.
Section 11. Time is of the Essence. Time is of the essence of this
Note.
Section 12. Governing Law. This Note shall be construed and
enforced in accordance with the laws of the State of Georgia.
Section 13. Loan Documents. All references herein to any document,
instrument or agreement shall be deemed to refer to such document, instrument or
agreement as the same may be amended, modified, restated, supplemented or
replaced from time to time.
Section 14. No Novation. THIS AMENDED AND RESTATED REVOLVING LOAN
PROMISSORY NOTE IS MADE AND GIVEN IN REPLACEMENT OF THAT CERTAIN REVOLVING LOAN
PROMISSORY NOTE DATED AS OF MARCH 28, 1997, IN THE ORIGINAL PRINCIPAL AMOUNT OF
$10,000,000.00, ISSUED BY THE BORROWER TO THE ORDER OF THE LENDER AND IS NOT
INTENDED TO BE A NOVATION.
IN WITNESS WHEREOF, the undersigned Borrower has executed
this instrument under seal as of the day and year first above written.
MEDIRISK, INC.
By:
-----------------------------------
Title:
--------------------------------
<PAGE> 102
EXHIBIT H
FORM OF SECURITY AGREEMENT
THIS AMENDED AND RESTATED SECURITY AGREEMENT dated as of June ___,
1998, is executed and delivered by MEDIRISK, INC., a Delaware corporation, with
an office located at Two Piedmont Center, Suite 400, 3565 Piedmont Road, N.E.,
Atlanta, Georgia 30305-1502 (the "Company"), in favor of NATIONSBANK, N.A., with
an office located at 600 Peachtree Street, N.E., Atlanta, Georgia 30308 (the
"Lender").
RECITALS
WHEREAS, the Company and the Lender are parties to that certain
Credit Agreement dated as of March 25, 1997 (the "Prior Credit Agreement"); and
WHEREAS, to secure the Obligations (as defined in the Prior Loan
Agreement), the Company and the Lender executed and delivered that certain
Security Agreement dated as of March 25, 1997 (the "Prior Security Agreement");
and
WHEREAS, the Company and the Lender have agreed to amend and
restate the Prior Loan Agreement to, among other things, increase the principal
amount of the Commitment (as defined therein), all as set forth in that certain
Amended and Restated Credit Agreement of even date herewith between the Company
and the Lender (as amended, restated, supplemented or otherwise modified from
time to time, the "Credit Agreement"); and
WHEREAS, it is a condition precedent to the closing of the Credit
Agreement that the Company shall have granted the security interest contemplated
by this Agreement;
NOW, THEREFORE, in consideration of the above premises and for
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged by the Company, the Company and the Lender hereby agree that
the Prior Security Agreement is hereby amended and restated in its entirety as
follows:
SECTION 1. GRANT OF SECURITY. To secure the prompt and complete
payment, observance and performance when due (whether at stated maturity, by
acceleration or otherwise) of all of the Obligations, the Company hereby
collaterally assigns and pledges to the Lender, and grants to the Lender, a
security interest and Lien in and upon, the Collateral (as hereinafter defined).
SECTION 2. REPRESENTATIONS AND WARRANTIES. The Company hereby
represents and warrants to the Lender as follows:
(a) Name: Taxpayer ID Number. The exact legal name of the Company
is set forth in the introductory paragraph of this Agreement. The Company does
not conduct, and, during the five-year period immediately preceding the date of
this Agreement, has not conducted, business under any trade name or other
fictitious name other than those set forth on Schedule 2(a) attached hereto. The
Internal Revenue Service taxpayer identification number, of the Company is
58-2256400.
<PAGE> 103
(b) Incorporation by Reference. Each representation and warranty
given by the Company as a Borrower set forth in the Credit Agreement and the
other Loan Documents, including, without limitation, Article 3 of the Credit
Agreement are hereby incorporated by reference herein as of the date hereof.
(c) Liens. None of the Collateral or other properties of the
Company is, as of the date hereof, subject to any Lien, except Permitted Liens.
No financing statement under the Uniform Commercial Code of any jurisdiction
which names the Company as debtor and covers any of the Collateral or any other
notice filed in the public records indicating the existence of a Lien thereon,
has been filed and is still effective in any state or other jurisdiction, and
the Company has not signed any such financing statement or notice or any
security agreement authorizing any Person to file any such financing statement
or notice.
(d) Intellectual Property. Schedule 2(d) attached hereto sets
forth a description all patents, patent rights and licenses, patent
applications, trademarks, trademark rights, trade names, trade name rights,
copyrights and other intellectual property and rights with respect to the
foregoing which are owned or possessed by the Company, and the same are not in
conflict with the rights of any other Person.
(e) Chief Executive Office. The chief executive office and
principal place of business of the Company and the books and records relating to
the Accounts and the other Collateral are located at the Company's office set
forth above. Schedule 2(e) sets forth the addresses of such offices and
principal place of business for the five-year period immediately preceding the
date hereof.
(f) Places of Business. The addresses (including the applicable
counties) of all of the places of business of the Company are set forth on
Schedule 2(f) attached hereto. Schedule 2(f) also sets forth a true, complete
and correct list of (i) all leases for real property in which inventory of the
Company is shared (together with the name and mailing address of each such
Lessor with respect thereto) and (ii) the name and address of each location at
which Inventory of the Company is shared with a reprocessor, warehouseman or
other bailee (together with the name and address of each such reprocessor,
warehouseman or bailee with respect thereto).
(g) Inventory. All Inventory (as hereinafter defined) is in good
condition, meets all standards imposed by any governmental agency, or department
or division thereof, having regulatory authority over such goods, their use or
sale, and is currently either usable or salable in the normal course of the
Company's business. All Inventory is located on one or more of the places set
forth on Schedule 2(f) attached hereto or is in transit to one of such
locations.
(h) Equipment. All Equipment (as hereinafter defined) of the
Company is in good order and repair and is located on or at one or more of the
places set forth on Schedule 2(f) attached hereto.
(i) Security Interest. It is the intent of the Company that this
Agreement create a valid and perfected first priority security interest (subject
only to Permitted Liens) in the Collateral, securing the payment of the
Obligations, and all filings and other actions necessary or desirable to perfect
such security interest under the Uniform Commercial Code as enacted in any
relevant jurisdiction have been duly taken.
(j) Title to Properties. The Company has good, marketable and
legal title to its properties and assets, including, but not limited to, those
reflected on the balance sheet of the
2
<PAGE> 104
Company, as at [MARCH 31, 1998], except those which have been disposed of by the
Company subsequent to such date in the ordinary course of business.
(k) Accounts. The originals of all chattel paper that evidence the
Accounts of the Company have been delivered to the Lender. None of the Accounts
of the Company is evidenced by a promissory note or other instrument, other than
a note or other instrument which has been delivered to the Lender.
SECTION 3. CONTINUED PRIORITY OF SECURITY INTEREST.
(a) The Security Interest shall at all times be valid, perfected
and of first priority (subject only to Permitted Liens) and enforceable against
the Company and all other Persons, in accordance with the terms of this
Agreement, as security for the Obligations.
(b) The Company shall, at its sole cost and expense, take all
action that may be necessary or desirable, or that the Lender may reasonably
request, so as at all times to maintain the validity, perfection, enforceability
and priority of the Security Interest in conformity with the requirements of
Section 3(a), or to enable the Lender to exercise or enforce its rights
hereunder, including, without limitation:
(i) Paying all taxes, assessments and other claims lawfully
levied or assessed on any of the Collateral, except to the extent
that such taxes, assessments and other claims constitute Permitted
Liens;
(ii) Obtaining landlords', mortgagees', mechanics', bailees',
warehousemen's or processors' releases, subordinations or waivers
with respect to any or all of the Collateral, in form and
substance satisfactory to the Lender;
(iii) Delivering to the Lender, endorsed or accompanied by
such instruments of assignment as the Lender may specify any and
all chattel paper, instruments, letters of credit and all other
advice of guaranty and documents evidencing or forming a part of
the Collateral;
(iv) At the request of the Lender from time to time, deliver
to the Lender complete and up-to-date copies of all Collateral
comprised of the books, records, files, computer programs, data
processing records, information contained on any database
maintained by the Company, computer software, documents,
correspondence and other information at any time evidencing,
describing or pertaining to or in any way related to the business
or operations of the Company or any of its Subsidiaries;
(v) At the request of the Lender, marking conspicuously each
document included in the Collateral and marking all chattel paper
and each of its records pertaining to the Collateral, with a
legend, in form and substance satisfactory to the Lender,
indicating that such document, chattel paper or Collateral is
subject to the Security Interest; and
(vi) Executing and delivering financing statements,
designations, mortgages, deeds to secure debt, deeds of trust,
hypothecations, notices and assignments, in each case in form and
substance satisfactory to the Lender, relating to the creation,
validity, perfection, priority or continuation of the Security
Interest under the Uniform Commercial Code or other Applicable
Law.
3
<PAGE> 105
(c) The Lender is hereby authorized to execute and file in all
necessary and appropriate jurisdictions (as determined by the Lender) one or
more financing or continuation statements (or any other document or instrument
referred to in Section 3(b)(v) above) in the name of the Company and to sign the
Company's name thereto. The Company authorizes the Lender to file any such
financing statement, document or instrument without the signature of the Company
to the extent permitted by Applicable Law. Further, to the extent permitted by
Applicable Law, a carbon, photographic, xerographic or other reproduction of
this Agreement or of any Financing Statement is sufficient as a financing
statement.
(d) The Company shall mark its books and records as may be
necessary or appropriate to evidence, protect and perfect the Security Interest
and shall cause their financial statements to reflect the Security Interest.
SECTION 4. COVENANTS REGARDING CONTRACTS.
(a) Anything herein to the contrary notwithstanding, (i) the
Company shall remain liable under all Assigned Contracts (as hereinafter
defined) to the extent set forth therein to perform its duties and obligations
thereunder to the same extent as if this Agreement had not been executed, (ii)
the exercise by the Lender of any of its rights hereunder shall not release the
Company from any of its duties or obligations under any of the Assigned
Contracts (except to the extent that such exercise prevents the Company from
satisfying such duties and obligations) and (iii) the Lender shall not have any
duties, obligations or liability under any of the Assigned Contracts or duties
by reason of this Agreement, nor shall the Lender be obligated to perform any of
the duties or obligations of the Company thereunder, to make any payment, to
make any inquiry as to the nature or sufficiency of any payment received by the
Company or the sufficiency of any performance by any party under any such
contract or agreement, or to take any action to collect or enforce any claim for
payment assigned hereunder.
(b) The Company shall at its expense:
(i) Perform and observe all the terms and provisions of the
Assigned Contracts to be performed or observed by them, maintain
the Assigned Contracts in full force and effect to the extent of
the Company's normal business practices, and enforce the Assigned
Contracts in accordance with their terms to the extent of the
Company's normal business practices; and
(ii) Furnish to the Lender promptly upon receipt thereof
copies of all notices, requests and other documents received by
the Company under or pursuant to the Assigned Contracts, and from
time to time (A) furnish to the Lender such information and
reports regarding the Assigned Contracts as the Lender may
reasonably request and (B) upon request of the Lender, make to
each other party to the Assigned Contracts such demands and
request for information and reports or for action as the Company
is entitled to make under the Assigned Contracts.
(c) Unless expressly set forth herein, all contracts and contract
rights of the Company shall constitute Assigned Contracts and shall constitute
part of the Collateral.
4
<PAGE> 106
SECTION 5. COVENANTS REGARDING COLLATERAL GENERALLY.
(a) Verification. The Lender shall have the right at any time and
from time to time, in the name of the Lender or in the name of the Company, to
verify the validity, amount or any other matter relating to any Accounts by
mail, telephone or otherwise.
(b) Delivery of Instruments. In the event any of the Collateral
becomes evidenced by a promissory note, trade acceptance or any other
instrument, the Company shall immediately thereafter deliver such instrument to
the Lender, appropriately endorsed to the Lender.
(c) Defense of Title. The Company shall at all times be the sole
owner of each and every item of Collateral and shall defend, at its sole cost
and expense, its title in and to, and the Security Interest of the Lender in,
the Collateral against the claims and demands of all Persons.
(d) Maintenance of Collateral. The Company shall maintain all
physical property that constitutes Collateral in good and workable condition,
with reasonable allowance for wear and tear, and shall exercise proper custody
over all such property.
(e) Insurance. The Company shall, at its own expense, maintain
insurance with respect to the Collateral in such amounts, against such risks, in
such form and with such insurers, as set forth in the Credit Agreement.
(f) Location of Office. The Company's chief executive office,
principal place of business and its books and records relating to the Collateral
shall continue to be kept at the address of the Company set forth above, and the
Company shall not change the location of such office and place of business or
such books and records without giving the Lender thirty (30) days' prior written
notice thereof.
(g) Location of Collateral. All Inventory, other than Inventory in
transit to any such location, and all Equipment shall at all times be kept by
the Company at the locations set forth on Schedule 2(f), and shall not, without
the thirty (30) days' prior written notice to the Lender, be removed therefrom
except in connection with sales thereof in the ordinary course of business.
(h) Change of Name, Structure, Etc. Without giving the Lender
thirty (30) days' prior written notice, the Company shall not (i) change its
name, identity or structure or (ii) conduct business under any trade name or
other fictitious name other than those set forth on Schedule 2(a).
(i) Records Relating to Collateral. The Company shall at all times
keep complete and accurate records of Inventory, Equipment and other Collateral.
(j) Inspection. The Lender (by any of its officers, employees or
agents) shall have the right, to the extent that the exercise of such right
shall be within the control of the Company, at any time or times during normal
business hours: (i) to inspect the Collateral, all files relating thereto and
the premises upon which any of the Collateral is located, (ii) to discuss the
Company's affairs and finances, insofar as the same are reasonably related to
the rights of the Lender hereunder with any Person, to verify the amount,
quantity, value and condition of, or any other matter relating to, any of the
Collateral and (iii) to review, audit and make extracts from all records and
files related to any of the Collateral.
5
<PAGE> 107
(k) Other Information. The Company shall furnish to the Lender
such other information with respect to the Collateral as the Lender may
reasonably request from time to time.
(l) Payments Directly to Lender. The Lender may at any time and
from time to time following the occurrence and during the continuation of an
Event of Default notify, or request the Company to notify, in writing or
otherwise, any account debtor or other obligor with respect to any one or more
of the Accounts or Assigned Contracts to make payment to the Lender or any agent
or designee of the Lender directly, at such address as may be specified by the
Lender. If, notwithstanding the giving of any notice, any account debtor or
other such obligor shall make payment to the Company, the Company shall hold all
such payments it receives in trust for the Lender, without commingling the same
with other funds or property of or held by the Company, and shall promptly
deliver the same to the Lender, or any such agent or designee, immediately upon
receipt by the Company in the identical form received, together with any
necessary endorsements.
(m) Sale of Collateral. Except as permitted under the terms of the
Credit Agreement, the Company shall not sell, transfer, convey or dispose of any
Collateral outside the ordinary course of its business; provided, however, that
the Company may dispose of its Inventory in the ordinary course of its business
so long as no Default or Event of Default shall have occurred. The inclusion of
"proceeds" of the Collateral under the Security Interest shall not be deemed a
consent by the Lender to any other sale or other disposition of any part or all
of the Collateral.
(n) Proceeds of Collateral. The Company shall account fully and
faithfully for, and, following the occurrence and during the continuation of an
Event of Default, upon the Lender's request, promptly pay or turn over to the
Lender, proceeds in whatever form received in disposition in any manner of any
of the Collateral. To the extent practicable, the Company shall at all times
keep the Collateral and proceeds thereof separate and distinct from other
property of the Company and shall keep accurate and complete records of the
Collateral and proceeds thereof.
SECTION 6. THE LENDER APPOINTED ATTORNEY-IN-FACT. The Company
hereby irrevocably appoints the Lender the Company's attorney-in-fact, with full
authority in the place and stead of the Company and in the name of the Company
or otherwise, following the occurrence and during the continuation of an Event
of Default from time to time in the Lender's discretion, to take any action and
to execute any instrument or document which the Lender may deem necessary or
advisable to accomplish the purposes of this Agreement and to exercise any
rights and remedies the Lender may have under this Agreement or Applicable Law,
including, without limitation: (i) to obtain and adjust insurance required to be
maintained pursuant to Section 5(e) hereof; (ii) to ask, demand, collect, sue
for, recover, compromise, receive and give acquittance and receipts for moneys
due and to become due under or in respect of any of the Collateral, including,
without limitation, any Account; (iii) to receive, endorse and collect any
drafts or other instruments, documents and chattel paper, in connection with
clause (i) or (ii) above; (iv) to sell or assign any Account upon such terms,
for such amount and at such time or times as the Lender may deem advisable, to
settle, adjust, compromise, extend or renew any Account or to discharge and
release any Account; and (v) to file any claims or take any action or institute
any proceedings which the Lender may deem necessary or desirable for the
collection of any of the Collateral or otherwise to enforce the rights of the
Lender with respect to any of the Collateral. The power-of-attorney granted
hereby shall be irrevocable and coupled with an interest.
6
<PAGE> 108
SECTION 7. THE LENDER MAY PERFORM. If the Company fails to perform
any agreement contained herein, the Lender may, without notice to the Company,
itself perform, or cause performance of, such agreement, and the expenses of the
Lender incurred in connection therewith shall be payable by the Company under
Section 12 hereof.
SECTION 8. THE LENDER'S DUTIES. The powers conferred on the Lender
hereunder are solely to protect its interest in the Collateral and shall not
impose any duty upon the Lender to exercise any such powers. Except for the safe
custody of any Collateral in its possession and the accounting for moneys
actually received by it hereunder, the Lender shall have no duty as to any
Collateral. The Lender shall be deemed to have exercised reasonable care in the
custody of the Collateral in its possession if the Collateral is accorded
treatment substantially equal to that which the Lender accords its own property;
it being understood that the Lender shall be under no obligation to take any
necessary steps to preserve rights against prior parties or any other rights
pertaining to any Collateral, but may do so at its option, and all reasonable
expenses incurred in connection therewith shall be for the sole account of the
Company and shall be added to the Obligations.
SECTION 9. REMEDIES. The Lender may take any or all of the
following actions upon the occurrence and during the continuation of an Event of
Default.
(a) Inventory and Equipment.
(i) Entry. The Lender may enter upon any premises on which
Inventory or Equipment may be located and, without resistance or
interference by the Company, take physical possession of any or
all thereof and maintain such possession on such premises or move
the same or any part thereof to such other place or places as the
Lender shall choose, without being liable to the Company on
account of any loss, damage or depreciation that may occur as a
result thereof, other than for actions that were not taken in good
faith.
(ii) Assembly. The Company shall, upon request of and without
charge to the Lender, assemble the Inventory and Equipment and
maintain or deliver it into the possession of the Lender or any
agent or representative of the Lender at such place or places as
the Lender may reasonably designate.
(iii) Warehousing. The Lender may, at the expense of the
Company, cause any of the Inventory and Equipment to be placed in
a public or field warehouse, and the Lender shall not be liable to
the Company on account of any loss, damage or depreciation that
may occur as a result thereof, other than for actions that were
not taken in good faith.
(b) Use of Premises and Intellectual Property. The Lender
may:
(i) without notice, demand or other process, and without
payment of any rent or any other charge enter any of the Company's
premises and, without breach of the peace, until the Lender
completes the enforcement of its rights in the Collateral, take
possession of such premises or place custodians in exclusive
control thereof, remain on such premises and use the same and any
of the Company's equipment; and
(ii) in the exercise of the rights of the Lender under this
Agreement, without payment or compensation of any kind, use any
and all trademarks, trade
7
<PAGE> 109
styles, trade names, patents, patent applications, licenses,
franchises and the like to the extent of the rights of the Company
therein, and the Company hereby grants a license to the Lender for
this purpose.
(c) Lock Boxes. The Lender may establish or cause to be
established one or more lock boxes or other arrangement for the deposit of
proceeds of Accounts, and, in such case, the Company shall cause to be forwarded
to the Lender at the Lender's office set forth above, on a daily basis,
collection reports in form and substance satisfactory to the Lender.
(d) Rights as a Secured Creditor. The Lender may exercise all of
the rights and remedies of a secured party under the Uniform Commercial Code and
under any other Applicable Law, including, without limitation, the right,
without notice except as specified below and with or without taking possession
thereof, to sell the Collateral or any part thereof in one or more parcels at
public or private sale at any location chosen by the Lender, for cash, on credit
or for future delivery, and at such price or prices and upon such other terms as
the Lender may deem commercially reasonable. The Company agrees that, to the
extent notice of sale shall be required by law, at least ten (10) days' notice
to the Company of the time and place of any public sale or the time after which
any private sale is to be made shall constitute reasonable notification, but
notice given in any other reasonable manner or at any other reasonable time
shall constitute reasonable notification. The Lender shall not be obligated to
make any sale of Collateral regardless of notice of sale having been given. The
Lender may adjourn any public or private sale from time to time by announcement
at the time and place fixed therefor, and such sale may, without further notice,
be made at the time and place to which it was so adjourned. The Lender may bid
all or any portion of the Obligations at any such sale.
(e) Waiver of Marshaling. The Company hereby waives any right to
require any marshaling of assets and any similar right.
(f) Appointment of Receiver. The Lender shall be entitled to the
appointment of a receiver, without notice of any kind whatsoever and without
regard to the adequacy of any security for the Obligations or the solvency of
any party bound for its payment, to take possession of all or any portion of the
Collateral and the business operations of the Company and to exercise such power
as the court shall confer upon such receiver.
(g) Accounts/Assigned Contracts. The Lender shall have the
exclusive right to assert, either directly or on behalf of the Company, any and
all rights and claims the Company may have under any Accounts and any of the
Assigned Contracts as the Lender may deem proper and to receive and collect any
and all Accounts and Assigned Contracts and any and all rent, fees, damages,
awards and other monies arising thereunder or resulting therefrom and to apply
the same on account of any of the Obligations.
SECTION 10. APPLICATION OF PROCEEDS. All proceeds from each sale
of, or other realization upon, all or any part of the Collateral following an
Event of Default, and all insurance proceeds payable by reason of any damage or
destruction of any of the Collateral, shall be applied or paid over as follows:
(a) First: to the payment of all costs and expenses incurred in
connection with such sale or other realization, including reasonable attorneys'
fees if the Lender endeavored to collect the Obligations by or through an
attorney at law;
8
<PAGE> 110
(b) Second: to the payment of the accrued interest upon the
Revolving Loans as provided in the Credit Agreement;
(c) Third: to the payment of the outstanding principal of the
Revolving Loans as provided in the Credit Agreement;
(d) Fourth: to the payment of the remaining outstanding
Obligations as provided in the Credit Agreement; and
(e) Fifth: the balance (if any) of such proceeds shall be paid to
the Company or to whomsoever may be legally entitled thereto.
The Company shall remain liable and shall pay, on demand, any deficiency
remaining in respect of the Obligations, together with interest thereon at a
rate per annum equal to the highest rate then payable under the Credit Agreement
on such Obligations, which interest shall constitute part of the Obligations.
SECTION 11. RIGHTS CUMULATIVE. The rights and remedies of the
Lender under this Agreement, the Credit Agreement and the other Loan Documents
shall be cumulative and not exclusive of any rights or remedies which it would
otherwise have, including, but not limited to, those rights afforded by the
Uniform Commercial Code and other Applicable Laws. In exercising its rights and
remedies the Lender may be selective, and no failure or delay by the Lender in
exercising any right shall operate as a waiver of it, nor shall any single or
partial exercise of any power or right preclude its other or further exercise or
the exercise of any other power or right.
SECTION 12. EXPENSES. The Company shall pay, on demand, all
reasonable out-of-pocket expenses incurred by the Lender in connection with: (a)
the negotiation, preparation, execution, delivery and administration of this
Agreement and any document or instrument evidencing any of the Obligations
whenever the same shall be executed and delivered, including all appraisers'
fees, search fees, recording fees, intangibles and stamp taxes payable by the
Lender with respect to the Obligations and this Agreement and the Security
Interest created hereby and the fees and disbursements of counsel for the
Lender, and of each local counsel retained by the Lender; (b) the restructuring,
refinancing or "workout" of the transactions contemplated hereby and of the
Obligations, and the preparation, negotiation, execution and delivery of any
waiver, amendment or consent by the Lender relating to this Agreement or the
Obligations, including, without limitation, the fees, out-of-pocket expenses and
other disbursements of counsel to the Lender; (c) the collection or enforcement
of the Obligations including reasonable fees and disbursements of counsel to the
Lender if such collection or enforcement is done through or by an attorney; and
(d) the exercise by the Lender of any right or remedy granted to it under this
Agreement whether or not a Default or Event of Default has occurred, including,
without limitation, the expenses incurred by the Lender in connection with the
collection of Accounts directly from account debtors.
SECTION 13. AMENDMENTS, ETC. No amendment or waiver of any
provision of this Agreement nor consent to any departure by the Company here
from shall in any event be effective unless the same shall be in writing and
signed by the parties hereto, and then such waiver or consent shall be effective
only in the specific instance and for the specific purpose for which given.
SECTION 14. NOTICES. Unless otherwise provided herein,
communications provided for hereunder shall be in writing and shall be mailed,
telecopied or delivered, to each party at
9
<PAGE> 111
the address specified for such party in the Credit Agreement. All such notices
and other communications to the Company shall be effective upon satisfaction of
the conditions set forth for similar notices in the Credit Agreement.
SECTION 15. CONTINUING SECURITY INTEREST. This Agreement shall
create a continuing security interest in the Collateral and shall (i) remain in
full force and effect until indefeasible payment in full of the Obligations,
(ii) be binding upon the Company, its successors and assigns and (iii) inure the
benefit of the Lender, and its successors and assigns. The Company's successors
and assigns shall include, without limitation, a receiver, trustee or
debtor-in-possession thereof or therefor. Upon the indefeasible payment in full
of all of the Obligations, the Security Interest granted hereby shall terminate
and all rights to the Collateral shall revert to the Company. Upon any such
termination, the Lender shall at the Company's expense, execute and deliver to
the Company such documents as the Company shall reasonably request to evidence
such termination.
SECTION 16. APPLICABLE LAW; SEVERABILITY. THIS AGREEMENT SHALL BE
GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF GEORGIA
APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE
(WITHOUT REGARD TO ANY CONFLICT OF LAWS PROVISIONS THAT INDICATE THE
APPLICABILITY OF ANY OTHER LAWS). Whenever possible, each provision of this
Agreement shall be interpreted in such a manner as to be effective and valid
under Applicable Law, but if any provision of this Agreement shall be prohibited
by or invalid under Applicable Law, such provisions shall be ineffective only to
the extent of such prohibition or invalidity, without invalidating the remainder
of such provisions or the remaining provisions of this Agreement.
SECTION 17. LITIGATION/WAIVERS. (a) THE LENDER AND THE COMPANY
BOTH ACKNOWLEDGE AND AGREE THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS
AGREEMENT OR THE RELATIONSHIP OF THE COMPANY AND THE LENDER ESTABLISHED HEREBY
AND THE DOCUMENTS AND INSTRUMENTS EVIDENCING THE OBLIGATIONS WOULD BE BASED UPON
DIFFICULT AND COMPLEX ISSUES. ACCORDINGLY, TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, EACH OF THE LENDER AND THE COMPANY HEREBY WAIVES ITS RESPECTIVE
RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING OF ANY KIND OR NATURE IN
ANY COURT OR TRIBUNAL IN WHICH AN ACTION MAY BE COMMENCED BY OR AGAINST THE
COMPANY OR THE LENDER ARISING OUT OF THIS AGREEMENT, THE OBLIGATIONS OR ANY
OTHER DOCUMENT EXECUTED AND DELIVERED IN CONNECTION HEREWITH OR THEREWITH OR IN
CONNECTION WITH THE COLLATERAL OR THE SECURITY INTEREST THEREIN OR BY REASON OF
ANY OTHER CAUSE OR DISPUTE WHATSOEVER BETWEEN THE COMPANY AND THE LENDER OF ANY
KIND OR NATURE.
(b) THE COMPANY AND THE LENDER EACH HEREBY AGREE THAT THE FEDERAL
COURT OF THE NORTHERN DISTRICT OF GEORGIA, OR AT THE OPTION OF LENDER, ANY STATE
COURT LOCATED IN FULTON COUNTY, GEORGIA, SHALL HAVE JURISDICTION TO HEAR AND
DETERMINE ANY CLAIMS OR DISPUTES BETWEEN THE COMPANY AND THE LENDER, PERTAINING
DIRECTLY OR INDIRECTLY TO THIS AGREEMENT, THE OBLIGATIONS OR TO ANY MATTER
ARISING THEREFROM, THE COLLATERAL OR THE SECURITY INTEREST THEREIN OR ANY OTHER
DOCUMENT EXECUTED AND DELIVERED IN CONNECTION HEREWITH OR THEREWITH. THE COMPANY
EXPRESSLY SUBMIT
10
<PAGE> 112
AND CONSENTS IN ADVANCE TO SUCH JURISDICTION IN ANY ACTION OR PROCEEDING
COMMENCED IN SUCH COURTS. THE CHOICE OF FORUM SET FORTH IN THIS PARAGRAPH SHALL
NOT BE DEEMED TO PRECLUDE THE BRINGING OF ANY ACTION BY THE LENDER OR THE
ENFORCEMENT BY THE LENDER OF ANY JUDGMENT OBTAINED IN SUCH FORUM IN ANY OTHER
APPROPRIATE JURISDICTION.
(c) FURTHER, THE COMPANY WAIVES (I) ANY NOTICE PRIOR TO THE TAKING
POSSESSION OR CONTROL OF THE COLLATERAL OR ANY POSTING OF ANY BOND OR SECURITY
WHICH MIGHT BE REQUIRED BY ANY COURT PRIOR TO ALLOWING THE LENDER TO EXERCISE
ANY OF THE LENDER'S REMEDIES SET FORTH HEREIN, INCLUDING THE ISSUANCE OF AN
IMMEDIATE WRIT OF POSSESSION AND (II) THE BENEFIT OF ALL VALUATION, APPRAISEMENT
AND EXEMPTION LAWS.
(d) THE FOREGOING WAIVERS HAVE BEEN MADE WITH THE ADVICE OF
COUNSEL AND WITH A FULL UNDERSTANDING OF THE LEGAL CONSEQUENCES THEREOF.
SECTION 18. INDEMNIFICATION. The Company agrees to indemnify the
Lender, from and against any and all liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, costs, expenses or disbursements of any
kind or nature whatsoever which may at any time be imposed on, incurred by or
asserted against the Lender in any way relating to or arising out of the
operation of the Company's business, any action taken by the Lender with respect
to any Account or Assigned Contract pursuant to this Agreement or any other
action taken by the Lender pursuant to the terms of this Agreement; provided,
however, that the Company shall not be liable for any portion of such
liabilities, obligations, losses, damages, penalties, actions, judgments, suits,
costs, expenses or disbursements resulting solely from the Lender's gross
negligence or willful misconduct. Without limiting the generality of the
foregoing, the Company agrees to reimburse the Lender promptly upon demand for
any out-of-pocket expenses (including counsel fees of the counsel(s) of the
Lender's own choosing) incurred by the Lender in connection with the
preparation, execution, administration, or enforcement of, or legal advice with
respect to the rights or responsibilities of the parties under, this Agreement,
any suit or action brought by the Lender to enforce the terms of this Agreement,
any "lender liability" suit or claim brought against the Lender, and any claim
or suit brought against the Lender arising under any Federal or state
environmental statute, rule or regulation including, without limitation, the
Superfund Act, or the Federal Resource Conservation and Recovery Act of 1976, as
amended. Such out-of-pocket expenses (including counsel fees) shall be advanced
by the Company on the request of the Lender notwithstanding any claim or
assertion that the Lender is not entitled to indemnification hereunder upon
receipt of an undertaking by the Lender that the Lender will reimburse the
Company if it is actually and finally determined by a court of competent
jurisdiction that the Lender is not so entitled to indemnification. The
agreements in this Section shall survive the termination of this Agreement. The
Lender agrees to give the Company prompt notice of any suit or cause of action
brought against the Lender which is covered by this Section.
SECTION 19. COUNTERPARTS. This Agreement may be executed in
several counterparts, each of which shall be an original and all of which, taken
together, shall constitute but one and the same instrument.
11
<PAGE> 113
SECTION 20. DEFINITIONS. (a) For the purposes of this Agreement:
"Accounts" means all accounts and any and all rights to the
payment of money or other forms of consideration of any kind (whether classified
under the Uniform Commercial Code as accounts, chattel paper, general
intangibles, or otherwise) for goods sold or leased or for services rendered
including, but not limited to, accounts receivable, proceeds of any letters of
credit naming the Company as beneficiary, all contract rights, notes, drafts,
instruments, documents, acceptances in favor of the Company, and all other
debts, obligations and liabilities in whatever form owing by any Person to the
Company.
"Agreement" means this Amended and Restated Security Agreement, as
the same may be amended, supplemented, restated or otherwise modified from time
to time.
"Assigned Contract" means any contract or agreement to which the
Company is a party or which runs in favor of the Company and which constitutes
part of the Collateral.
"Collateral" means all of the Company's right, title and interest
in and to each of the following, wherever located and whether now or hereafter
existing, or now owned or hereafter acquired or arising:
(a) all Accounts;
(b) all Inventory;
(c) all Equipment;
(d) all general intangibles of the Company of every kind and
nature including, but not limited to, all contract rights, rights under
warranties and service contracts, choses in action and causes of action of the
Company against any Person or property, all tax refunds owing to the Company,
all insurance policies of the Company and all rights of the Company to receive
monies thereunder and all licenses, franchises, trademarks, trade names, trade
secrets, patents, copyrights and any and all other intellectual property of the
Company;
(e) all investment property of the Company, including, without
limitation, all securities, whether certificated or uncertificated, security
entitlements, securities accounts, commodity contracts and commodity accounts;
(f) all rights of the Company as an unpaid vendor or lienor
(including, without limitation, stoppage in transit, replevin and reclamation)
with respect to any Inventory or other properties of the Company;
(g) all chattel paper, documents and instruments of the Company
including all documents of title and certificates of insurance;
(h) all books, records, files, computer programs, data processing
records, information contained within any database maintained by the Company,
computer software, documents, correspondence and other information at any time
evidencing, describing or pertaining to or in any way related to any of the
foregoing or otherwise pertaining or relating to the business or operations of
the Company;
(i) any and all balances, credits, deposits, accounts, items and
monies of the Company now or hereafter with the Lender or any affiliate of the
Lender or deposited with the
12
<PAGE> 114
Lender or any financial institution selected by the Lender pursuant to any lock
box, deposit, escrow or other collection agreement or otherwise, and all
property of the Company of every kind and description now or hereafter in the
possession or control of the Lender or any Lender for any reason; and
(j) any and all products and proceeds of any of the foregoing
(including, but not limited to, any claims to any items referred to in this
definition, and any claims of the Company against third parties for loss of,
damage to or destruction of, any or all of the Collateral or for proceeds
payable under, or unearned premiums with respect to, policies of insurance) in
whatever form, including, but not limited to, cash, instruments, general
intangibles, investment property, accounts, equipment, inventory, farm products,
other goods, documents and chattel paper and all proceeds of such proceeds.
"Company" has the meaning set forth in the first paragraph hereof.
"Default" means any of the events specified in the definition of
Event of Default, whether or not there has been satisfied any requirement for
giving of notice, lapse of time or the happening of any other condition.
"Equipment" means all equipment, machinery, apparatus, fittings,
fixtures, furniture, signage and other tangible personal property (other than
Inventory) of every kind and description used in the Company's business
operations or owned by the Company or in which the Company may have an interest,
and all parts, accessories and special tools and all increases and accessions
thereto and substitutions and replacements therefor.
"Financing Statements" means any and all financing statements
executed and delivered by or on behalf of the Company in connection with the
perfection of the Security Interest, together with any amendments thereto and
any continuations thereof.
"Inventory" means (a) all inventory of the Company and all goods
intended for sale or lease by the Company, or for display or demonstration; (b)
all work-in-process; (c) all raw materials and other materials and supplies of
every nature and description used or which might be used in connection with the
manufacture, packing, shipping, advertising, selling, leasing or furnishing of
such goods or otherwise used or consumed in the Company's business; and (d) all
documents relating to any of the foregoing.
"Lender" has the meaning set forth in the first paragraph hereof.
"Lien", as applied to the property of any Person, means any
security interest, lien, encumbrance, mortgage, deed to secure debt, deed of
trust, pledge, charge, conditional sale or other title retention agreement, or
other encumbrance of any kind covering any property of such Person, or upon the
income or profits therefrom or any agreement to convey any of the foregoing or
any other agreement or interest covering the property of a Person which is
intended to provide collateral security for the obligation of such Person.
"Security Interest" means the Lien of the Lender upon, and the
collateral assignments to the Lender of, the Collateral effected hereby or
pursuant to the terms hereof.
"Uniform Commercial Code" shall mean the Uniform Commercial Code
as in effect in the State of Georgia, as the same may be amended from time to
time.
13
<PAGE> 115
(b) Unless otherwise set forth herein to the contrary, all terms
not otherwise defined herein and which are defined in the Uniform Commercial
Code are used herein with the meanings ascribed to them in the Uniform
Commercial Code.
(c) Capitalized terms used herein and not defined herein are used
herein with the meaning ascribed to them in the Credit Agreement.
[SIGNATURES ON NEXT PAGE]
14
<PAGE> 116
IN WITNESS WHEREOF, the Company has caused this Agreement to be
duly executed and delivered under seal by its duly authorized officers as of the
day first above written.
COMPANY:
MEDIRISK, INC.
By:
----------------------------------
Name:
-----------------------------
Title:
----------------------------
Agreed and accepted as of the date first written above.
NATIONSBANK, N.A.
By:
--------------------------------
Name:
------------------------------
Title:
-----------------------------
<PAGE> 117
EXHIBIT J
SUBSIDIARY GUARANTY
This SUBSIDIARY GUARANTY (this "Guaranty") is made as of this ___
day of June, 1998, as follows:
RECITALS
WHEREAS, Medirisk, Inc., a Delaware corporation (the
"Company") and NationsBank, N.A. (the "Lender") have entered into that certain
Amended and Restated Credit Agreement dated as of June __, 1998 (as the same may
be amended, supplemented or otherwise modified from time to time, the "Credit
Agreement") pursuant to which the Lender has agreed to make certain financial
accommodations to the Company in an aggregate principal amount not to exceed
$25,000,000 (the "Revolving Loans"), as evidenced by that certain Revolving Loan
Promissory Note issued by the Company to the order of the Lender (as such note
may be amended, modified, extended or renewed from time to time being
hereinafter referred to as the "Revolving Note"); and
WHEREAS, the entities listed on Exhibit A attached hereto,
and those additional entities that hereafter become parties hereto by executing
the form of Supplement attached hereto as Annex 1 (collectively, the
"Guarantors") are Subsidiaries of the Company; and
WHEREAS, the Company and the Guarantors are mutually
dependent on each other in the conduct of their respective businesses as an
integrated operation; and
WHEREAS, each of the Guarantors has determined that its
execution, delivery and performance of this Guaranty directly benefit, and are
within the corporate purposes and in the best interests of such Guarantor; and
WHEREAS, as a condition to the closing of the Credit
Agreement and the making of Revolving Loans thereunder, the Guarantors have
agreed to execute this Subsidiary Guaranty (the "Guaranty") guaranteeing the
payment and performance by the Subsidiaries of their Obligations (as defined in
the Loan Agreement) under the Revolving Note, the Credit Agreement and the other
Loan Documents executed by the Company (collectively, as such may be amended,
modified or extended from time to time, hereinafter referred to as the
"Guaranteed Agreements");
NOW, THEREFORE, in consideration of the above premises,
Ten Dollars ($10.00) in hand paid and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Guarantors hereby
guarantee to the Lender: (i) the full and prompt payment and performance of all
obligations of the Company to the Lender under the Guaranteed Agreements
(including, without limitation, any interest fees and other charges in respect
of the Guaranteed Agreements that would accrue but for the filing of a
bankruptcy action with respect to the Company, whether or not such claim is
allowed in such bankruptcy action); (ii) payment of any and all damages which
the Lender may suffer by reason of a breach of any obligation, covenant or
undertaking with respect to this Guaranty or any of the Guaranteed Agreements;
(iii) payment and performance of all of the obligations of any obligor to
<PAGE> 118
the Lender under this Guaranty and the Guaranteed Agreements, or as a result of
making the Revolving Loans; and (iv) any extensions, renewals or amendments of
any of the foregoing, however created, acquired, arising or evidenced, whether
direct or indirect, absolute or contingent, now or hereafter existing, or due or
to become due, including any interest thereon, plus reasonable attorneys' fees
and expenses if the obligations represented by this Guaranty are collected by
law, through an attorney-at-law, or under advice therefrom (all of the foregoing
obligations (i), (ii), (iii) and (iv) being hereinafter collectively referred to
as the "Obligations").
Each of the Guarantor and the Lender hereby further agree
that:
1. Capitalized terms used herein and not otherwise
defined shall have the meanings ascribed thereto in the Credit Agreement.
2. Regardless of whether any proposed guarantor or
any other Person or Persons is or are or shall become in any other way
responsible to the Lender for or in respect of the Obligations or any part
thereof, and regardless of whether or not any Person or Persons now or hereafter
responsible to the Lender for the Obligations or any part thereof, whether under
this Guaranty or otherwise, shall cease to be so liable, each Guarantor hereby
declares and agrees that this Guaranty shall be a several obligation, shall be a
continuing guaranty and shall be operative and binding until the earlier of such
time as (i) the Obligations shall have been paid or performed in full and the
Commitment shall have terminated or (ii) each Guarantor shall have satisfied all
of its obligations under this Guaranty.
3. Upon the execution and delivery of this Guaranty
to the Lender, this Guaranty shall be deemed to be finally executed and
delivered by each Guarantor and shall not be subject to or affected by any
promise or condition affecting or limiting such Guarantor's liability, and no
statement, representation, agreement or promise on the part of the Lender or the
Company, or either of them, or any officer, employee or agent thereof, unless
contained herein, forms any part of this Guaranty or has induced the making
thereof or shall be deemed in any way to affect such Guarantor's liability
hereunder.
4. No alteration or waiver of this Guaranty or of
any of its terms, provisions or conditions shall be binding upon the parties
against whom enforcement is sought unless made in writing and signed by an
authorized officer of such party.
5. The Lender may from time to time, without
exonerating or releasing any Guarantor in any way under this Guaranty, (i) take
such further or other security or securities for the Obligations or any part
thereof as the Lender may deem proper, (ii) release, discharge, abandon or
otherwise deal with or fail to deal with any guarantor of the Obligations or any
security or securities therefor or any part thereof now or hereafter held by the
Lender or (iii) amend, modify, extend, accelerate or waive in any manner any of
the provisions, terms, or conditions of the Guaranteed Agreements, all as the
Lender may consider expedient or appropriate in its sole discretion. Without
limiting the generality of the foregoing, or of Paragraph 6 hereof, it is
understood that the Lender may, without exonerating or releasing any Guarantor,
give up, modify or abstain from perfecting or taking advantage of any security
for the Obligations and accept or make any compositions or arrangements, and
realize upon
-2-
<PAGE> 119
any security for the Obligations when, and in such manner, and with or without
notice, all as the Lender may deem expedient.
6. Each Guarantor acknowledges and agrees that no
change in the nature or terms of the Obligations or any of the Guaranteed
Agreements, or other agreements, instruments or contracts evidencing, related to
or attendant with the Obligations (including any novation), shall discharge all
or any part of the liabilities and obligations of such Guarantor pursuant to
this Guaranty; it being the purpose and intent of each Guarantor and the Lender
that the covenants, agreements and all liabilities and obligations of such
Guarantor hereunder are absolute, unconditional and irrevocable under any and
all circumstances. Without limiting the generality of the foregoing, each
Guarantor agrees that until each and every one of the covenants and agreements
of this Guaranty is fully performed, such Guarantor's undertakings hereunder
shall not be released, in whole or in part, by any action or thing which might,
but for this paragraph of this Guaranty, be deemed a legal or equitable
discharge of a surety or guarantor, or by reason of any waiver, omission of the
Lender or its failure to proceed promptly or otherwise, or by reason of any
action taken or omitted by the Lender whether or not such action or failure to
act varies or increases the risk of, or affects the rights or remedies of, such
Guarantor or by reason of any further dealings between the Company on the one
hand and the Lender on the other hand or any other guarantor or surety, and each
Guarantor hereby expressly waives and surrenders any defense to its liability
hereunder based upon, and shall be deemed to have consented to, any of the
foregoing acts, omissions, things, agreements or waivers.
7. The Lender, without demand or notice of any kind
upon or to any Guarantor, at any time or from time to time when any amount shall
be due and payable hereunder by any Guarantor, if the Company shall not have
timely paid any of the Obligations after the lapse of any applicable cure
period, shall appropriate and apply to any portion of the Obligations hereby
guaranteed, and in such order of application as provided for in the Credit
Agreement, any property, balances, credit accounts or moneys of any Guarantor in
the possession of the Lender, or any affiliate of the Lender, or under its
control for any purpose.
8. The creation or existence from time to time of
Obligations in excess of the amount committed to or outstanding on the date of
this Guaranty is hereby authorized, without notice to any Guarantor, and shall
in no way impair or affect this Guaranty or the rights of the Lender herein. It
is the intention of each Guarantor and the Lender that each Guarantor's
obligations hereunder shall be equal to, but not in excess of, the maximum
amount permitted by applicable Federal or state bankruptcy, insolvency,
fraudulent conveyance or transfer, or other Applicable Laws. To that end, but
only to the extent such obligations would otherwise be subject to avoidance
under the Applicable Laws if any Guarantor is not deemed to have received
valuable consideration, fair value or reasonably equivalent value for its
obligations under this Guaranty, such Guarantor's obligations under this
Guaranty shall be reduced to that amount which, after giving effect hereto,
would not render such Guarantor insolvent, or leave such Guarantor with
unreasonably small capital to conduct its business or cause such Guarantor to
have incurred debts (or intended to have incurred debts) beyond its ability to
pay such debts as they mature, at the time such obligations are deemed to have
been incurred under the Applicable Laws. As used herein, the terms "insolvent"
-3-
<PAGE> 120
and "unreasonably small capital" shall likewise be determined in accordance with
the Applicable Laws.
9. Upon the bankruptcy or winding up or other
distribution of assets of the Company or of any surety or guarantor, or any of
the Guarantors, for any Obligations of the Company to the Lender, the Lender's
rights against all other Guarantors shall not be affected or impaired by the
Lender's omission to prove its claim, as appropriate, or to prove its full
claim, as appropriate, and the Lender may prove such claims as it sees fit, and
may refrain from proving any claim and, in its sole discretion, may value as it
sees fit or refrain from valuing any security held by it, without in any way
releasing, reducing or otherwise affecting the liability of any Guarantor
hereunder.
10. Any amount received by the Lender from whatsoever
source and applied toward the payment of the Obligations shall be applied as
provided for in the Credit Agreement.
11. Each Guarantor hereby expressly waives: (a)
notice of acceptance of this Guaranty; (b) notice of any liabilities,
indebtedness or Obligations to which it may apply, presentment, demand for
payment, protest, notice of dishonor or nonpayment of any liabilities; (c)
notice of intent to accelerate, notice of acceleration and notice of any suit or
the taking of other action by the Lender against the Company, any Guarantor or
any other person, any applicable statute of limitations and any other notice to
any party liable on any Loan Document (including Guarantor); (d) any claim,
right or remedy which such Guarantor may now have or hereafter acquire against
the Company that arises hereunder or from the performance by any other
guarantor, including, without limitation, any claim, remedy or right of
subrogation, reimbursement, exoneration, contribution, indemnification, or
participation in any claim, right or remedy of the Lender against the Company or
against any security which the Lender now has or hereafter acquires, whether or
not such claim, right or remedy arises in equity, under contract, by statute,
under common law or otherwise; and (e) the benefits of any provision of law
requiring that the Lender exhaust any right or remedy, or take any action,
against the Company, any other guarantor, any other person or property.
The Lender may at any time and from time to time (whether
before or after revocation or termination of this Guaranty) without notice to
the Guarantors (except as required by law), without incurring responsibility to
the Guarantors, without impairing, releasing or otherwise affecting the
obligations of the Guarantors, in whole or in part, and without the indorsement
or execution by any Guarantor of any additional consent, waiver or guaranty: (a)
change the manner, place or terms of payment, or change or extend the time of or
renew, or change any interest rate or alter any liability or Obligation or
installment thereof, or any security therefor; (b) loan additional monies or
extend additional credit to the Company, with or without security, thereby
creating new Obligations the payment or performance of which shall be guaranteed
hereunder, and the Guaranty herein made shall apply to the Obligations as so
changed, extended, surrendered, realized upon or otherwise altered; (c) sell,
exchange, release, surrender, realize upon or otherwise deal with in any manner
and in any order any property at any time pledged or mortgaged to secure the
Obligations and any offset there against; (d) exercise or refrain from
exercising any rights against the Company or others (including
-4-
<PAGE> 121
any Guarantor) or act or refrain from acting in any other manner; (e) settle or
compromise any Obligation or any security therefor and subordinate the payment
of all or any part thereof to the payment of any Obligation of any other parties
primarily or secondarily liable on any of the Obligations; (f) release or
compromise any liability of the Guarantor hereunder or any liability or
obligation of any other parties primarily or secondarily liable on any of the
Obligations; or (g) apply any sums from any sources to any liability without
regard to any liabilities remaining unpaid.
12. The Lender may, to the extent permitted under
the Credit Agreement, sell, assign or transfer all or any part of the
Obligations, and in such event each and every immediate and successive assignee,
transferee or holder of all or any of the Obligations, shall have the right to
enforce this Guaranty, by suit or otherwise, for the benefit of such assignee,
transferee or holder as fully as if such assignee, transferee or holder were
herein by name specifically given such rights, powers and benefits, but the
Lender shall have an unimpaired right, prior and superior to that of any such
assignee, transferee or holder, to enforce this Guaranty for the benefit of the
Lender, as to so much of the Obligations as the Lender shall have not sold,
assigned or transferred.
13. No failure to exercise, and no delay in
exercising, any right hereunder or under any of the other Loan Documents held by
the Lender shall operate as a waiver thereof, nor shall any single or partial
exercise of any such right preclude any other or future exercise thereof or the
exercise of any other right. The rights and remedies of the Lender provided
herein and in the other Loan Documents are cumulative and are in addition to,
and not exclusive of, any rights or remedies provided by law. The rights and
remedies of the Lender hereunder or under any other Loan Documents against any
party thereto are not conditional or contingent on any attempt by the Lender to
exercise any of its rights under any other Loan Document against such party or
against any other Person.
14. This Guaranty shall be binding upon each
Guarantor, its successors and assigns and inure to the benefit of the
successors and assigns of the Lender. No Guarantor shall assign its rights or
obligations under this Guaranty without the prior written consent of the
Lender.
15. This is a guaranty of payment not of collection.
In the event the Lender makes a demand upon any Guarantor under this Guaranty,
such Guarantor shall be held and bound to the Lender directly as debtor in
respect of the payment of the amounts hereby guaranteed. All costs and expenses,
including reasonable attorneys' fees and expenses, incurred by the Lender in
obtaining performance of or collecting payments due under this Guaranty to the
extent permitted by the Credit Agreement, shall be deemed part of the
Obligations guaranteed hereby. Any notice or demand which the Lender may wish to
give shall be served upon the Guarantors in the fashion prescribed for notices
in Section 8.1 of the Credit Agreement, and the notice so sent shall be deemed
to be served as set forth in Section 8.1 of the Credit Agreement, to the address
of such Guarantor set forth on Exhibit A hereto or on any Supplement attached to
this Guaranty in accordance with Section 21 hereof.
16. Each Guarantor expressly represents and
acknowledges that any financial accommodations by the Lender to the Company,
including, without limitation,
-5-
<PAGE> 122
the extension of the Revolving Loans, are and will be of direct interest,
benefit and advantage to such Guarantor.
17. Each Guarantor covenants and agrees that so long
as any amount is owing on account of the Revolving Loans, the Revolving Note or
otherwise pursuant to this Guaranty, such Guarantor shall permit, as provided in
the Credit Agreement with respect to the Company, representatives of the Lender
to visit and inspect properties of such Guarantor, inspect such Guarantor's
books and records and discuss with the principal officers of such Guarantor its
businesses, assets, liabilities, financial positions, results of operations and
business prospects.
18. This Guaranty shall be construed in accordance
with and governed by the internal laws of the State of Georgia applicable to
contracts made and to be performed wholly within such state. This Guaranty,
together with all documents referred to herein, constitutes the entire agreement
between the Guarantors and the Lender with respect to the subject matter hereof
and may not be modified except by a writing executed by the Guarantors and the
Lender, and no waiver of any provision of this Guaranty, and no consent to any
departure by the Guarantors therefrom, shall in any event be effective unless
the same shall be in writing and signed by the Lender and then such waiver or
consent shall be effective only in the specific instance and for the specific
purpose for which given. This Guaranty shall be binding upon each Guarantor and
its successors and assigns, and shall inure to the benefit of the Lender and its
successors and assigns.
19. In the event any term or condition contained
herein is inconsistent with the terms and conditions contained in the Credit
Agreement, the terms and conditions of the Credit Agreement shall control.
20. Whenever possible each provision of this
Guaranty shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Guaranty shall be prohibited or
invalid under such law, such provision shall be ineffective only to the extent
of such prohibition or invalidity, without invalidating the remainder of such
provision of this Guaranty.
21. Pursuant to Section 4.9 of the Credit Agreement,
any new Subsidiary (whether by acquisition, creation or designation) of the
Company is required to enter into this Guaranty by executing and delivering to
the Lender an instrument in the form of Annex 1 attached hereto (a
"Supplement"). Upon the execution and delivery of a Supplement by such new
Subsidiary, such Subsidiary shall become a Guarantor hereunder with the same
force and effect as if originally named as a Guarantor herein. The execution and
delivery of any instrument adding an additional Guarantor as a party to this
Guaranty shall not require the consent of any other Guarantor hereunder. The
rights and obligations of each Guarantor hereunder shall remain in full force
and effect notwithstanding the addition of any new Guarantor hereunder.
IN WITNESS WHEREOF, the Guarantors have caused this Guaranty to be
executed and sealed as of the date first above written.
-6-
<PAGE> 123
GUARANTORS: MEDIRISK OF ILLINOIS, INC.
By:
-----------------------------------
Its:
-------------------------------
MEDIRISK OF MISSOURI, INC.
By:
-----------------------------------
Its:
-------------------------------
CIVS, INC.
By:
-----------------------------------
Its:
-------------------------------
CAREDATA REPORTS, INC.
By:
-----------------------------------
Its:
-------------------------------
MEDSOURCE, INC.
By:
-----------------------------------
Its:
-------------------------------
HEALTHDEMOGRAPHICS, INC.
By:
-----------------------------------
Its:
-------------------------------
SUCCESSFUL SOLUTIONS, INC.
By:
-----------------------------------
Its:
-------------------------------
SWEETWATER HEALTH ENTERPRISES, INC.
By:
-----------------------------------
Its:
-------------------------------
-7-
<PAGE> 124
Exhibit A
to Subsidiary Guaranty
Name Address
Medirisk of Missouri, Inc.
CIVS, INC.
CareData Reports, Inc.
Medsource, Inc.
HealthDemographics, Inc.
Successful Solutions, Inc.
-8-
<PAGE> 125
ANNEX 1
Supplement No. __ (this "Supplement") dated as of ________ to the
Subsidiary Guaranty dated as of June __, 1998 (as amended, modified or
supplemented, the "Subsidiary Guaranty") by each of the parties listed on the
signature pages thereto and those additional entities that thereafter become
parties thereto (each a "Guarantor") and NationsBank, N.A. (the "Lender").
WITNESSETH:
WHEREAS, Medirisk, Inc., a Delaware corporation (the "Company")
and the Lender are parties to that certain Amended and Restated Credit Agreement
dated as of June __, 1998, (as the same may be amended from time to time, the
"Credit Agreement"), pursuant to which the Lenders have agreed to make loans and
provide other financial accommodations to the Company (the "Loans"), as
evidenced by those certain promissory notes issued or to be issued by the
Company to the Lender (as such notes may be amended, modified, extended, or
renewed from time to time, the "Notes");
WHEREAS, the Guarantors have entered into the Subsidiary Guaranty
in order to induce the Lender to make, or to continue to make, the Loans; and
WHEREAS, pursuant to Section 4.9 of the Credit Agreement, new
Subsidiaries of the Company (whether by acquisition, creation, or designation),
must execute and deliver certain Loan Documents, including the Subsidiary
Guaranty, and the execution of the Subsidiary Guaranty by the undersigned new
Subsidiary or Subsidiaries (collectively, the "New Guarantor") may be
accomplished by the execution of this Supplement in favor of the Lender;
WHEREAS, capitalized terms used herein and not otherwise defined
herein shall have the meanings assigned to such terms in the Subsidiary
Guaranty;
NOW, THEREFORE, for and in consideration of the foregoing and
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the New Guarantor hereby agrees as follows:
SECTION 1. In accordance with Section 21 of the Guaranty, the New
Guarantor, by its signature below, becomes a 'Guarantor' under the Subsidiary
Guaranty with the same force and effect as if originally named therein as a
'Guarantor' and the New Guarantor hereby (a) agrees to all of the terms and
provisions of the Subsidiary Guaranty applicable to it as a 'Guarantor'
thereunder and (b) represents and warrants that the representations and
warranties made by it as a 'Guarantor' thereunder are true and correct on and as
of the date hereof. In furtherance of the foregoing, the New Guarantor, as
security for the payment and performance in full of the Obligations, does hereby
guarantee to the Lender the full and prompt payment of the Obligations pursuant
to the Credit Agreement, the Revolving Note and every other Loan Document,
including, without limitation, all costs and expenses, including reasonable
attorneys' fees and expenses, incurred by the Lender in obtaining performance of
or collecting payments due under the Guaranty to the extent permitted by the
Credit Agreement. Each reference to a 'Guarantor' in the Subsidiary Guaranty
shall be deemed to include the New Guarantor. The Subsidiary Guaranty is
incorporated herein by reference.
<PAGE> 126
SECTION 2. The New Guarantor represents and warrants to the Lender
that this Supplement has been duly executed and delivered by the New Guarantor
and constitutes its legal, valid and binding obligation, enforceable against it
in accordance with its terms, except as enforceability thereof may be limited by
bankruptcy, insolvency, reorganization, fraudulent transfer, moratorium or other
similar laws affecting creditors' rights generally and general principles of
equity (regardless of whether such enforceability is considered in a proceeding
at law or in equity).
SECTION 3. This Supplement may be executed in multiple
counterparts, each of which shall be deemed to be an original, but all such
separate counterparts shall together constitute but one and the same instrument.
SECTION 4. Except as expressly supplemented hereby, the Subsidiary
Guaranty shall remain in full force and effect.
SECTION 5. This Supplement shall be construed and interpreted in
accordance with the laws of the State of Georgia.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
-10-
<PAGE> 127
IN WITNESS WHEREOF, the New Guarantor has duly executed this
Supplement to the Subsidiary Guaranty as of the day and year first above
written.
NEW GUARANTOR: [Name of New Guarantor]
By:
--------------------------
Name:
------------------------
Address: Title:
----------------------- -----------------------
-----------------------
-----------------------
------------------------------
By:
--------------------------
Name:
------------------------
Address: Title:
-----------------------
-----------------------
-----------------------
-----------------------
<PAGE> 128
EXHIBIT K
FORM OF SUBSIDIARY SECURITY AGREEMENT
THIS AMENDED AND RESTATED SUBSIDIARY SECURITY
AGREEMENT dated as of June ____, 1998 (as amended, restated, supplemented or
otherwise modified from time to time, this "Agreement), is executed and
delivered by each of the undersigned (each, a "Guarantor" and collectively, the
"Guarantors"), as a direct or indirect Subsidiary of Medirisk, Inc., a Delaware
corporation (the "Company"), with an office located at Two Piedmont Center,
Suite 400, 3565 Piedmont Road, N.E., Atlanta, Georgia 30305-1502, in favor of
NationsBank, N.A. (the "Lender"), with an office located at 600 Peachtree
Street, N.E., Atlanta, Georgia 30308-4899.
RECITALS
WHEREAS, the Company and the Lender are parties to that
certain Credit Agreement dated as of March 25, 1997 (the "Prior Credit
Agreement"); and
WHEREAS, to secure the Obligations (as defined in the
Prior Loan Agreement), each of the Guarantors has entered into and delivered in
favor of the Lender a separate Subsidiary Security Agreement (collectively, the
"Prior Subsidiary Security Agreements"); and
WHEREAS, the Company and the Lender have agreed to amend
and restate the Prior Loan Agreement to, among other things, increase the
principal amount of the Commitment (as defined therein), all as set forth in
that certain Amended and Restated Credit Agreement of even date herewith between
the Company and the Lender (as amended, restated, supplemented or otherwise
modified from time to time, the "Credit Agreement"); and
WHEREAS, each Guarantor has entered into a Subsidiary
Guaranty of even date herewith (as the same may be amended, supplemented,
restated or otherwise modified from time to time, the "Guaranty") with the
Lender; and
WHEREAS, the Guaranty secures all of the Obligations of
the Company under the Credit Agreement; and
WHEREAS, it is a condition precedent to the Lender's
extension of financial accommodations under the Credit Agreement that each
Guarantor grant, as additional security for all obligations of the Guarantor to
the Lender, a security interest in and to the Collateral (as hereinafter
defined);
NOW, THEREFORE, in consideration of the above premises and
for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged by each Guarantor, each Guarantor and the Lender hereby
agree that each of the Prior Subsidiary Security Agreements are hereby
consolidated herein and are hereby amended and restated in their entirety as
follows:
SECTION 1. GRANT OF SECURITY. To secure the prompt
and complete payment, observance and performance of all of the obligations of
the Guarantor to the
<PAGE> 129
Lender under this Agreement and the Guaranty, each Guarantor hereby collaterally
assigns and pledges to the Lender, and grants to the Lender, a security interest
and Lien in and upon, the Collateral owned by such Guarantor.
SECTION 2. REPRESENTATIONS AND WARRANTIES. Each
Guarantor hereby represents and warrants to the Lender as follows:
(a) Name: Taxpayer ID Number. The exact legal name
of such Guarantor is set forth in the introductory paragraph of this Agreement.
Such Guarantor does not conduct, and, during the five-year period immediately
preceding the date of this Agreement, has not conducted, business under any
trade name or other fictitious name other than those set forth on Schedule 2(a)
attached hereto. The Internal Revenue Service taxpayer identification number, of
such Guarantor is set forth on Schedule 2(a) attached hereto.
(b) Incorporation by Reference. Each representation
and warranty given by the Company as a Borrower on behalf of such Guarantor, as
a Subsidiary of the Company, as set forth in the Credit Agreement and the other
Loan Documents, including, without limitation, Article 3 of the Credit
Agreement, are hereby incorporated by reference herein as of the date hereof.
(c) Liens. None of the Collateral or other
properties of such Guarantor is, as of the date hereof, subject to any Lien,
except Permitted Liens. No financing statement under the Uniform Commercial Code
of any jurisdiction which names such Guarantor as debtor and covers any of the
Collateral or any other notice filed in the public records indicating the
existence of a Lien thereon, has been filed and is still effective in any state
or other jurisdiction, and such Guarantor has not signed any such financing
statement or notice or any security agreement authorizing any Person to file any
such financing statement or notice.
(d) Intellectual Property. Schedule 2(d) attached
hereto sets forth a description all patents, patent rights and licenses, patent
applications, trademarks, trademark rights, trade names, trade name rights,
copyrights and other intellectual property and rights with respect to the
foregoing which are owned or possessed by such Guarantor, and the same are not
in conflict with the rights of any other Person.
(e) Chief Executive Office. The chief executive
office and principal place of business of such Guarantor and the books and
records relating to the Accounts and the other Collateral are located at such
Guarantor's office set forth above. Schedule 2(e) sets forth the addresses of
such offices and principal place of business for the five-year period
immediately preceding the date hereof.
(f) Places of Business. The addresses (including
the applicable counties) of all of the places of business of such Guarantor
are set forth on Schedule 2(f) attached hereto. Schedule 2(f) also sets forth a
true, complete and correct list of (i) all leases for real property in which
inventory of such Guarantor is shared (together with the name and mailing
address of each such Lessor with respect thereto) and (ii) the name and address
of each location at which Inventory of such Guarantor is shared with a
reprocessor, warehouseman or other bailee (together with the name and address
of each such reprocessor, warehouseman or bailee with respect thereto).
-2-
<PAGE> 130
(g) Inventory. All Inventory (as hereinafter
defined) is in good condition, meets all standards imposed by any governmental
agency, or department or division thereof, having regulatory authority over such
goods, their use or sale, and is currently either usable or salable in the
normal course of such Guarantor's business. All Inventory is located on one or
more of the places set forth on Schedule 2(f) attached hereto or is in transit
to one of such locations.
(h) Equipment. All Equipment (as hereinafter
defined) of such Guarantor is in good order and repair and is located on or at
one or more of the places set forth on Schedule 2(f) attached hereto.
(i) Security Interest. It is the intent of such
Guarantor that this Agreement create a valid and perfected first priority
security interest in the Collateral owned by such Guarantor (subject only to
Permitted Liens), securing the payment of all of the obligations of the
Guarantors to the Lender under this Agreement and the Guaranty, and all filings
and other actions necessary or desirable to perfect such security interest under
the Uniform Commercial Code as enacted in any relevant jurisdiction have been
duly taken.
(j) Title to Properties. Such Guarantor has good,
marketable and legal title to its properties and assets except those which have
been disposed of by such Guarantor in the ordinary course of business.
(k) Accounts. The originals of all chattel paper
that evidence the Accounts of such Guarantor have been delivered to the Lender.
None of the Accounts of such Guarantor is evidenced by a promissory note or
other instrument, other than a note or other instrument which has been delivered
to the Lender.
SECTION 3. CONTINUED PRIORITY OF SECURITY INTEREST.
(a) The Security Interest shall at all times be
valid, perfected and of first priority (subject only to Permitted Liens) and
enforceable against each Guarantor and all other Persons, in accordance with the
terms of this Agreement, as security for all of the obligations of each
Guarantor to the Lender under this Agreement and the Guaranty.
(b) Each Guarantor shall, at its sole cost and
expense, take all action that may be necessary or desirable, or that the Lender
may reasonably request, so as at all times to maintain the validity, perfection,
enforceability and priority of the Security Interest in conformity with the
requirements of Section 3(a), or to enable the Lender to exercise or enforce its
rights hereunder including, without limitation:
(i) Paying all taxes, assessments and other claims
lawfully levied or assessed on any of the Collateral,
except to the extent that such taxes, assessments and
other claims constitute Permitted Liens;
(ii) Obtaining landlords', mortgagees', mechanics',
bailees', warehousemen's or processors' releases,
subordinations or waivers with respect to any or all of
the Collateral, in form and substance satisfactory to the
Lender;
(iii) Delivering to the Lender, endorsed or
accompanied by such instruments of assignment as the
Lender may specify any and all chattel
-3-
<PAGE> 131
paper, instruments, letters of credit and all other advice
of guaranty and documents evidencing or forming a part of
the Collateral;
(iv) At the request of the Lender from time to time,
deliver to the Lender complete and up-to-date copies of
all Collateral comprised of the books, records, files,
computer programs, data processing records, information
contained on any database maintained by such Guarantor,
computer software, documents, correspondence and other
information at any time evidencing, describing or
pertaining to or in any way related to the business or
operations of such Guarantor or any of its Subsidiaries;
(v) At the request of the Lender, marking
conspicuously each document included in the Collateral and
marking all chattel paper and each of its records
pertaining to the Collateral, with a legend, in form and
substance satisfactory to the Lender, indicating that such
document, chattel paper or Collateral is subject to the
Security Interest; and
(vi) Executing and delivering financing statements,
designations, mortgages, deeds to secure debt, deeds of
trust, hypothecations, notices and assignments, in each
case in form and substance satisfactory to the Lender,
relating to the creation, validity, perfection, priority
or continuation of the Security Interest under the Uniform
Commercial Code or other Applicable Law.
(c) The Lender is hereby authorized to execute and
file in all necessary and appropriate jurisdictions (as determined by the
Lender) one or more financing or continuation statements (or any other document
or instrument referred to in Section 3(b)(v) above) in the name of each
Guarantor and to sign each Guarantor's name thereto. Each Guarantor authorizes
the Lender to file any such financing statement, document or instrument without
the signature of such Guarantor to the extent permitted by Applicable Law.
Further, to the extent permitted by Applicable Law, a carbon, photographic,
xerographic or other reproduction of this Agreement or of any Financing
Statement is sufficient as a financing statement.
(d) Each Guarantor shall mark its books and records
as may be necessary or appropriate to evidence, protect and perfect the Security
Interest and shall cause its financial statements to reflect the Security
Interest.
SECTION 4. COVENANTS REGARDING CONTRACTS.
(a) Anything herein to the contrary notwithstanding,
(i) each Guarantor shall remain liable under all Assigned Contracts (as
hereinafter defined) to which it is a party to the extent set forth therein to
perform its duties and obligations thereunder to the same extent as if this
Agreement had not been executed, (ii) the exercise by the Lender of any of its
rights hereunder shall not release any Guarantor from any of its duties or
obligations under any of the Assigned Contracts to which it is a party (except
to the extent that such exercise prevents such Guarantor from satisfying such
duties and obligations), and (iii) the Lender shall not have any duties,
obligations or liability under any of the Assigned Contracts or duties by reason
of this Agreement, nor shall the Lender be obligated to perform any of the
duties or obligations of any Guarantor thereunder, to make any payment, to make
any inquiry as to the nature or sufficiency of any payment received by any
Guarantor or the sufficiency of any performance by any party under any such
-4-
<PAGE> 132
contract or agreement, or to take any action to collect or enforce any claim for
payment assigned hereunder.
(b) Each Guarantor shall at its expense:
(i) Perform and observe all the terms and
provisions of the Assigned Contracts to be performed or
observed by it, maintain the Assigned Contracts in full
force and effect to the extent of such Guarantor's normal
business practices, and enforce the Assigned Contracts in
accordance with their terms to the extent of such
Guarantor's normal business practices; and
(ii) Furnish to the Lender promptly upon receipt
thereof copies of all notices, requests and other
documents received by such Guarantor under or pursuant to
the Assigned Contracts, and from time to time (A) furnish
to the Lender such information and reports regarding the
Assigned Contracts as the Lender may reasonably request
and (B) upon request of the Lender, make to each other
party to the Assigned Contracts such demands and request
for information and reports or for action as such
Guarantor is entitled to make under the Assigned
Contracts.
(c) Unless expressly set forth herein, all contracts
and contract rights of each Guarantor shall constitute Assigned Contracts and
shall constitute part of the Collateral.
SECTION 5. COVENANTS REGARDING COLLATERAL GENERALLY.
(a) Verification. The Lender shall have the right at
any time and from time to time, in the name of the Lender or in the name of any
Guarantor, to verify the validity, amount or any other matter relating to any
Accounts by mail, telephone or otherwise.
(b) Delivery of Instruments. In the event any of
the Collateral becomes evidenced by a promissory note, trade acceptance or any
other instrument, the applicable Guarantor shall immediately thereafter deliver
such instrument to the Lender, appropriately endorsed to the Lender.
(c) Defense of Title. The Guarantors shall at all
times be the sole owners of each and every item of Collateral and shall defend,
at their sole cost and expense, their respective title in and to, and the
Security Interest of the Lender in, the Collateral against the claims and
demands of all Persons.
(d) Maintenance of Collateral. Each Guarantor shall
maintain all physical property that constitutes Collateral in good and workable
condition, with reasonable allowance for wear and tear, and shall exercise
proper custody over all such property.
(e) Insurance. Each Guarantor shall maintain in
force with reputable insurers acceptable to the Lender such insurance with
respect to the Collateral as is required with respect to the Company under the
Credit Agreement. Each such insurance policy shall name the Lender as additional
named loss payee to the extent of the Guarantors' obligations hereunder and
shall provide for at least thirty (30) days' prior
-5-
<PAGE> 133
written notice to the Lender of any expiration of, termination of or proposed
cancellation of such policy.
(f) Location of Office. Each Guarantor's chief
executive office, principal place of business and its books and records relating
to the Collateral shall continue to be kept at the address of such Guarantor set
forth above, and each Guarantor shall not change the location of such office and
place of business or such books and records without giving the Lender thirty
(30) days' prior written notice thereof.
(g) Location of Collateral. All Inventory, other
than Inventory in transit to any such location, and all Equipment shall at all
times be kept by the Guarantors at the locations set forth on Schedule 2(f), and
shall not, without the thirty (30) days' prior written notice to the Lender, be
removed therefrom except in connection with sales thereof in the ordinary course
of business.
(h) Change of Name, Structure, Etc. Without giving
the Lender thirty (30) days' prior written notice, none of the Guarantors shall
(i) change its name, identity or structure or (ii) conduct business under any
trade name or other fictitious name other than those set forth with respect to
such Guarantor on Schedule 2(a).
(i) Records Relating to Collateral. Each Guarantor
shall at all times keep complete and accurate records of Inventory, Equipment
and other Collateral.
(j) Inspection. The Lender (by any of its officers,
employees or agents) shall have the right, to the extent that the exercise of
such right shall be within the control of any Guarantor, at any time or times
during normal business hours: (i) to inspect the Collateral, all files relating
thereto and the premises upon which any of the Collateral is located, (ii) to
discuss such Guarantor's affairs and finances, insofar as the same are
reasonably related to the rights of the Lender hereunder with any Person, to
verify the amount, quantity, value and condition of, or any other matter
relating to, any of the Collateral and (iii) to review, audit and make extracts
from all records and files related to any of the Collateral.
(k) Other Information. Each Guarantor shall furnish
to the Lender such other information with respect to the Collateral as the
Lender may reasonably request from time to time.
(l) Payments Directly to Lender. Upon the
occurrence, and during the continuation, of an Event of Default, the Lender may
at any time and from time to time notify, or request any Guarantor to notify, in
writing or otherwise, any account debtor or other obligor with respect to any
one or more of the Accounts or Assigned Contracts to make payment to the Lender
or any agent or designee of the Lender directly, at such address as may be
specified by the Lender. If, notwithstanding the giving of any notice, any
account debtor or other such obligor shall make payment to any Guarantor, such
Guarantor shall hold all such payments it receives in trust for the Lender,
without commingling the same with other funds or property of or held by such
Guarantor, and shall promptly deliver the same to the Lender, or any such agent
or designee, immediately upon receipt by such Guarantor in the identical form
received, together with any necessary endorsements.
(m) Sale of Collateral. Except as permitted under
the terms of the Credit Agreement, none of the Guarantors shall sell, transfer,
convey or dispose of any Collateral
-6-
<PAGE> 134
outside the ordinary course of its business; provided, however, that a Guarantor
may dispose of its Inventory in the ordinary course of its business so long as
no Default or Event of Default shall have occurred. The inclusion of "proceeds"
of the Collateral under the Security Interest shall not be deemed a consent by
the Lender to any other sale or other disposition of any part or all of the
Collateral.
(n) Proceeds of Collateral. Each Guarantor shall
account fully and faithfully for, and, following the occurrence and during the
continuation of an Event of Default, upon the Lender's request, promptly pay or
turn over to the Lender, proceeds in whatever form received in disposition in
any manner of any of the Collateral. To the extent practicable, each Guarantor
shall at all times keep the Collateral and proceeds thereof separate and
distinct from other property of such Guarantor and shall keep accurate and
complete records of the Collateral and proceeds thereof.
SECTION 6. THE LENDER APPOINTED ATTORNEY-IN-FACT. Each
Guarantor hereby irrevocably appoints the Lender such Guarantor's
attorney-in-fact, with full authority in the place and stead of such Guarantor
and in the name of such Guarantor or otherwise, following the occurrence and
during the continuation of an Event of Default from time to time in the Lender's
discretion, to take any action and to execute any instrument or document which
the Lender may deem necessary or advisable to accomplish the purposes of this
Agreement and to exercise any rights and remedies the Lender may have under this
Agreement or Applicable Law, including, without limitation: (i) to obtain and
adjust insurance required to be maintained pursuant to Section 5(e) hereof; (ii)
to ask, demand, collect, sue for, recover, compromise, receive and give
acquittance and receipts for moneys due and to become due under or in respect of
any of the Collateral, including, without limitation, any Account; (iii) to
receive, endorse and collect any drafts or other instruments, documents and
chattel paper, in connection with clause (i) or (ii) above; (iv) to sell or
assign any Account upon such terms, for such amount and at such time or times as
the Lender may deem advisable, to settle, adjust, compromise, extend or renew
any Account or to discharge and release any Account; and (v) to file any claims
or take any action or institute any proceedings which the Lender may deem
necessary or desirable for the collection of any of the Collateral or otherwise
to enforce the rights of the Lender with respect to any of the Collateral. The
power-of-attorney granted hereby shall be irrevocable and coupled with an
interest.
SECTION 7. THE LENDER MAY PERFORM. If any Guarantor
fails to perform any agreement contained herein, the Lender may, without notice
to any Guarantor, itself perform, or cause performance of, such agreement, and
the expenses of the Lender incurred in connection therewith shall be payable by
the Guarantors under Section 12 hereof.
SECTION 8. THE LENDER'S DUTIES. The powers conferred on
the Lender hereunder are solely to protect its interest in the Collateral and
shall not impose any duty upon the Lender to exercise any such powers. Except
for the safe custody of any Collateral in its possession and the accounting for
moneys actually received by it hereunder, the Lender shall have no duty as to
any Collateral. The Lender shall be deemed to have exercised reasonable care in
the custody of the Collateral in its possession if the Collateral is accorded
treatment substantially equal to that which the Lender accords its own property;
it being understood that the Lender shall be under no obligation to take any
necessary steps to preserve rights against prior parties or any other rights
pertaining to any Collateral, but may do so at its option, and all reasonable
expenses incurred in
-7-
<PAGE> 135
connection therewith shall be for the sole account of the Guarantors and shall
be added to the obligations of the Guarantors secured hereunder.
SECTION 9. REMEDIES. The Lender may take any or all of the
following actions upon the occurrence and during the continuation of an Event of
Default.
(a) Inventory and Equipment.
(i) Entry. The Lender may enter upon any premises
on which Inventory or Equipment may be located and,
without resistance or interference by any Guarantor, take
physical possession of any or all thereof and maintain
such possession on such premises or move the same or any
part thereof to such other place or places as the Lender
shall choose, without being liable to any Guarantor on
account of any loss, damage or depreciation that may occur
as a result thereof, other than for actions that were not
taken in good faith.
(ii) Assembly. Each Guarantor shall, upon request of
and without charge to the Lender, assemble the Inventory
and Equipment and maintain or deliver it into the
possession of the Lender or any agent or representative of
the Lender at such place or places as the Lender may
reasonably designate.
(iii) Warehousing. The Lender may, at the expense of
the Guarantors, cause any of the Inventory and Equipment
to be placed in a public or field warehouse, and the
Lender shall not be liable to any Guarantor on account of
any loss, damage or depreciation that may occur as a
result thereof, other than for actions that were not taken
in good faith.
(b) Use of Premises and Intellectual Property. The
Lender may:
(i) without notice, demand or other process, and
without payment of any rent or any other charge enter any
of the Guarantors' premises and, without breach of the
peace, until the Lender completes the enforcement of its
rights in the Collateral, take possession of such premises
or place custodians in exclusive control thereof, remain
on such premises and use the same and any of the
Guarantors' equipment; and
(ii) in the exercise of the rights of the Lender
under this Agreement, without payment or compensation of
any kind, use any and all trademarks, trade styles, trade
names, patents, patent applications, licenses, franchises
and the like to the extent of the rights of any Guarantor
therein, and each Guarantor hereby grants a license to the
Lender for this purpose.
(c) Lock Boxes. The Lender may establish or cause to
be established one or more lock boxes or other arrangement for the deposit of
proceeds of Accounts, and, in such case, each Guarantor shall cause to be
forwarded to the Lender at the Lender's office set forth above, on a daily
basis, collection reports in form and substance satisfactory to the Lender.
(d) Rights as a Secured Creditor. The Lender may
exercise all of the rights and remedies of a secured party under the Uniform
Commercial Code and under any
-8-
<PAGE> 136
other Applicable Law, including, without limitation, the right, without notice
except as specified below and with or without taking possession thereof, to sell
the Collateral or any part thereof in one or more parcels at public or private
sale at any location chosen by the Lender, for cash, on credit or for future
delivery, and at such price or prices and upon such other terms as the Lender
may deem commercially reasonable. Each Guarantor agrees that, to the extent
notice of sale shall be required by law, at least ten (10) days' notice to any
Guarantor of the time and place of any public sale or the time after which any
private sale is to be made shall constitute reasonable notification, but notice
given in any other reasonable manner or at any other reasonable time shall
constitute reasonable notification. The Lender shall not be obligated to make
any sale of Collateral regardless of notice of sale having been given. The
Lender may adjourn any public or private sale from time to time by announcement
at the time and place fixed therefor, and such sale may, without further notice,
be made at the time and place to which it was so adjourned. The Lender may bid
all or any portion of the obligations of the Guarantors to the Lender secured
hereunder at any such sale.
(e) Waiver of Marshaling. Each Guarantor hereby
waives any right to require any marshaling of assets and any similar right.
(f) Appointment of Receiver. The Lender shall be
entitled to the appointment of a receiver, without notice of any kind whatsoever
and without regard to the adequacy of any security for all of the obligations of
the Guarantors to the Lender or the solvency of any party bound for its payment,
to take possession of all or any portion of the Collateral and the business
operations of any Guarantor and to exercise such power as the court shall confer
upon such receiver.
(g) Accounts/Assigned Contracts. The Lender shall
have the exclusive right to assert, either directly or on behalf of any
Guarantor, any and all rights and claims any Guarantor may have under any
Accounts and any of the Assigned Contracts as the Lender may deem proper and to
receive and collect any and all Accounts and Assigned Contracts and any and all
rent, fees, damages, awards and other monies arising thereunder or resulting
therefrom and to apply the same on account of any of the obligations of the
Guarantors secured hereunder.
SECTION 10. APPLICATION OF PROCEEDS. All proceeds from
each sale of, or other realization upon, all or any part of the Collateral
following an Event of Default, and all insurance proceeds payable by reason of
any damage or destruction of any of the Collateral, shall be applied or paid
over as follows:
(a) First: to the payment of all costs and expenses
incurred in connection with such sale or other realization, including reasonable
attorneys' fees if the Lender endeavored to collect the Obligations by or
through an attorney at law;
(b) Second: to the payment of the accrued interest
upon the Revolving Loans as provided in the Credit Agreement;
(c) Third: to the payment of the outstanding
principal of the Revolving Loans as provided in the Credit Agreement;
(d) Fourth: to the payment of the remaining
outstanding Obligations as provided in the Credit Agreement; and
-9-
<PAGE> 137
(e) Fifth: the balance (if any) of such proceeds
shall be paid to the Guarantors or to whomsoever may be legally entitled
thereto.
Each Guarantor shall remain liable and shall pay, on demand, any deficiency
remaining in respect of the Obligations, together with interest thereon at a
rate per annum equal to the highest rate then payable under the Credit Agreement
on such Obligations, which interest shall constitute part of the Obligations.
SECTION 11. RIGHTS CUMULATIVE. The rights and remedies
of the Lender under this Agreement, the Credit Agreement and the other Loan
Documents shall be cumulative and not exclusive of any rights or remedies which
it would otherwise have, including, but not limited to, those rights afforded by
the Uniform Commercial Code and other Applicable Laws. In exercising its rights
and remedies the Lender may be selective, and no failure or delay by the Lender
in exercising any right shall operate as a waiver of it, nor shall any single or
partial exercise of any power or right preclude its other or further exercise or
the exercise of any other power or right.
SECTION 12. EXPENSES. The Guarantors, jointly and
severally, agree to pay, on demand, all reasonable out-of-pocket expenses
incurred by the Lender in connection with: (a) the negotiation, preparation,
execution, delivery and administration of this Agreement and any document or
instrument evidencing any of the Obligations whenever the same shall be executed
and delivered, including all appraisers' fees, search fees, recording fees,
intangibles and stamp taxes payable by the Lender with respect to the
Obligations and this Agreement and the Security Interest created hereby and the
fees and disbursements of counsel for the Lender, and of each local counsel
retained by the Lender; (b) the restructuring, refinancing or "workout" of the
transactions contemplated hereby and of the Obligations, and the preparation,
negotiation, execution and delivery of any waiver, amendment or consent by the
Lender relating to this Agreement or the Obligations, including, without
limitation, the fees, out-of-pocket expenses and other disbursements of counsel
to the Lender; (c) the collection or enforcement of the Obligations including
reasonable fees and disbursements of counsel to the Lender if such collection or
enforcement is done through or by an attorney; and (d) the exercise by the
Lender of any right or remedy granted to it under this Agreement whether or not
a Default or Event of Default has occurred, including, without limitation, the
expenses incurred by the Lender in connection with the collection of Accounts
directly from account debtors.
SECTION 13. AMENDMENTS, ETC. No amendment or waiver of
any provision of this Agreement nor consent to any departure by any Guarantor
here from shall in any event be effective unless the same shall be in writing
and signed by the parties hereto, and then such waiver or consent shall be
effective only in the specific instance and for the specific purpose for which
given.
SECTION 14. NOTICES. Unless otherwise provided herein,
communications provided for hereunder shall be in writing and shall be mailed,
telecopied or delivered, to each party at the address specified for such party
on the signature pages hereof. All such notices and other communications shall
be effective upon satisfaction of the conditions set forth for similar notices
in Section 8.1 of the Credit Agreement.
SECTION 15. CONTINUING SECURITY INTEREST. This Agreement
shall create a continuing security interest in the Collateral and shall (i)
remain in full force and effect until indefeasible payment in full of the
Obligations, (ii) be binding upon each Guarantor, its successors and assigns and
(iii) inure the benefit of the Lender, and its successors and
-10-
<PAGE> 138
assigns. Each Guarantor's successors and assigns shall include, without
limitation, a receiver, trustee or debtor-in-possession thereof or therefor.
Upon the indefeasible payment in full of all of the Obligations, the Security
Interest granted hereby shall terminate and all rights to the Collateral shall
revert to the applicable Guarantor. Upon any such termination, the Lender shall
at the Guarantors' expense, execute and deliver to such Guarantor such documents
as such Guarantor shall reasonably request to evidence such termination.
SECTION 16. APPLICABLE LAW; SEVERABILITY. THIS AGREEMENT
SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF
GEORGIA APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH
STATE (WITHOUT REGARD TO ANY CONFLICT OF LAWS PROVISIONS THAT INDICATE THE
APPLICABILITY OF ANY OTHER LAWS). Whenever possible, each provision of this
Agreement shall be interpreted in such a manner as to be effective and valid
under Applicable Law, but if any provision of this Agreement shall be prohibited
by or invalid under Applicable Law, such provisions shall be ineffective only to
the extent of such prohibition or invalidity, without invalidating the remainder
of such provisions or the remaining provisions of this Agreement.
SECTION 17. LITIGATION/WAIVERS. (a) THE LENDER AND EACH
GUARANTOR ACKNOWLEDGE AND AGREE THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS
AGREEMENT OR THE RELATIONSHIP OF SUCH GUARANTOR AND THE LENDER ESTABLISHED
HEREBY AND THE DOCUMENTS AND INSTRUMENTS EVIDENCING THE OBLIGATIONS WOULD BE
BASED UPON DIFFICULT AND COMPLEX ISSUES. ACCORDINGLY, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, THE LENDER AND THE GUARANTORS EACH HEREBY WAIVE
THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING OF ANY
KIND OR NATURE IN ANY COURT OR TRIBUNAL IN WHICH AN ACTION MAY BE COMMENCED BY
OR AGAINST ANY GUARANTOR OR THE LENDER ARISING OUT OF THIS AGREEMENT, THE
OBLIGATIONS OR ANY OTHER DOCUMENT EXECUTED AND DELIVERED IN CONNECTION HEREWITH
OR THEREWITH OR IN CONNECTION WITH THE COLLATERAL OR THE SECURITY INTEREST
THEREIN OR BY REASON OF ANY OTHER CAUSE OR DISPUTE WHATSOEVER BETWEEN ANY
GUARANTOR AND THE LENDER OF ANY KIND OR NATURE.
(b) EACH GUARANTOR AND THE LENDER HEREBY AGREE
THAT THE FEDERAL COURT OF THE NORTHERN DISTRICT OF GEORGIA, OR AT THE OPTION OF
LENDER, ANY STATE COURT LOCATED IN FULTON COUNTY, GEORGIA, SHALL HAVE
JURISDICTION TO HEAR AND DETERMINE ANY CLAIMS OR DISPUTES BETWEEN SUCH GUARANTOR
AND THE LENDER, PERTAINING DIRECTLY OR INDIRECTLY TO THIS AGREEMENT, THE
OBLIGATIONS OR TO ANY MATTER ARISING THEREFROM, THE COLLATERAL OR THE SECURITY
INTEREST THEREIN OR ANY OTHER DOCUMENT EXECUTED AND DELIVERED IN CONNECTION
HEREWITH OR THEREWITH. EACH GUARANTOR EXPRESSLY SUBMITS AND CONSENTS IN ADVANCE
TO SUCH JURISDICTION IN ANY ACTION OR PROCEEDING COMMENCED IN SUCH COURTS. THE
CHOICE OF FORUM SET FORTH IN THIS PARAGRAPH SHALL NOT BE DEEMED TO PRECLUDE THE
BRINGING OF ANY ACTION BY THE LENDER OR THE ENFORCEMENT BY THE LENDER OF ANY
JUDGMENT OBTAINED IN SUCH FORUM IN ANY OTHER APPROPRIATE JURISDICTION.
-11-
<PAGE> 139
(c) FURTHER, EACH GUARANTOR WAIVES (I) ANY NOTICE
PRIOR TO THE TAKING POSSESSION OR CONTROL OF THE COLLATERAL OR ANY POSTING OF
ANY BOND OR SECURITY WHICH MIGHT BE REQUIRED BY ANY COURT PRIOR TO ALLOWING THE
LENDER TO EXERCISE ANY OF THE LENDER'S REMEDIES SET FORTH HEREIN, INCLUDING THE
ISSUANCE OF AN IMMEDIATE WRIT OF POSSESSION AND (II) THE BENEFIT OF ALL
VALUATION, APPRAISEMENT AND EXEMPTION LAWS.
(d) THE FOREGOING WAIVERS HAVE BEEN MADE WITH THE
ADVICE OF COUNSEL AND WITH A FULL UNDERSTANDING OF THE LEGAL
CONSEQUENCES THEREOF.
SECTION 18. INDEMNIFICATION. Each Guarantor agrees
to indemnify the Lender, from and against any and all liabilities, obligations,
losses, damages, penalties, actions, judgments, suits, costs, expenses or
disbursements of any kind or nature whatsoever which may at any time be imposed
on, incurred by or asserted against the Lender in any way relating to or arising
out of the operation of such Guarantor's business, any action taken by the
Lender with respect to any Account or Assigned Contract pursuant to this
Agreement or any other action taken by the Lender pursuant to the terms of this
Agreement; provided, however, that such Guarantor shall not be liable for any
portion of such liabilities, obligations, losses, damages, penalties, actions,
judgments, suits, costs, expenses or disbursements resulting solely from the
Lender's gross negligence or willful misconduct. Without limiting the generality
of the foregoing, each Guarantor agrees to reimburse the Lender promptly upon
demand for any out-of-pocket expenses (including counsel fees of the counsel(s)
of the Lender's own choosing) incurred by the Lender in connection with the
preparation, execution, administration, or enforcement of, or legal advice with
respect to the rights or responsibilities of the parties under, this Agreement,
any suit or action brought by the Lender to enforce the terms of this Agreement,
any "lender liability" suit or claim brought against the Lender, and any claim
or suit brought against the Lender arising under any Federal or state
environmental statute, rule or regulation including, without limitation, the
Superfund Act, or the Federal Resource Conservation and Recovery Act of 1976, as
amended. Such out-of-pocket expenses (including counsel fees) shall be advanced
by such Guarantor on the request of the Lender notwithstanding any claim or
assertion that the Lender is not entitled to indemnification hereunder upon
receipt of an undertaking by the Lender that the Lender will reimburse such
Guarantor if it is actually and finally determined by a court of competent
jurisdiction that the Lender is not so entitled to indemnification. The
agreements in this Section shall survive the termination of this Agreement. The
Lender agrees to give the Guarantors prompt notice of any suit or cause of
action brought against the Lender which is covered by this Section.
SECTION 19. COUNTERPARTS. This Agreement may be executed
in several counterparts, each of which shall be an original and all of which,
taken together, shall constitute but one and the same instrument.
SECTION 20. DEFINITIONS. (a) For the purposes of this
Agreement:
"Accounts" means all accounts and any and all rights to
the payment of money or other forms of consideration of any kind (whether
classified under the Uniform Commercial Code as accounts, chattel paper, general
intangibles, or otherwise) for goods sold or leased or for services rendered
including, but not limited to, accounts receivable, proceeds of any letters of
credit naming any Guarantor as beneficiary, all contract rights,
-12-
<PAGE> 140
notes, drafts, instruments, documents, acceptances in favor of any Guarantor,
and all other debts, obligations and liabilities in whatever form owing by any
Person to any Guarantor.
"Agreement" means this Amended and Restated Subsidiary
Security Agreement, as the same may be amended, supplemented, restated or
otherwise modified from time to time.
"Assigned Contract" means any contract or agreement to
which any Guarantor is a party or which runs in favor of any Guarantor and which
constitutes part of the Collateral.
"Collateral" means, with respect to each Guarantor, all of
such Guarantor's right, title and interest in and to each of the following,
wherever located and whether now or hereafter existing, or now owned or
hereafter acquired or arising:
(a) all Accounts;
(b) all Inventory;
(c) all Equipment;
(d) all general intangibles of such Guarantor of
every kind and nature including, but not limited to, all contract rights, rights
under warranties and service contracts, choses in action and causes of action of
such Guarantor against any Person or property, all tax refunds owing to such
Guarantor, all insurance policies of such Guarantor and all rights of such
Guarantor to receive monies thereunder and all licenses, franchises, trademarks,
trade names, trade secrets, patents, copyrights and any and all other
intellectual property of such Guarantor;
(e) all investment property of such Guarantor,
including, without limitation, all securities, whether certificated or
uncertificated, security entitlements, securities accounts, commodity contracts
and commodity accounts;
(f) all rights of such Guarantor as an unpaid vendor
or lienor (including, without limitation, stoppage in transit, replevin and
reclamation) with respect to any Inventory or other properties of such
Guarantor;
(g) all chattel paper, documents and instruments of
such Guarantor including all documents of title and certificates of insurance;
(h) all books, records, files, computer programs,
data processing records, information contained within any database maintained by
such Guarantor, computer software, documents, correspondence and other
information at any time evidencing, describing or pertaining to or in any way
related to any of the foregoing or otherwise pertaining or relating to the
business or operations of such Guarantor;
(i) any and all balances, credits, deposits,
accounts, items and monies of such Guarantor now or hereafter with the Lender or
any affiliate of the Lender or deposited with the Lender or any financial
institution selected by the Lender pursuant to any lock box, deposit, escrow or
other collection agreement or otherwise, and all property of such Guarantor of
every kind and description now or hereafter in the possession or control of the
Lender or any Lender for any reason; and
-13-
<PAGE> 141
(j) any and all products and proceeds of any of the
foregoing (including, but not limited to, any claims to any items referred to in
this definition, and any claims of such Guarantor against third parties for loss
of, damage to or destruction of, any or all of the Collateral or for proceeds
payable under, or unearned premiums with respect to, policies of insurance) in
whatever form, including, but not limited to, cash, instruments, general
intangibles, investment property, accounts, equipment, inventory, farm products,
other goods, documents and chattel paper and all proceeds of such proceeds.
"Default" means any of the events specified in the
definition of Event of Default, whether or not there has been satisfied any
requirement for giving of notice, lapse of time or the happening of any other
condition.
"Equipment" means all equipment, machinery, apparatus,
fittings, fixtures, furniture, signage and other tangible personal property
(other than Inventory) of every kind and description used in any Guarantor's
business operations or owned by any Guarantor or in which any Guarantor may have
an interest, and all parts, accessories and special tools and all increases and
accessions thereto and substitutions and replacements therefor.
"Financing Statements" means any and all financing
statements executed and delivered by or on behalf of any Guarantor in connection
with the perfection of the Security Interest, together with any amendments
thereto and any continuations thereof.
"Guarantor" and "Guarantors" each has the meaning set
forth in the first paragraph hereof.
"Inventory" means (a) all inventory of any Guarantor and
all goods intended for sale or lease by any Guarantor, or for display or
demonstration; (b) all work-in-process; (c) all raw materials and other
materials and supplies of every nature and description used or which might be
used in connection with the manufacture, packing, shipping, advertising,
selling, leasing or furnishing of such goods or otherwise used or consumed in
any Guarantor's business; and (d) all documents relating to any of the
foregoing.
"Lender" has the meaning set forth in the first paragraph
hereof.
"Lien", as applied to the property of any Person, means
any security interest, lien, encumbrance, mortgage, deed to secure debt, deed of
trust, pledge, charge, conditional sale or other title retention agreement, or
other encumbrance of any kind covering any property of such Person, or upon the
income or profits therefrom or any agreement to convey any of the foregoing or
any other agreement or interest covering the property of a Person which is
intended to provide collateral security for the obligation of such Person.
"Security Interest" means the Lien of the Lender upon, and
the collateral assignments to the Lender of, the Collateral effected hereby or
pursuant to the terms hereof.
"Uniform Commercial Code" shall mean the Uniform
Commercial Code as in effect in the State of Georgia, as the same may be amended
from time to time.
-14-
<PAGE> 142
(b) Unless otherwise set forth herein to the
contrary, all terms not otherwise defined herein and which are defined in the
Uniform Commercial Code are used herein with the meanings ascribed to them in
the Uniform Commercial Code.
(c) Capitalized terms used herein and not defined
herein are used herein with the meaning ascribed to them in the Credit
Agreement.
SECTION 21. NEW GUARANTORS. Pursuant to Section 4.9 of
the Credit Agreement, any new Subsidiary of the Company is required to enter
into this Agreement by executing and delivering to the Lender an instrument in
the form of Annex 1 attached hereto. Upon the execution and delivery of Annex 1
by such new Subsidiary, such Subsidiary shall become a Guarantor hereunder with
the same force and effect as if originally named as a Guarantor herein. The
execution and delivery of any instrument adding an additional Guarantor as a
party to this Agreement shall not require the consent of any other Guarantor
hereunder. The rights and obligations of each Guarantor hereunder shall remain
in full force and effect notwithstanding the addition of any new Guarantor
hereunder.
[SIGNATURES ON NEXT PAGE]
-15-
<PAGE> 143
IN WITNESS WHEREOF, each Guarantor has caused this Agreement to
be duly executed and delivered under seal by its duly authorized officers as of
the day first above written.
GUARANTORS: MEDIRISK OF MISSOURI, INC., a
Missouri corporation
Address:
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
MEDIRISK OF ILLINOIS, INC., an Indiana
corporation
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
CIVS, INC., a Maryland corporation
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
CAREDATA REPORTS, INC., a New York
corporation
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
MEDSOURCE, INC., a Minnesota
corporation
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
-16-
<PAGE> 144
HEALTHDEMOGRAPHICS, INC., a
Delaware corporation
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
SUCCESSFUL SOLUTIONS, INC., a
Delaware corporation
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
SWEETWATER HEALTH ENTERPRISES,
INC., a Texas corporation
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
Agreed and accepted as of the
date first written above.
NATIONSBANK, N.A.
By:
----------------------------
Name:
--------------------------
Title:
-------------------------
-17-
<PAGE> 145
Annex 1 to Subsidiary
Security Agreement --
Form of Supplement
Supplement No. (this "Supplement") dated as of to the
Subsidiary Security Agreement dated as of June __,
1998 (as amended, restated, supplemented or otherwise
modified from time to time, the "Subsidiary Security
Agreement") by and among each of the parties listed
on the signature pages thereto and those additional
entities that thereafter become parties thereto
(collectively, the "Guarantors") and NationsBank,
N.A. (the "Lender").
WITNESSETH:
WHEREAS, Medirisk, Inc., a Delaware corporation (the
"Company") and the Lender are parties to that certain Amended and Restated
Credit Agreement dated as of June __, 1998 (as amended, restated, supplemented
or otherwise modified from time to time, the "Credit Agreement"); and
WHEREAS, capitalized terms used herein and not otherwise
defined herein shall have the meanings assigned to such terms in the Subsidiary
Security Agreement; and
WHEREAS, the Guarantors have entered into the Subsidiary
Security Agreement in order to induce the Lender to extend credit to the Company
pursuant to the Credit Agreement; and
WHEREAS, pursuant to the provisions of Section 4.9 of the
Credit Agreement, Subsidiaries of the Company must execute and deliver to the
Lender certain Loan Documents and Security Documents, including the Subsidiary
Security Agreement, and the execution of the Subsidiary Security Agreement by
the undersigned new Subsidiary or Subsidiaries (collectively, the "New
Guarantor") may be accomplished by the execution of the Supplement in favor of
the Lender;
NOW, THEREFORE, for and in consideration of the foregoing
and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto agree as follows:
SECTION 1. In accordance with Section 21 of the Subsidiary
Security Agreement, the New Guarantor, by its signature below, becomes a
'Guarantor' under the Subsidiary Security Agreement with the same force and
effect as if originally named therein as a 'Guarantor' and the New Guarantor
hereby (a) agrees to all of the terms and provisions of the Subsidiary Security
Agreement applicable to it as a 'Guarantor' thereunder and (b) represents and
warrants that the representations and warranties made by it as a 'Guarantor'
thereunder are true and correct on and as of the date hereof. In furtherance of
the foregoing, the New Guarantor, as security for the payment and
-18-
<PAGE> 146
performance in full of the Obligations, does hereby grant and assign to the
Lender, and its successors and assigns, a continuing security interest in and
security title to all of the Collateral (as defined in the Subsidiary Security
Agreement) of the New Guarantor and all additions thereto and replacements
thereof, and all other property of the New Guarantor whether now owned or
hereafter created, acquired or reacquired. The Schedules attached hereto
supplement the Schedules to the Subsidiary Security Agreement, and shall be
deemed a part thereof for all purposes of the Subsidiary Security Agreement.
Each reference to a 'Guarantor' in the Subsidiary Security Agreement shall be
deemed to include the New Guarantor. The Subsidiary Security Agreement is
incorporated herein by reference.
SECTION 2. The New Guarantor represents and warrants to the Lender
that this Supplement has been duly executed and delivered by the New Guarantor
and constitutes its legal, valid and binding obligation, enforceable against it
in accordance with its terms, except as enforceability thereof may be limited by
bankruptcy, insolvency, reorganization, fraudulent transfer, moratorium or other
similar laws affecting creditors' rights generally and general principles of
equity (regardless of whether such enforceability is considered in a proceeding
at law or in equity).
SECTION 3. This Supplement may be executed in multiple
counterparts, each of which shall be deemed to be an original, but all such
separate counterparts shall together constitute but one and the same instrument.
SECTION 4. Except as expressly supplemented hereby, the Subsidiary
Security Agreement shall remain in full force and effect.
SECTION 5. This Supplement shall be construed and interpreted in
accordance with the internal laws of the State of Georgia applicable to
agreements to be made and performed wholly within the State of Georgia.
[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]
-19-
<PAGE> 147
IN WITNESS WHEREOF, the New Guarantor and the Lender have duly
executed this Supplement to the Subsidiary Security Agreement as of the day and
year first above written.
NEW GUARANTOR: [Name of New Guarantor]
By:
ADDRESS --------------------------------
Name:
--------------------------------
Title:
-------------------------------
LENDER: NATIONSBANK, N.A.
By:
ADDRESS --------------------------------
Name:
--------------------------------
Title:
-------------------------------
<PAGE> 1
EXHIBIT 11
MEDIRISK, INC. AND SUBSIDIARIES
STATEMENTS OF COMPUTATION OF PER SHARE LOSS
(in thousands, except per share amounts)
<TABLE>
<CAPTION>
THREE MONTHS SIX MONTHS
ENDED JUNE 30, ENDED JUNE 30,
1998 1997 1998 1997
-------- -------- -------- ---------
<S> <C> <C> <C> <C>
Net loss attributable to common stock $ (8,405) $ (2,561) $(13,031) $ (3,310)
======== ======== ======== =========
Net loss per share of common stock - basic and diluted:
Loss per share before extraordinary item $ (1.59) $ (0.63) $ (2.67) $ (0.68)
Loss per share - extraordinary item -- -- -- (0.22)
-------- -------- -------- ---------
Net loss per share of common stock $ (1.59) $ (0.63) $ (2.67) $ (0.90)
======== ======== ======== =========
Weighted average number of common shares outstanding -
basic and diluted 5,275 4,051 4,885 3,658
======== ======== ======== =========
</TABLE>
-19-
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM THE MEDIRISK, INC.
CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30,
1998 AND THE MEDIRISK, INC. CONSOLIDATED CONDENSED BALANCE SHEET AS OF JUNE 30,
1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH CONSOLIDATED
CONDENSED FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1998
<PERIOD-START> JAN-01-1998
<PERIOD-END> JUN-30-1998
<CASH> 23,460
<SECURITIES> 0
<RECEIVABLES> 6,489
<ALLOWANCES> 386
<INVENTORY> 0
<CURRENT-ASSETS> 31,447
<PP&E> 4,942
<DEPRECIATION> 1,878
<TOTAL-ASSETS> 57,027
<CURRENT-LIABILITIES> 6,239
<BONDS> 0
0
0
<COMMON> 7
<OTHER-SE> 50,754
<TOTAL-LIABILITY-AND-EQUITY> 57,027
<SALES> 10,592
<TOTAL-REVENUES> 10,592
<CGS> 0
<TOTAL-COSTS> 23,626
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 3
<INCOME-PRETAX> (13,031)
<INCOME-TAX> 0
<INCOME-CONTINUING> (13,031)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (13,031)
<EPS-PRIMARY> (2.67)
<EPS-DILUTED> (2.67)
</TABLE>
